QUARTERLY REPORT

Q1 2020 — Quarterly report

Q1 2020PDF · 93 pages725 KB
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 	10-Q
(Mark One)
☑ 	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended 	March 31, 2020
OR
☐ 	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ____ to ____
Commission file number 	001-00035
GENERAL ELECTRIC COMPANY
(Exact name of registrant as specified in its charter)
New York 	14-0689340
(State or other jurisdiction of incorporation or organization) 	(I.R.S. Employer Identification No.)
5 Necco Street 	Boston 	MA 	02210
(Address of principal executive offices) 	(Zip Code)
(Registrant’s telephone number, including area code) 	(617) 	443-3000
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 	Trading Symbol(s) 	Name of each exchange on which registered
Common stock, par value $0.06 per share 	GE 	New York Stock Exchange
Floating Rate Notes due 2020 	GE 20E 	New York Stock Exchange
0.375% Notes due 2022 	GE 22A 	New York Stock Exchange
1.250% Notes due 2023 	GE 23E 	New York Stock Exchange
0.875% Notes due 2025 	GE 25 	New York Stock Exchange
1.875% Notes due 2027 	GE 27E 	New York Stock Exchange
1.500% Notes due 2029 	GE 29 	New York Stock Exchange
7 1/2% Guaranteed Subordinated Notes due 2035 	GE /35 	New York Stock Exchange
2.125% Notes due 2037 	GE 37 	New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for
the past 90 days. 	Yes 	þ 	No 	¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of
Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes 	þ 	No 	¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an
emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in
Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer 	☑ 	Accelerated filer 	☐
Non-accelerated filer 	☐ 	Smaller reporting company 	☐
Emerging growth company 	☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 	¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes 	☐ 	No 	☑
There were 	8,747,092,000 	shares of common stock with a par value of $0.06 per share outstanding at 	March 31, 2020.

-- 1 of 93 --

TABLE OF CONTENTS
Page
About General Electric 	3
Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) 	3
Consolidated Results 	4
Segment Operations 	7
Corporate Items and Eliminations 	14
Other Consolidated Information 	16
Capital Resources and Liquidity 	17
Critical Accounting Estimates 	23
Other Items 	23
Non-GAAP Financial Measures 	24
Controls and Procedures 	28
Risk Factors 	28
Legal Proceedings 	29
Financial Statements and Notes 	30
Statement of Earnings (Loss) 	30
Statement of Financial Position 	32
Statement of Cash Flows 	34
Consolidated Statement of Comprehensive Income (Loss) 	36
Consolidated Statement of Changes in Shareholders' Equity 	36
Note 1 Basis of Presentation and Summary of Significant Accounting Policies 	37
Note 2 Businesses Held for Sale and Discontinued Operations 	38
Note 3 Investment Securities 	39
Note 4 Current and Long-Term Receivables 	41
Note 5 Financing Receivables and Allowances 	42
Note 6 Inventories 	42
Note 7 Property, Plant and Equipment 	42
Note 8 Goodwill and Other Intangible Assets 	43
Note 9 Revenues 	44
Note 10 Contract and Other Deferred Assets & Progress Collections and Deferred Income 	44
Note 11 Borrowings 	46
Note 12 Insurance Liabilities and Annuity Benefits 	47
Note 13 Postretirement Benefit Plans 	48
Note 14 Income Taxes 	48
Note 15 Shareholders' Equity 	49
Note 16 Earnings Per Share Information 	50
Note 17 Financial Instruments 	50
Note 18 Variable Interest Entities 	52
Note 19 Commitments, Guarantees, Product Warranties and Other Loss Contingencies 	52
Note 20 Intercompany Transactions 	55
Note 21 Guarantor Financial Information 	55
Note 22 Baker Hughes Summarized Financial Information 	58
Note 23 Other Income 	58
Forward-Looking Statements 	59
Exhibits 	60
Form 10-Q Cross Reference Index 	60
Signatures 	61

-- 2 of 93 --

MD&A
ABOUT GENERAL ELECTRIC
General Electric Company (General Electric or the Company) is a high-tech industrial company that operates worldwide through its four industrial segments,
Power, Renewable Energy, Aviation and Healthcare, and its financial services segment, Capital. The Power segment offers technologies, solutions, and
services related to energy production, including gas and steam turbines, generators, and power generation services. The Renewable Energy segment provides
wind turbine platforms, hardware and software, offshore wind turbines, solutions, products and services to hydropower industry, blades for onshore and offshore
wind turbines, and high voltage equipment. The Aviation segment provides jet engines and turboprops for commercial airframes, maintenance, component
repair, and overhaul services, as well as replacement parts, additive machines and materials, and engineering services. The Healthcare segment provides
healthcare technologies in medical imaging, digital solutions, patient monitoring, and diagnostics, drug discovery, and performance enhancement solutions. The
Capital segment leases and finances aircraft, aircraft engines and helicopters, provides financial and underwriting solutions, and manages our run-off insurance
operations. See the Consolidated Results section of Management’s Discussion and Analysis of Financial Condition and Results of Operations and Note 2 to the
consolidated financial statements for information regarding our recent business portfolio actions. Results of segments reclassified to discontinued operations
have been recast for all periods presented.
GE’s Internet address at www.ge.com, Investor Relations website at www.ge.com/investor-relations and our corporate blog at www.gereports.com, as well as
GE’s Facebook page, Twitter accounts and other social media, including @GE_Reports, contain a significant amount of information about GE, including
financial and other information for investors. GE encourages investors to visit these websites from time to time, as information is updated and new information is
posted.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (MD&A)
The consolidated financial statements of General Electric Company (the Company) combine the industrial manufacturing and services businesses of GE with
the financial services businesses of GE Capital or Financial Services and are prepared in conformity with U.S. generally accepted accounting principles (GAAP).
Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented in this report are calculated from the
underlying numbers in millions. Discussions throughout MD&A are based on continuing operations unless otherwise noted. The MD&A should be read in
conjunction with the Financial Statements and Notes to the consolidated financial statements. For purposes of the financial statement display of sales and costs
of sales in our consolidated Statement of Earnings (Loss), “goods” is required by SEC regulations to include all sales of tangible products, and "services" must
include all other sales, including other services activities. Throughout MD&A we refer to sales under product services agreements and sales of both goods (such
as spare parts and equipment upgrades) and related services (such as monitoring, maintenance and repairs) as sales of “services,” which is an important part of
our operations.
We believe investors will gain a better understanding of our company if they understand how we measure and talk about our results. Because of the diversity in
our businesses, we present our financial statements in a three-column format, which allows investors to see our GE Industrial operations separately from our GE
Capital operations. We believe that this provides useful information to investors. When used in this report, unless otherwise indicated by the context, we use
these terms to mean the following:
Consolidated 	– the adding together of GE and GE Capital, giving effect to the elimination of transactions between the two. We present consolidated results in
the left-side column of our consolidated Statements of Earnings (Loss), Financial Position and Cash Flows.
GE 	– the adding together of all affiliates except GE Capital, whose continuing operations are presented on a one-line basis, giving effect to the elimination of
transactions among such affiliates. As GE presents the continuing operations of GE Capital on a one-line basis, any intercompany profits resulting from
transactions between GE and GE Capital are eliminated at the GE level. We present the results of GE in the center column of our consolidated Statements of
Earnings (Loss), Financial Position and Cash Flows.
GE Capital 	– the adding together of all affiliates of GE Capital giving effect to the elimination of transactions among such affiliates. We present the results of GE
Capital in the right-side column of our consolidated Statements of Earnings (Loss), Financial Position and Cash Flows.
GE Industrial 	– GE excluding the continuing operations of GE Capital. We believe that this provides investors with a view as to the results of our industrial
businesses and corporate items.
This document contains “forward-looking statements” - for details about the uncertainties that could cause our actual results to be materially different than those
expressed in our forward-looking statements, see the Risk Factors and Forward-Looking Statements sections.
In the accompanying analysis of financial information, we sometimes use information derived from consolidated financial data but not presented in our financial
statements prepared in accordance with GAAP. Certain of these data are considered “non-GAAP financial measures” under SEC rules. See the Non-GAAP
Financial Measures section for the reasons we use these non-GAAP financial measures and the reconciliations to their most directly comparable GAAP financial
measures.
2020 1Q FORM 10-Q 	3

-- 3 of 93 --

MD&A 	CONSOLIDATED RESULTS
CONSOLIDATED RESULTS
SIGNIFICANT DEVELOPMENTS.
Coronavirus Disease 2019 (COVID-19) Pandemic. 	The COVID-19 pandemic has significantly impacted global economies, resulting in workforce and travel
restrictions, supply chain and production disruptions and reduced demand and spending across many sectors. During the latter part of the first quarter of 2020,
these factors began having a material adverse impact on our operations, financial performance and prices of our securities, as well as on the operations and
financial performance of many of the customers and suppliers in industries that we serve.
We have adopted operational and governance rhythms across the Company to coordinate actions related to the COVID-19 pandemic, including an internal task
force to protect the health and safety of our employees globally and maintain business continuity; the assessment of financial and operating impacts and
mitigating actions in response; funding and liquidity management and related treasury actions; and enterprise risk management and other functional activities.
Each of GE’s businesses and Corporate are taking cost and liquidity actions to manage risk and aggressively mitigate financial impact as supply and demand
dynamics in GE’s industries continue to shift. We also continue to evaluate market conditions as they evolve and take precautionary measures to strengthen our
financial position. We ended the first quarter of 2020 with $47.3 billion of consolidated cash, cash equivalents and restricted cash, in addition to our available
credit lines. See the Capital Resources and Liquidity section within MD&A for further information.
This section summarizes the most significant impacts related to the COVID-19 pandemic that we have experienced to date, and we have included additional
details as applicable throughout other sections of this report. Given that many of these impacts did not begin to be felt broadly across our businesses until the
latter part of the first quarter of 2020, in some instances we have identified an impact during the quarter that we would attribute primarily to COVID-19
developments rather than other business or market factors. However, in future periods, depending on the severity, magnitude and duration of the COVID-19
pandemic and its economic consequences, we anticipate that it will become more difficult to distinguish specific aspects of our operational and financial
performance that are most directly related to COVID-19 from those that are more broadly influenced by ongoing macroeconomic, market and industry dynamics
that may also be, to varying degrees, related to the COVID-19 pandemic and its consequences.
While factors related directly and indirectly to the COVID-19 pandemic have begun impacting operations and financial performance at varying levels across all
our businesses, the most significant financial impact to date has been at our Aviation segment and our GE Capital Aviation Services (GECAS) aircraft leasing
business within our Capital segment. The COVID-19 pandemic is having a material adverse effect on the global airline industry, resulting in reduced flight
schedules worldwide, an increased number of idle aircraft, lower utilization, workforce reductions and declining financial performance within the airline industry,
as well as requests for government financial assistance by various industry participants. This has decreased demand for higher margin services revenues within
our Aviation segment directly impacting our profitability and cash flows during the three months ended March 31, 2020. Our Healthcare segment experienced
increased demand for certain types of products and services, including respiratory, computed tomography (CT), monitoring solutions, x-ray, anesthesia and
point-of-care ultrasound product lines, partially offset by decreased demand in other parts of the business where hospitals and other customers have deferred
services amidst the COVID-19 pandemic. Our other businesses were also adversely impacted by market developments, including delays or cancellations of new
projects, new orders and related down payments. In addition, workplace, travel and supply chain disruptions have caused delays of deliveries and the
achievement of other billing milestones directly impacting our profitability and cash flows for the three months ended March 31, 2020. We anticipate many of
these impacts experienced in the latter part of first quarter of 2020 related to demand, profitability and cash flows will continue in future periods depending on the
severity and duration of the pandemic. For additional details about impacts related to Aviation and GECAS, Healthcare and our other businesses, refer to the
respective segment sections within MD&A.
In addition, financial, oil and gas and other commodity markets, including interest rates and credit spreads, have been experiencing significant volatility, which
had a material adverse impact on the market values of certain assets, such as our remaining equity interest in Baker Hughes and the value of our investment
portfolios supporting our long-term insurance liabilities and pension obligations. In accordance with GAAP, we remeasure the values of our investment portfolio
supporting our pension liabilities, our associated pension liabilities and our long-term insurance liabilities only annually, and our financial statements at March 31,
2020 therefore do not reflect the impact of the recent market conditions on these assets and obligations.
During the three months ended March 31, 2020, COVID-19 factors described above negatively impacted GE cash from operating activities (CFOA) and
Industrial free cash flows (FCF)* by approximately $1 billion, GE Industrial profit by approximately $0.8 billion and GE Capital earnings by approximately $0.1
billion. Excluding restructuring of $0.1 billion, adjusted GE Industrial profit* was negatively impacted by $0.7 billion.
See the Consolidated Results, and Critical Accounting Estimates sections within MD&A, as well as Notes 3, 10 and 12 to the consolidated financial statements
for further information.
We are taking cost and cash actions to manage risk and proactively mitigate the financial impacts from COVID-19. In 2020, we are targeting more than $2 billion
in operational cost out and more than $3 billion in cash preservation actions across the company, including more than $1 billion in cost out and more than $2
billion in cash preservation actions in Aviation, to right-size its cost structure and preserve its ability to serve customers.
At this time, GE cannot forecast the full duration and magnitude of COVID-19 impacts, or the pace of recovery from the COVID-19 pandemic across our end
markets, operations, and supply chains. See the Risk Factors section for further information about related risks and uncertainties.
*Non-GAAP Financial Measure
4 	2020 1Q FORM 10-Q

-- 4 of 93 --

MD&A 	CONSOLIDATED RESULTS
BioPharma. 	On March 31, 2020, we completed the sale of our BioPharma business within our Healthcare segment to Danaher Corporation for consideration of
$21.1 billion, subject to customary working capital and other post-close adjustments, and recognized a pre-tax gain of $12.3 billion 	($11.1 billion 	after tax) in our
consolidated Statement of Earnings (Loss). See Note 2 to the consolidated financial statements for further information.
Baker Hughes. 	We recognized a pre-tax unrealized loss of 	$5.7 billion 	($4.6 billion 	after tax) for the three months ended March 31, 2020, on our investment in
Baker Hughes, based on a share price of 	$10.50. See Notes 2 and 3 for further information.
Debt offering and tender. 	On April 22, 2020, we issued $6 billion of GE Company debt and used the proceeds to complete a tender offer to purchase $4.2
billion of GE senior notes with maturities ranging from 2022 to 2024. We intend to use the remaining proceeds to repurchase, redeem or repay GE’s outstanding
debt obligations, including other notes or commercial paper. These transactions will be leverage neutral and liquidity enhancing by extending our near-term
industrial debt maturities. Additionally, on April 23, 2020, GE Capital, using proceeds from the repayment of the intercompany loan by GE, completed a tender
for $5.4 billion of its 2020 maturities. See Capital Resources and Liquidity section within MD&A for further information.
FIRST QUARTER 2020 RESULTS. 	Consolidated revenues were $20.5 	billion, 	down 	$1.7 billion 	for the quarter primarily driven by 	decreased GE Industrial and
GE Capital revenues. GE Industrial revenues 	decreased 	$1.5 billion 	(7%) driven by our Aviation and Power segments, partially offset by our Renewable Energy
segment.
Continuing earnings per share was $0.72. Excluding gains (losses) on business dispositions, unrealized gains (losses), non-operating benefit costs,
restructuring and other charges and BioPharma tax benefit, Adjusted earnings per share* was 	$0.05.
For the three months ended 	March 31, 2020, GE Industrial profit was 	$6.6 billion 	and profit margins were 	34.9%, 	up 	$5.5 billion, driven primarily by the gain on
sale of our BioPharma business of 	$12.3 billion, partially offset by an unrealized loss on our investment in Baker Hughes of 	$5.7 billion. 	Adjusted GE Industrial
organic profit* 	decreased 	$1.0 billion 	(47%), primarily as a result of the impacts of COVID-19, particularly at our Aviation segment, as well as decreases at
Power and Renewable Energy.
GE CFOA of continuing operations was $(1.7) 	billion and 	$(0.6) billion 	for the three months ended 	March 31, 2020 	and 2019, respectively. GE CFOA decreased
primarily due to higher cash used for working capital and lower net income, primarily due to COVID-19 impacts, compared to 2019, partially offset by lower cash
used for contract & other deferred assets. GE Industrial free cash flows* were 	$(2.2) billion 	and 	$(1.2) billion 	for the three months ended 	March 31, 2020 	and
2019, respectively. The decrease was primarily due to the same decreases in GE CFOA as noted above. See the Capital Resources and Liquidity - Statement
of Cash Flows section for further information.
Orders are contractual commitments with customers to provide specified goods or services for an agreed upon price.
GE INDUSTRIAL ORDERS 	Three months ended March 31
(In billions) 	2020 	2019
Equipment 	$ 	9.2 	$ 	10.0
Services 	10.3 	10.6
Total orders(a) 	$ 	19.5 	$ 	20.6
Total organic orders 	$ 	19.6 	$ 	20.2
(a) Included $1.1 billion and $1.0 billion related to BioPharma for the three months ended March 31, 2020 and 2019, respectively.
For the three months ended 	March 31, 2020, orders 	decreased $1.1 	billion (5%) on a reported basis and decreased $0.6 billion (3%) organically with growth
at Power and Healthcare more than offset by double-digit declines at Aviation, due to the 737 MAX grounding and the impact of COVID-19, and Renewable
Energy. Equipment orders were down $0.3 billion (3%) organically and services orders were down $0.3 billion (3%) organically. Excluding BioPharma, orders
decreased $0.8 billion (4%) organically.
Backlog is unfilled customer orders for products and product services (expected life of contract sales for product services).
GE INDUSTRIAL BACKLOG 	(In billions) 	March 31, 2020 	December 31, 2019 	March 31, 2019
Equipment 	$ 	76.9 	$ 	79.0 	$ 	79.0
Services 	324.2 	325.6 	274.3
Total backlog(a) 	$ 	401.1 	$ 	404.6 	$ 	353.3
(a) Backlog as of March 31, 2020 excludes the BioPharma business due to its disposition in the first quarter of 2020.
As of 	March 31, 2020, 	backlog decreased $3.5 billion (1%) from December 31, 2019, driven by currency movement due to a stronger U.S. dollar of $1.2 billion,
the disposition of our BioPharma business of $1.2 billion and reductions of backlog slightly exceeding new additions, primarily at Renewable Energy. Backlog
increased $47.8 	billion (14%) from March 31, 2019, due to 	an increase 	in services backlog of $49.9 	billion (18%), primarily at Aviation, partially offset by a
decrease in equipment backlog of $2.2 	billion (3%), primarily at Power. Excluding the BioPharma disposition, backlog increased $48.9 billion (14%) from March
31, 2019.
*Non-GAAP Financial Measure
2020 1Q FORM 10-Q 	5

-- 5 of 93 --

MD&A 	CONSOLIDATED RESULTS
Remaining performance obligation (RPO), a defined term under GAAP, is backlog excluding any purchase order that provides the customer with the ability to
cancel or terminate without incurring a substantive penalty, even if the likelihood of cancellation is remote based on historical experience. We plan to continue
reporting backlog as we believe that it is a useful metric for investors, given its relevance to total orders. See Note 9 to the consolidated financial statements for
further information.
March 31, 2020 	(In billions) 	Equipment 	Services 	Total
Backlog 	$ 	76.9 	$ 	324.2 	$ 	401.1
Adjustments 	(31.7) 	(129.0) 	(160.7)
Remaining performance obligation 	$ 	45.2 	$ 	195.2 	$ 	240.4
Adjustments to reported backlog of 	$160.7 billion 	as of 	March 31, 2020 	are largely driven by adjustments of $149.9 billion in our Aviation segment: (1) backlog
includes engine contracts for which we have received purchase orders that are cancelable. We have included these in backlog as our historical experience has
shown no net cancellations, as any canceled engines are typically moved by the airframer to other program customers; (2) our services backlog includes
contracts that are cancelable without substantive penalty, primarily time and materials contracts; (3) backlog includes engines contracted under long-term
service agreements, even if the engines have not yet been put into service. These adjustments to reported backlog are expected to be satisfied beyond one
year.
REVENUES 	Three months ended March 31
(In billions) 	2020 	2019
Consolidated revenues 	$ 	20.5 	$ 	22.2
Equipment 	9.2 	9.6
Services 	9.7 	10.7
GE Industrial revenues 	$ 	18.8 	$ 	20.3
GE Capital revenues 	$ 	1.9 	$ 	2.2
For the three months ended 	March 31, 2020, 	consolidated 	revenues were 	down 	$1.7 billion, primarily driven by 	decreased GE Industrial revenues of 	$1.5
billion 	and decreased GE Capital revenues of 	$0.3 	billion. The overall foreign currency impact on consolidated revenues was a decrease of 	$0.2 billion.
GE Industrial 	revenues 	decreased $1.5 	billion (7%), as decreases at Aviation and Power were partially offset by an increase at Renewable Energy. The
decrease in services was driven by the impact of COVID-19, resulting in a decrease in commercial services at Aviation due to lower part shipments and
decreased shop visits, as well as a decrease in Gas Power services due to declines in transactional and upgrades revenues. This decrease included the net
effects of dispositions of 	$0.4 billion 	and the effects of a stronger U.S. dollar of 	$0.2 billion. Excluding the effects of acquisitions, dispositions and foreign
currency translation, GE Industrial organic revenues* decreased 	$1.0 billion 	(5%), with equipment revenues flat and a decrease in services revenues of $1.0
billion (9%). Excluding the BioPharma disposition, GE Industrial organic revenues* decreased $1.1 billion (6%).
GE Capital 	revenues decreased $0.3 	billion (14%), primarily due to volume declines, mark-to-market effects and impairments as a result of COVID-19 and
related market impacts.
EARNINGS (LOSS) AND EARNINGS (LOSS) PER SHARE 	Three months ended March 31
(In billions; per-share in dollars and diluted) 	2020 	2019
Continuing earnings 	$ 	6.3 	$ 	0.9
Continuing earnings per share 	$ 	0.72 	$ 	0.10
For the three months ended 	March 31, 2020, 	consolidated 	continuing earnings increased $5.4 	billion due to an increase in GE Industrial profit of 	$5.5 billion,
partially offset by a decrease in GE Capital earnings of $0.2 	billion.
GE Industrial 	profit increased 	$5.5 billion 	driven primarily by the gain on the sale of our BioPharma business of 	$12.3 billion, partially offset by an unrealized
loss on our investment in Baker Hughes of $5.7 billion. 	Adjusted GE Industrial profit* was $1.1 billion, a decrease of 	47% 	organically*, primarily due to decreases
at our Aviation, Power and Renewable Energy segments. GE Industrial profit margin was 34.9%, an increase from 5.3%, driven primarily by the gain on the sale
of our BioPharma business, partially offset by an unrealized loss on our investment in Baker Hughes described above. Adjusted GE industrial profit margin* was
5.8%, a decrease of 450 basis points organically*, primarily due to declines at our Aviation, Power, and Renewable Energy segments. At Aviation, the primary
drivers were lower commercial services volume and spare parts demand as a result of COVID-19. At Power, the primary drivers were supply chain constraints
and cost overruns on services agreements. Additionally, at Renewable Energy, declines were largely due to project fulfillment delays and execution challenges,
as well as the nonrecurrence of a $0.1 billion non-cash gain from the termination of two Offshore Wind contracts in the first quarter of 2019.
GE Capital 	continuing earnings decreased $0.2 	billion primarily due volume declines, mark-to-market effects and impairments as a result of COVID-19 and
related market impacts, partially offset by lower excess interest cost. Gains were $0.2 billion in the first quarters of both 2020 and 2019, which primarily related
to sales of GECAS aircraft and engines resulting in gains of $0.1 billion in both 2020 and 2019.
*Non-GAAP Financial Measure
6 	2020 1Q FORM 10-Q

-- 6 of 93 --

MD&A 	CONSOLIDATED RESULTS
AVIATION AND GECAS 737 MAX. 	Aviation develops, produces, and sells LEAP aircraft engines through CFM International (CFM), a company jointly owned by
GE and Safran Aircraft Engines, a subsidiary of the Safran Group of France. The LEAP-1B engine is the exclusive engine for the Boeing 737 MAX. In March
2019, global regulatory authorities ordered a temporary fleet grounding of the Boeing 737 MAX. During the second quarter of 2019, Boeing announced a
temporary reduction in the 737 MAX production rate, and CFM reduced its production rate for the LEAP-1B to meet Boeing's revised aircraft build rate. In
December 2019, Boeing announced that it would temporarily suspend production of the 737 MAX beginning in January 2020. In March 2020, CFM and Boeing
reached an agreement to align production rates for 2020 and secure payment terms for engines delivered in 2019 and 2020, net of progress collections. CFM
and Boeing continue to work closely to ensure a successful reentry into service, with a strong commitment to safety while navigating near term industry
disruption.
As of 	March 31, 2020, GECAS owned 29 of these aircraft, 26 of which are contracted for lease to various airlines that remain obligated to make contractual
rental payments. In addition, GECAS has made pre-delivery payments to Boeing related to 143 of these aircraft on order and has made financing commitments
to acquire a further 18 aircraft under purchase and leaseback contracts with airlines. During April 2020, GECAS agreed with Boeing to restructure its 737 MAX
orderbook including previously canceled positions, resulting in the cancellation of 69 orders with 82 orders now remaining.
As of 	March 31, 2020, we have approximately $2.5 billion of net assets ($4.8 billion of assets and $2.3 billion of liabilities) related to the 737 MAX program that
primarily comprise Aviation accounts receivable offset by progress collections and GECAS pre-delivery payments and owned aircraft subject to lease. No
impairment charges were incurred related to the 737 MAX aircraft and related balances, as we continue to believe these assets are fully recoverable. We
continue to monitor 737 MAX return to service and return to delivery developments with our airline customers, lessees and Boeing.
LEAP continues to be a strong engine program for us, and we delivered 272 engines for Boeing and Airbus platforms in the first quarter of 2020 and 3,662
engines since inception.
SEGMENT OPERATIONS. 	Segment revenues include sales of products and services by segment. Industrial segment profit is determined based on
performance measures used by our Chief Operating Decision Maker (CODM), who is our Chief Executive Officer (CEO), to assess the performance of each
business in a given period.
Please refer to our Annual Report on Form 10-K for the year ended December 31, 2019, for further information regarding our determination of Industrial and
Capital segment profit for continuing operations, and for our allocations of corporate costs to our segments.
SUMMARY OF REPORTABLE SEGMENTS 	Three months ended March 31
(In millions) 	2020 	2019 	V%
Power 	$ 	4,025 	$ 	4,617 	(13) 	%
Renewable Energy 	3,194 	2,538 	26 	%
Aviation 	6,892 	7,954 	(13) 	%
Healthcare 	4,727 	4,683 	1 	%
Capital 	1,923 	2,227 	(14) 	%
Total segment revenues 	20,761 	22,019 	(6) 	%
Corporate items and eliminations 	(237) 	183 	U
Consolidated revenues 	$ 	20,524 	$ 	22,202 	(8) 	%
Power 	$ 	(129) 	$ 	110 	U
Renewable Energy 	(302) 	(187) 	(61) 	%
Aviation 	1,005 	1,660 	(39) 	%
Healthcare 	896 	781 	15 	%
Capital 	(30) 	135 	U
Total segment profit (loss) 	1,441 	2,500 	(42) 	%
Corporate items and eliminations 	6,064 	(228) 	F
GE interest and other financial charges 	(370) 	(520) 	29 	%
GE non-operating benefit costs 	(616) 	(564) 	(9) 	%
GE benefit (provision) for income taxes 	(187) 	(268) 	30 	%
Earnings (loss) from continuing operations attributable to GE common shareholders 	6,332 	920 	F
Earnings (loss) from discontinued operations, net of taxes 	(178) 	2,663 	U
Less net earnings attributable to noncontrolling interests, discontinued operations 	(2) 	34 	U
Earnings (loss) from discontinued operations, net of tax and noncontrolling interest 	(176) 	2,629 	U
Consolidated net earnings (loss) attributable to the GE common shareholders 	$ 	6,156 	$ 	3,549 	73 	%
2020 1Q FORM 10-Q 	7

-- 7 of 93 --

MD&A 	SEGMENT OPERATIONS
POWER
We are monitoring the impacts of COVID-19 on near-term demand and the impact it is having on our operations, including the supply chain and our ability to
service our installed base. Our ability to close transactions in the near term will become more challenging due to the impact of lower oil prices on certain
customer budgets, the payback of investments and upgrades at lower gas prices, and access to financing for new projects. We are seeing the impact on our
suppliers and within our supply chain, which has resulted in delays in parts and equipment output. In addition, the servicing of our customers' assets has been
delayed due to travel and country restrictions. Although there may be obstacles in the near term, we believe the long-term outlook for the role of gas in the
power market has not materially changed.
Power is continuing to right size its business to better align with market demand and driving its businesses with an operational rigor and discipline that is focused
on its customers’ lifecycle experience. We continue to partner with our customers, working through field service travel disruptions to effectively service their
fleets to maintain operability. 	As a result of expected volume declines from COVID-19 in the near term, we are taking several measures to offset these
pressures. During the first quarter of 2020, Power had approximately 700 headcount reductions and notified approximately 1,300 contractors. In addition, we
executed on a hiring freeze, are accelerating planned employee reductions where possible, and are initiating meaningful incremental headcount reduction plans
in line with the demand profile.
Looking ahead, we anticipate the power market to continue to be impacted by overcapacity in the industry, increased price pressure from competition on
servicing the installed base, and the uncertain timing of deal closures due to financing and the complexities of working in emerging markets. Market factors such
as increasing energy efficiency and renewable energy penetration continue to impact long-term demand.
While we navigate the near-term impacts of the COVID-19 pandemic, we will continue to invest in new product development, such as our HA-Turbines, and
upgrades as these are critical to our customers and the long-term strategy of the business. Our fundamentals remain strong with approximately $85 billion in
backlog and a gas turbine installed base greater than 7,000 units.
Three months ended March 31
Orders 	Sales
(In units) 	2020 	2019 	2020 	2019
GE Gas Turbines 	9 	15 	7 	9
Heavy-Duty Gas Turbines(a) 	6 	11 	5 	7
HA-Turbines(b) 	2 	3 	4 	1
Aeroderivatives(a) 	3 	4 	2 	2
GE Gas Turbine Gigawatts(c) 	2.2 	2.1
(a) Heavy-Duty Gas Turbines and Aeroderivatives are subsets of GE Gas Turbines.
(b) HA-Turbines are a subset of Heavy-Duty Gas Turbines.
(c) Gigawatts reported associated with financial orders in the periods presented.
(In billions) 	March 31, 2020 	March 31, 2019
Equipment 	$ 	18.2 	$ 	19.1
Services 	66.9 	66.8
Total backlog 	$ 	85.1 	$ 	85.9
Three months ended March 31
( Dollars in billions) 	2020 	2019
Equipment 	$ 	1.5 	$ 	1.0
Services 	2.6 	2.7
Total orders 	$ 	4.1 	$ 	3.7
Gas Power 	$ 	2.9 	$ 	3.3
Power Portfolio 	1.2 	1.4
Total segment revenues 	$ 	4.0 	$ 	4.6
Equipment 	$ 	1.5 	$ 	1.6
Services 	2.5 	3.0
Total segment revenues 	$ 	4.0 	$ 	4.6
Segment profit (loss) 	$ 	(0.1) 	$ 	0.1
Segment profit margin 	(3.2) 	% 	2.4 	%
8 	2020 1Q FORM 10-Q

-- 8 of 93 --

MD&A 	SEGMENT OPERATIONS
For the 	three 	months ended 	March 31, 2020, segment orders were 	up 	$0.4 	billion (12%), segment revenues were 	down 	$0.6 	billion (13%) and segment
profit was 	down 	$0.2 	billion.
Backlog as of 	March 31, 2020 	decreased 	$0.7 billion 	(1%) due to 	a decrease 	in equipment backlog.
Orders increased $0.5 billion (14%) organically, primarily due to an increase in Steam equipment orders at Power Portfolio and Gas Power equipment orders
due to incremental power plant scope on unit orders, partially offset by a decrease in Heavy-Duty Gas Turbine unit orders.
Revenues decreased $0.5 billion (12%) organically*, 	primarily due to decreases in services revenues at Gas Power and Steam services at Power Portfolio.
Services revenues at Gas Power decreased due to delays in planned outages and transactional part sales due to COVID-19 and lower revenues on upgrades,
primarily in the Middle East, where low oil prices are impacting customer budgets.
Profit decreased $0.2 billion organically* due to lower revenues, as well as supply chain constraints and cost overruns on service agreements, partially offset by
improved cost productivity driven by continued efforts to right size the business.
RENEWABLE ENERGY
We are monitoring the impact of COVID-19 on the renewable energy industry, including electricity consumption forecasts and customer capital expenditure
levels, supply chain, availability of financing and our ability to execute on equipment and long-term projects, including the impact of possible customer related
delays. While we have observed delays in equipment output at several of our manufacturing facilities, we continue to service our customer assets absent any
specific country or other restrictions. In response to expected near-term volume declines from COVID-19, we initiated additional cost reduction measures,
restructuring and cash preservation actions.
The onshore wind market in the U.S. continues to see a positive impact from the Production Tax Credit (PTC) cycle and customer preference shifting to larger,
more efficient units to drive down costs and compete with other power generation options. Despite the competitive nature of the market, onshore wind order
pricing has stabilized due to demand caused by the progressive phase-down of PTCs in the U.S., which has recently been extended by one year to include
projects meeting certain criteria by 2020 that will be completed through 2024. We expect to continue high levels of production for 2020 deliveries at Onshore
Wind and are closely monitoring our execution during this period including risks of delivery delays and possible project postponements due to COVID-19 or
otherwise.
The grid market continues to be challenging as we continue to experience order declines in the High Voltage Direct Current (HVDC) and High Voltage (HV)
product lines. Both the Grid Solutions equipment and services (Grid) and Hydro businesses are executing their turnaround plans.
New product introductions remain important to our customers who are demonstrating the willingness to adopt the new technology of larger turbines that
decrease the levelized cost of energy. We continue to focus on cost reduction initiatives of our products, in-sourcing blade production and developing larger,
more efficient turbines like the Haliade-X (Offshore Wind) and Cypress (Onshore Wind). Final certification of the Haliade-X is expected in the second half of
2020.
Three months ended March 31
Orders 	Sales
(In units) 	2020 	2019 	2020 	2019
Onshore
Wind Turbines 	738 	970 	731 	353
Wind Turbine Megawatts 	2,333 	2,664 	2,093 	988
Repower 	6 	100 	219 	156
(In billions) 	March 31, 2020 	March 31, 2019
Equipment 	$ 	15.8 	$ 	15.6
Services 	10.7 	9.6
Total backlog 	$ 	26.5 	$ 	25.2
Three months ended March 31
(In billions) 	2020 	2019
Equipment 	$ 	2.7 	$ 	3.0
Services 	0.4 	0.5
Total orders 	$ 	3.1 	$ 	3.5
Onshore Wind 	$ 	2.1 	$ 	1.4
Grid Solutions equipment and services 	0.8 	0.9
Hydro, Offshore Wind and other 	0.2 	0.2
Total segment revenues 	$ 	3.2 	$ 	2.5
*Non-GAAP Financial Measure
2020 1Q FORM 10-Q 	9

-- 9 of 93 --

MD&A 	SEGMENT OPERATIONS
Three months ended March 31
(Dollars in billions) 	2020 	2019
Equipment 	$ 	2.6 	$ 	2.0
Services 	0.6 	0.6
Total segment revenues 	$ 	3.2 	$ 	2.5
Segment profit (loss) 	$ 	(0.3) 	$ 	(0.2)
Segment profit margin 	(9.5) 	% 	(7.4) 	%
For the 	three 	months ended 	March 31, 2020, segment orders were 	down 	$0.4 	billion (13%), segment revenues were 	up 	$0.7 	billion (26%) and segment
profit was 	down 	$0.1 	billion (61%).
Backlog as of 	March 31, 2020 	increased $1.3 	billion (5%) driven by higher services backlog associated with a larger Onshore Wind installed equipment base
and increased equipment backlog at Onshore and Offshore Wind, partially offset by foreign currency translation and lower orders at Grid and Hydro.
Orders decreased $0.4 billion (11%) organically, primarily due to the nonrecurrence of a large Grid Automated Control Systems (ACS) order and lower Wind
orders, primarily from the impact of U.S. PTCs compared to the prior year.
Revenues increased $0.7 billion (28%) organically*, primarily from 378 more wind turbine shipments on a unit basis, or 112% more megawatts shipped, than in
the prior year, partially offset by lower Grid revenues, primarily due to COVID-19.
Profit of $(0.3) billion decreased $0.1 billion (66%) organically*, primarily due to 	the impact of higher sales volume at Onshore Wind more than offset by project
execution losses, costs associated with new product introductions and lower sales volume, primarily at Grid due to supply chain and project fulfillment
disruptions associated with COVID-19, as well as the nonrecurrence of a $0.1 billion non-cash gain from the termination of two Offshore Wind contracts in the
first quarter of 2019.
AVIATION
The global COVID-19 pandemic is having a material adverse effect on the global airline industry. 	A key underlying driver of Aviation’s commercial engine and
services businesses is global passenger air travel, which in turn is driven by economic activity and consumer and business propensity to travel. The COVID-19
pandemic evolved rapidly in March 2020, and resulted in government travel restrictions, public health advisories, and related declines in economic activity.
These factors caused a significant drop in passenger air traffic, and as a result, airlines have grounded their fleets and, in many cases, completely ceased
passenger operations. Aviation is closely monitoring government actions and economic and industry forecasts, although such forecasts continue to evolve and
reflect the uncertainty about the severity and duration of the decline in passenger air traffic. For example, the International Air Transport Association (IATA) in
April 2020 forecasted a 48% reduction in revenue passenger kilometers (RPK) for the full year 2020 compared to 2019, lowering a prior forecast from March
2020 of a 38% reduction based on updated assessments about the depth of the economic impact and speed of the recovery in passenger air traffic. More
broadly, we are in frequent dialogue with our airline and airframe customers about the outlook for passenger air travel, new aircraft production, and after-market
services. Due to the global airline industry contraction, Aviation’s airline and airframe customers are taking measures to address reduced demand, which, in
turn, is having a material adverse impact on Aviation’s business operations and financial performance.
Aviation has and is continuing to take several business actions to respond to the current adverse environment. We continue to partner with our airline and
leasing customers to respond to an increased number of requests for short-term payment deferrals and are working closely with our airframe customers to align
production rates for 2020. During the first quarter of 2020, Aviation took several measures including a hiring freeze, cancellation of salaried merit increases, and
a reduction of all non-safety related discretionary spending, including capital expenditures and engineering and development efforts. Aviation also announced a
reduction of approximately 10% of its total United States (U.S.) workforce and a temporary furlough impacting approximately 50% of its U.S. maintenance, repair
and overhaul employees for 90 days. Additionally, Aviation announced a temporary furlough impacting its U.S. assembly operations and component
manufacturing shops for approximately four weeks during the second quarter of 2020. Aviation is also working with the appropriate parties to properly address
its global workforce.
Looking ahead, Aviation’s operational and financial performance is impacted by demand for passenger air travel, demand for freight, oil prices, fleet retirements,
and demand for new aircraft. We monitor and forecast each of these factors as part of Aviation’s long-term planning process, which may result in additional
business restructuring actions. Given the uncertainty related to the severity and length of the global COVID-19 pandemic and the impact on these factors across
the aviation sector, Aviation could be required to record additional charges, impairments, or other adverse financial impacts in future periods.
As it relates to the military environment, the U.S. Department of Defense and foreign governments have continued flight operations, and have increased budgets
to upgrade and modernize their existing fleets, creating future growth opportunities for our Military business.
Total engineering, comprised of both company and customer funded spending, decreased compared to prior year. Company-funded research and development
spend decreased compared to the first quarter of 2019, and we expect the reduction to continue in line with the actions outlined above. However, customer-
funded engineering efforts, primarily in our Military business, continued to increase.
*Non-GAAP Financial Measure
10 	2020 1Q FORM 10-Q

-- 10 of 93 --

MD&A 	SEGMENT OPERATIONS
Aviation is taking actions to protect its ability to serve its customers now and as the global airline industry recovers. While its near-term focus remains on
navigating the COVID-19 pandemic, Aviation’s deep history of innovation and technology leadership, commercial engine installed base of approximately 38,000
units, military engine installed base of approximately 27,000 units, and $273 billion backlog represents strong long-term fundamentals. Aviation is actively taking
actions to strengthen its business and seeks to emerge from this crisis stronger and drive long-term cash and profitable growth over time.
Refer to the Aviation and GECAS 737 MAX discussion in Consolidated Results for information regarding the Company's exposure related to the temporary fleet
grounding of the Boeing 737 MAX.
Three months ended March 31
Orders 	Sales
(In units, except where noted) 	2020 	2019 	2020 	2019
Commercial Engines 	145 	799 	472 	751
LEAP Engines(a) 	6 	636 	272 	424
Military Engines 	272 	26 	146 	161
Spare Parts Rate(b) 	$ 	26.9 	$ 	30.1
(a) LEAP engines are subsets of commercial engines.
(b) Commercial externally shipped spare parts and spare parts used in time and material shop visits in millions of dollars per day.
(In billions) 	March 31, 2020 	March 31, 2019
Equipment 	$ 	39.2 	$ 	38.0
Services 	234.1 	185.4
Total backlog 	$ 	273.2 	$ 	223.5
Three months ended March 31
(Dollars in billions) 	2020 	2019
Equipment 	$ 	2.2 	$ 	3.2
Services 	5.2 	5.5
Total orders 	$ 	7.4 	$ 	8.7
Commercial Engines & Services 	$ 	4.8 	$ 	5.9
Military 	1.0 	1.0
Systems & Other 	1.2 	1.0
Total segment revenues 	$ 	6.9 	$ 	8.0
Equipment 	$ 	2.4 	$ 	3.1
Services 	4.4 	4.8
Total segment revenues 	$ 	6.9 	$ 	8.0
Segment profit 	$ 	1.0 	$ 	1.7
Segment profit margin 	14.6 	% 	20.9 	%
For the 	three 	months ended 	March 31, 2020, segment orders were 	down 	$1.3 	billion (14%), segment revenues were 	down 	$1.1 billion 	(13%) and
segment profit was 	down 	$0.7 billion 	(39%).
Backlog as of 	March 31, 2020 	increased $49.8 	billion (22%), primarily due to an increase in long-term service agreements. 	This included approximately 200
LEAP-1B unit order cancellations in the first quarter of 2020.
Orders decreased $1.1 billion (13%) organically, primarily driven by lower 	commercial equipment orders due to the 737 MAX grounding and the impact of
COVID-19. Military equipment and service total orders increased 60% compared to the prior year, including a significant order from the U.S. Department of
Navy’s Naval Air Systems Command (NAVAIR) for F414 engines.
Revenues decreased $0.9 billion (11%) organically*. 	Equipment revenues decreased, primarily due to 279 fewer commercial install and spare engine units,
including 152 fewer LEAP units and 98 fewer CFM56 units versus the prior year. Services revenues also decreased, primarily due to lower commercial spare
part shipments and decreased shop visits in our service agreements, due to the impact of COVID-19. Military revenues decreased due to lower volume of
engine and spare part shipments, partially offset by increased revenues on development contracts.
Profit decreased $0.6 billion (39%) organically*, primarily 	due to Services decreased after-market volume and lower volume of commercial spare engines.
During the three months ended March 31, 2020, Aviation recorded period expense of $0.1 billion related to abnormal production volumes and initiated
restructuring actions given decreases in customer demand primarily related to LEAP engines and COVID-19. Aviation also recorded pre-tax charges totaling
$0.1 billion due to expected future losses related to customer credit risk given the current environment. In addition, Aviation recorded a $0.1 billion non-cash,
pre-tax charge (reduction in revenues and profit) to reflect the cumulative impacts of changes to assumptions for certain long-term service agreements.
Additional adjustments are likely to occur in future periods and could be material as conditions related to COVID-19 continue to evolve.
*Non-GAAP Financial Measure
2020 1Q FORM 10-Q 	11

-- 11 of 93 --

MD&A 	SEGMENT OPERATIONS
HEALTHCARE
During the first quarter of 2020, there was an increase in demand for certain of our products that are highly correlated to the response to COVID-19, including
respiratory, computed tomography (CT), monitoring solutions, x-ray, anesthesia and point-of-care ultrasound product lines. However, we also saw reduction in
demand and delays in procurement in other products and services that were not critical to the COVID-19 response efforts or where procedures could be
postponed (magnetic resonance, contrast agents and nuclear tracers). COVID-19 is driving uncertainty in our markets globally, as well as additional supply
chain and logistics costs, and we expect this to continue. In response to expected near term volatility and cost pressures from COVID-19, we have initiated
additional cost reduction, restructuring and cash preservation actions.
The global healthcare market has continued to expand, driven by macro trends relating to growing and aging populations, increasing chronic and lifestyle-related
diseases, accelerating demand for healthcare in emerging markets, and increasing use of diagnostic imaging. Technological innovation that makes it possible to
address an increasing number of diseases, conditions and patients in a more cost-effective manner has also driven growth across each of our global markets.
The Healthcare Systems equipment market over the long term continues to expand at low single-digit rates or better, while demand continues for services on
new equipment as well as on our existing installed base. However, there is short-term variation driven by market-specific political, environmental and economic
cycles. Growth in emerging markets is driven by long-term trends of expanding demand and access to healthcare. Developed markets are expected to remain
steady in the near term driven by macro trends in the healthcare industry.
Dynamics related to tariffs tempered China's growth in 2019. The impact of tariffs on certain types of medical equipment and components that we import from
China resulted in increased product costs. We continue to take mitigating actions including moving our sourcing and manufacturing for these parts outside of
China. With softening in recent U.S.-China trade relations and continued mitigation actions there has been some moderation in tariffs in both U.S. and China.
The Life Sciences market, which encompasses Pharmaceutical Diagnostics and BioPharma, continues to be strong. The Pharmaceutical Diagnostics business
is positioned in the contrast agent and nuclear tracer markets. This market is expected to grow over the long-term, driven by continued diagnostic imaging
procedure growth and increasing contrast and tracer-enhanced biomarkers of these same procedures, as these products help to increase the precision of the
diagnostic information provided to clinicians. However, in the short-term the reduction in procedures not related to COVID-19 has temporarily reduced demand.
We disposed of the BioPharma business on March 31, 2020.
We continue focusing on creating new products and solutions as well as expanding uses of existing offerings that are tailored to the different needs of our global
customers. In the first quarter of 2020, we introduced the LOGIQ™ E10 Series ultrasound that is powered by advanced algorithms and the same artificial
intelligence technology behind advanced gaming. It can process 10 times more data and generate images faster than our previous ultrasound systems to help
clinicians bring fast, precise answers to their patients. We continue to ramp production of critical medical equipment used to diagnose and treat COVID-19
patients, respiratory, computed tomography (CT), monitoring solutions, x-ray, anesthesia and point-of-care ultrasound product lines.
(In billions) 	March 31, 2020 	March 31, 2019
Equipment 	$ 	6.0 	$ 	6.6
Services 	11.4 	11.3
Total backlog(a) 	$ 	17.4 	$ 	17.9
Three months ended March 31
(In billions) 	2020 	2019
Equipment 	$ 	3.3 	$ 	2.9
Services 	2.0 	2.0
Total orders(a) 	$ 	5.3 	$ 	4.9
Healthcare Systems (HCS) 	$ 	3.4 	$ 	3.4
Life Sciences(b) 	1.3 	1.3
Total segment revenues 	$ 	4.7 	$ 	4.7
(a) Backlog as of March 31, 2020 excluded the BioPharma business due to its disposition in the first quarter of 2020. Orders included $1.1 billion and $1.0
billion related to BioPharma for the three months ended March 31, 2020 and 2019, respectively.
(b) Included revenues of $0.8 billion and $0.8 billion from BioPharma for the three months ended March 31, 2020 and 2019, respectively.
12 	2020 1Q FORM 10-Q

-- 12 of 93 --

MD&A 	SEGMENT OPERATIONS
Three months ended March 31
(Dollars in billions) 	2020 	2019
Equipment 	$ 	2.7 	$ 	2.7
Services 	2.0 	2.0
Total segment revenues 	$ 	4.7 	$ 	4.7
Segment profit 	$ 	0.9 	$ 	0.8
Segment profit margin 	19.0 	% 	16.7 	%
For the 	three 	months ended 	March 31, 2020, segment orders were 	up 	$0.4 	billion (7%), segment revenues were up (1%) and segment profit was 	up
$0.1 billion 	(15%).
Overall, backlog as of 	March 31, 2020 	decreased $0.5 	billion (3%). 	HCS backlog was up $0.6 billion, but was more than offset by the removal of BioPharma
backlog of $1.1 billion due to the sale of the business on March 31, 2020. Excluding Biopharma, backlog increased $0.6 billion (4%).
Orders increased $0.4 billion (9%) organically, driven by HCS up 8% organically due to COVID-19 related increases in demand and Life Sciences up 10%
organically, driven by BioPharma, partially offset by pressure in Pharmaceutical Diagnostics due to COVID-19. 	Excluding BioPharma, orders increased $0.3
billion (6%) organically.
Revenues increased $0.1 billion (2%) organically*, driven by increased demand in HCS products used directly in response to COVID-19 and Life Sciences,
driven by BioPharma, partially offset by pressure in Pharmaceutical Diagnostics from a decrease in non-essential elective procedures due to COVID-19.
Excluding BioPharma, revenues increased (1%) organically*.
Profit increased $0.1 billion (10%) organically*, primarily driven by volume growth and cost productivity due to current year cost and prior year restructuring
actions, design engineering and service initiatives. These increases were partially offset by inflation, logistics pressure from COVID-19, and investments in
research and development, which includes digital product innovations and Healthcare Systems programs. Excluding BioPharma, profits increased (3%)
organically*.
CAPITAL
We continue to evaluate strategic options to accelerate the further reduction in the size of GE Capital, some of which could have a material financial charge
depending on the timing, negotiated terms and conditions of any ultimate arrangements.
GE Capital made capital contributions to its insurance subsidiaries of $2.0 billion and $1.9 billion in the first quarters of 2020 and 2019, respectively, and expects
to provide further capital contributions of approximately $7 billion through 2024. See the Critical Accounting Estimates section within MD&A for further
information.
At GE Capital, the primary effect of COVID-19 pertains to its GECAS business. The COVID-19 outbreak has led to worldwide reduction of flight schedules and it
is difficult to predict its longer-term impact. The resulting pressure on its airline customers had led to GECAS preparing for redeployments and repossessions, as
well as lease modifications in some cases, while continuing to respond to customer requests for short-term rent deferrals. Continued deterioration in cash flow
projections, including current rents, downtime, release rates and residual assumptions could result in further impairments in the operating lease portfolio.
Additionally, the COVID-19 market-related volatility resulted in higher credit spreads on the investment securities held by our run-off insurance business, which
resulted in marks and impairments taken in the first quarter.
As of March 31, 2020, GECAS owned 986 fixed-wing aircraft, of which five with a book value of $0.1 billion were available to lease to customers (aircraft on the
ground). We test recoverability of each fixed-wing aircraft in our operating lease portfolio at least annually. Additionally, we perform quarterly evaluations in
circumstances such as when assets are re-leased or current lease terms have changed.
During the three months ended March 31, 2020 and 2019, GECAS recognized pre-tax impairments of $45 million and $3 million, respectively, in its operating
lease fixed-wing aircraft. The increase in pre-tax impairments was driven by declining cash flow projections for aircraft as a result of COVID-19 and related
market impacts.
As of March 31, 2020, GECAS has received deferral requests (primarily short term in nature) from approximately 75% of its airline customers operating in
approximately 64 countries and expects to continue to receive requests for rent deferrals and/or lease restructures from its global airline customers as a result of
COVID-19 and related market impacts. An extended disruption of regional or international travel could result in an increase in these types of requests in future
periods, which could result in an increase to the trade receivable balance. As GECAS evaluates future lease restructures, there is a risk of lease modifications
that could have a material adverse effect on GECAS operations, financial position and cash flows. Additionally, the portfolio utilization in our helicopter business
was 86% as of March 31, 2020.
Refer to the Aviation and GECAS 737 MAX discussion in Consolidated Results for information regarding the Company's exposure related to the temporary fleet
grounding of the Boeing 737 MAX.
*Non-GAAP Financial Measure
2020 1Q FORM 10-Q 	13

-- 13 of 93 --

MD&A 	SEGMENT OPERATIONS
(Dollars in billions) 	March 31, 2020 	December 31, 2019
GECAS 	$ 	37.3 	$ 	38.0
EFS 	1.8 	1.8
WCS(a) 	7.8 	9.0
Insurance 	46.8 	46.3
Other continuing operations(a) 	17.5 	22.5
Total segment assets 	$ 	111.1 	$ 	117.5
GE Capital debt to equity ratio 	3.6:1 	3.9:1
(a) In the first quarter of 2020 the remaining Industrial Finance assets of $0.3 billion were transferred to Other continuing operations.
Three months ended March 31
(In billions) 	2020 	2019
GECAS 	$ 	1.1 	$ 	1.2
EFS 	0.1 	—
WCS 	0.1 	0.3
Insurance 	0.6 	0.7
Other continuing operations 	— 	—
Total segment revenues 	$ 	1.9 	$ 	2.2
GECAS 	$ 	0.2 	$ 	0.3
EFS 	0.1 	—
WCS 	— 	0.1
Insurance 	(0.1) 	—
Other continuing operations(a) 	(0.2) 	(0.3)
Total segment profit 	$ 	— 	$ 	0.1
(a) 	Other continuing operations primarily comprise excess interest costs from debt previously allocated to assets that have been sold as part of the GE Capital
Exit Plan, preferred stock dividend costs and interest costs not allocated to GE Capital segments, which are driven by GE Capital’s interest allocation
process. Interest costs are allocated to GE Capital segments based on the tenor of their assets using the market rate at the time of origination, which differs
from the asset profile when the debt was originated. As a result, actual interest expense is higher than interest expense allocated to the remaining GE
Capital segments. Substantially all preferred stock dividend costs will become a GE obligation in January 2021. See Note 15 to the consolidated financial
statements for further information. In addition, we anticipate unallocated interest costs to gradually decline as debt matures and/or is refinanced.
For the 	three 	months ended 	March 31, 2020, segment revenues decreased $0.3 	billion (14%) and segment earnings were down $0.2 billion.
Capital revenues decreased $0.3 	billion (14%), primarily due to volume declines, mark-to-market effects and impairments as a result of COVID-19 and related
market impacts. Capital earnings decreased $0.2 	billion, primarily due volume declines, mark-to-market effects and impairments, as a result of COVID-19 and
related market impacts, and the tax benefit related to the BioPharma sale, partially offset by the nonrecurrence of a 2019 tax reform enactment adjustment and
lower excess interest cost. Gains were $0.2 billion in the first quarters of both 2020 and 2019, which primarily related to sales of GECAS aircraft and engines
resulting in gains of $0.1 billion in the first quarters of both 2020 and 2019.
CORPORATE ITEMS AND ELIMINATIONS
Corporate items and eliminations includes the results of our Lighting segment and GE Digital business for all periods presented.
Three months ended March 31
(In millions) 	2020 	2019
Revenues
Corporate revenues 	$ 	377 	$ 	592
Eliminations and other 	(615) 	(408)
Total Corporate Items and Eliminations 	$ 	(237) 	$ 	183
Operating profit (cost)
Gains (losses) on disposals and held for sale businesses 	$ 	12,439 	$ 	365
Restructuring and other charges 	(207) 	(258)
Unrealized gains (losses) 	(5,794) 	13
Adjusted total corporate operating costs (Non-GAAP) 	(374) 	(348)
Total Corporate Items and Eliminations (GAAP) 	$ 	6,064 	$ 	(228)
Less: gains (losses) and restructuring & other 	6,438 	120
Adjusted total corporate operating costs (Non-GAAP) 	$ 	(374) 	$ 	(348)

-- 14 of 93 --

14 	2020 1Q FORM 10-Q

-- 15 of 93 --

MD&A 	CORPORATE ITEMS AND ELIMINATIONS
Three months ended March 31
(In millions) 	2020 	2019
Functions & operations 	$ 	(266) 	$ 	(357)
Eliminations 	(98) 	6
Environmental, health and safety (EHS) and other items 	(10) 	4
Adjusted total corporate operating costs (Non-GAAP) 	$ 	(374) 	$ 	(348)
Adjusted total corporate operating costs* excludes gains (losses) on disposals and held for sale businesses, restructuring and other charges and unrealized
gains (losses). We believe that adjusting corporate costs* to exclude the effects of items that are not closely associated with ongoing corporate operations
provides management and investors with a meaningful measure that increases the period-to-period comparability of our ongoing corporate costs.
Unrealized gains (losses) are primarily related to our mark-to-market impact on our Baker Hughes shares and an impairment on our Ventures portfolio for the
three months ended March 31, 2020, and to our Wabtec equity investment for the three months ended March 31, 2019.
For the three months ended 	March 31, 2020, revenues decreased by $0.4 billion, primarily as a result of a $0.2 billion decrease resulting from the sale of our
Current business in April 2019 and a $0.2 billion increase in inter-segment eliminations. Corporate costs decreased by $6.3 billion, primarily due to $12.1 billion
of higher net gains from disposed or held for sale businesses, which was primarily related to a $12.3 billion gain from the sale of our BioPharma business in the
first quarter of 2020, compared to gains in the first quarter of 2019 of $0.2 billion from the sale of our Digital ServiceMax business and $0.1 billion from a tax
indemnity release related to our legacy NBCU business. Corporate costs also decreased by $0.1 billion due to lower restructuring costs within Healthcare, which
were partially offset by higher restructuring actions taken in Aviation in the first quarter of 2020. These decreases were partially offset by $5.8 billion of higher net
unrealized losses, primarily related to a $5.7 billion mark-to market impact on our Baker Hughes shares and a $0.1 billion impairment on our Ventures portfolio.
Adjusted total corporate operating costs* remained relatively flat. Intercompany profit eliminations increased $0.1 billion, including the results of higher
intercompany activity from our Aviation segment to our GECAS business. This was mostly offset by a decrease in Functions and Operations of $0.1 billion
(25%), driven by cost reductions in our Digital business.
Although there were no significant impacts in the first quarter related to COVID-19, potential future impacts at Corporate may include, but are not limited to, the
increase in our long-term liabilities, primarily for pension and certain environmental obligations, or decrease in asset returns subject to interest rate changes,
additional asset impairments driven by overall market conditions, and lower revenue in our Digital and Lighting operations.
RESTRUCTURING. 	Restructuring actions are an essential component of our cost improvement efforts to both existing operations and those recently acquired.
Restructuring and other charges relate primarily to workforce reductions, facility exit costs associated with the consolidation of sales, service and manufacturing
facilities, the integration of acquisitions, and certain other asset write-downs such as those associated with product line exits. We will continue to closely monitor
the economic environment, including the impacts of COVID-19, and expect to undertake further restructuring actions to more closely align our cost structure with
earnings and cost reduction goals.
Three months ended March 31
(In billions) 	2020 	2019
Workforce reductions 	$ 	0.2 	$ 	0.2
Plant closures & associated costs and other asset write-downs 	— 	0.1
Acquisition/disposition net charges 	— 	—
Total restructuring and other charges 	$ 	0.2 	$ 	0.3
Cost of product/services 	$ 	0.1 	$ 	0.1
Selling, general and administrative expenses 	0.1 	0.2
Other income 	— 	—
Total restructuring and other charges 	$ 	0.2 	$ 	0.3
Power 	$ 	— 	$ 	—
Renewable Energy 	— 	—
Aviation 	0.1 	—
Healthcare 	— 	0.1
Corporate 	0.1 	0.1
Total restructuring and other charges 	$ 	0.2 	$ 	0.3
Cash expenditures for restructuring and other charges were approximately $0.2 billion and $0.3 billion for the three months ended March 31, 2020 and 2019
respectively.
*Non-GAAP Financial Measure
2020 1Q FORM 10-Q 	15

-- 16 of 93 --

MD&A 	CORPORATE ITEMS AND ELIMINATIONS
COSTS AND GAINS NOT INCLUDED IN SEGMENT RESULTS. 	As discussed in the Segment Operations section within the MD&A, certain amounts are not
included in industrial segment results because they are excluded from measurement of their operating performance for internal and external purposes. These
costs relate primarily to restructuring and acquisition and disposition activities.
Costs 	Gains (Losses)
Three months ended March 31 	Three months ended March 31
(In billions) 	2020 	2019 	2020 	2019
Power 	$ 	— 	$ 	— 	$ 	— 	$ 	—
Renewable Energy 	— 	— 	— 	—
Aviation 	0.1 	— 	— 	—
Healthcare 	— 	0.1 	12.3 	—
Total segments 	$ 	0.1 	$ 	0.1 	$ 	12.4 	$ 	—
Corporate Items & Eliminations 	0.1 	0.1 	(5.7) 	0.4
Total Industrial 	$ 	0.2 	$ 	0.3 	$ 	6.6 	$ 	0.4
OTHER CONSOLIDATED INFORMATION
INTEREST AND OTHER FINANCIAL CHARGES 	Three months ended March 31
(In billions) 	2020 	2019
GE 	$ 	0.4 	$ 	0.5
GE Capital 	0.5 	0.7
The decrease in GE interest and other financial charges for the three months ended March 31, 2020, was driven primarily by lower expenses on sales of GE
current and long-term receivables as well as lower interest on debt due to lower average borrowings balances. The primary components of GE interest and other
financial charges are interest on short- and long-term borrowings and financing costs on sales of receivables. Total GE interest and other financial charges of
$0.2 billion and $0.3 billion was recorded at Corporate and $0.1 billion and $0.2 billion was recorded by Industrial segments for the three months ended March
31, 2020 and 2019.
The decrease in GE Capital interest and other financial charges for the three months ended March 31, 2020 was primarily due to lower average borrowings
balances due to maturities and lower average interest rates due to changes in market rates.
CONSOLIDATED INCOME TAXES
For the three months ended 	March 31, 2020, the consolidated income tax rate was 1.0% compared to 12.5% for the three months ended March 31, 2019.
The consolidated provision for income taxes was $0.1 billion in the 	first 	quarter of 	2020 	and $0.1 billion in the 	first 	quarter of 	2019. The provision was essentially
unchanged as the tax benefit associated with the mark-to-market loss on the remaining investment in Baker Hughes ($1.1 billion) was offset by the tax expense
associated with the disposition of the BioPharma 	business excluding the amount recognized on preparatory steps in 2019 ($1.1 billion).
The consolidated tax provision (benefit) includes $0.2 billion and $0.3 billion for GE (excluding GE Capital) for the 	first 	quarters of 	2020 	and 	2019, respectively.
DISCONTINUED OPERATIONS. 	Discontinued operations primarily include our Baker Hughes and Transportation segments, and certain businesses in our GE
Capital segment (our mortgage portfolio in Poland and trailing liabilities associated with the sale of our GE Capital businesses).
The mortgage portfolio in Poland (Bank BPH) comprises floating rate residential mortgages, 86% of which are indexed to or denominated in foreign currencies
(primarily Swiss francs). At March 31, 2020, the total portfolio had a carrying value of $2.4 billion with a 1.46% 90-day delinquency rate and an average loan to
value ratio of approximately 70.3%. The portfolio is recorded at fair value less cost to sell, which reflects market yields as well as our best estimate of the effects
of ongoing litigation in Poland related to foreign currency-denominated mortgages. Discontinued operations income for the three months ended March 31, 2020,
includes the recognition of a $0.1 billion valuation allowance on the carrying value of the portfolio, primarily driven by a higher discount rate as a result of
COVID-19 and related market impacts. Future changes in the economic impact of COVID-19, market yields or changes in estimated legal liabilities could result
in further losses related to these loans in future reporting periods.
See Notes 2 and 19 to the consolidated financial statements for further financial information regarding our businesses in discontinued operations.
FINANCIAL INFORMATION FOR DISCONTINUED OPERATIONS 	Three months ended March 31
(In billions) 	2020 	2019
Earnings (loss) of discontinued operations, net of taxes 	$ 	(174) 	$ 	109
Gain (loss) on disposal, net of taxes 	(4) 	2,553
Earnings (loss) from discontinued operations, net of taxes 	$ 	(178) 	$ 	2,663
16 	2020 1Q FORM 10-Q

-- 17 of 93 --

MD&A 	CAPITAL RESOURCES AND LIQUIDITY
CAPITAL RESOURCES AND LIQUIDITY
FINANCIAL POLICY. 	We intend to maintain a disciplined financial policy, targeting a sustainable long-term credit rating in the Single-A range with a GE
Industrial net debt*-to-EBITDA ratio of less than 2.5x and a dividend in line with our peers over time, as well as a less than 4-to-1 debt-to-equity ratio for GE
Capital. In addition to net debt*-to-EBITDA, we also evaluate other measures, including gross debt-to-EBITDA, and we will ultimately size our deleveraging
actions across a range of measures to ensure we are operating the Company based on a strong balance sheet. We intend to continue to decrease our leverage
over time as we navigate this period of uncertainty, although we now expect to achieve our prior targets over a longer period than previously announced.
LIQUIDITY POLICY. 	We maintain a strong focus on liquidity and define our liquidity risk tolerance based on sources and uses to maintain a sufficient liquidity
position to meet our obligations under both normal and stressed conditions. At both GE and GE Capital, we manage our liquidity to provide access to sufficient
funding to meet our business needs and financial obligations, as well as capital allocation and growth objectives, throughout business cycles. We believe that
our consolidated liquidity and availability under our credit facilities will be sufficient to meet our liquidity needs.
CONSOLIDATED LIQUIDITY. 	Following is a summary of cash, cash equivalents and restricted cash at March 31, 2020.
(In billions) 	March 31, 2020 	March 31, 2020
GE 	$ 	33.8 	U.S. 	$ 	31.7
GE Capital 	13.5 	Non-U.S. 	15.6
Consolidated 	$ 	47.3 	Consolidated 	$ 	47.3
With net proceeds of $20.3 billion received from the sale of our BioPharma business, we ended the first quarter of 2020 with $47.3 billion of consolidated cash,
cash equivalents and restricted cash, in addition to our available credit lines. As described below, we have taken a number of actions to further de-risk and de-
lever our balance sheet and prudently manage our liquidity amid a challenging external environment.
Cash held in non-U.S. entities has generally been reinvested in active foreign business operations; however, substantially all of our unrepatriated earnings were
subject to U.S. federal tax and, if there is a change in reinvestment, we would expect to be able to repatriate available cash (excluding amounts held in countries
with currency controls) without additional federal tax cost. Any foreign withholding tax on a repatriation to the U.S. would potentially be partially offset by a U.S.
foreign tax credit.
GE LIQUIDITY. 	GE's primary sources of liquidity consist of cash and cash equivalents, free cash flows from our operating businesses, monetization of
receivables, proceeds from dispositions, and short-term borrowing facilities. Cash generation can be subject to variability based on many factors, including
seasonality, receipt of down payments on large equipment orders, timing of billings on long-term contracts, the effects of changes in end markets and our ability
to execute dispositions.
GE also has available short-term borrowing facilities to fund its operations, including a commercial paper program, revolving credit facilities and short-term
intercompany loans from GE Capital, which are generally repaid within the same quarter. See the Borrowings section for details of our credit facilities and
borrowing activity in our external short-term borrowing facilities.
GE cash, cash equivalents and restricted cash totaled $33.8 billion at March 31, 2020, including $2.3 billion of cash held in countries with currency control
restrictions and $0.5 billion of restricted use cash. Cash held in countries with currency controls represents amounts held in countries which may restrict the
transfer of funds to the U.S. or limit our ability to transfer funds to the U.S. without incurring substantial costs. Restricted use cash represents amounts that are
not available to fund operations, and primarily comprised collateral for receivables sold and funds restricted in connection with certain ongoing litigation matters.
In the first quarter of 2020, GE received $20.3 billion of net proceeds from the sale of our BioPharma business within our Healthcare segment. On April 1, 2020,
GE used $6.0 billion of these proceeds to repay a portion of the intercompany loans from GE Capital. In addition, our ending commercial paper balance
decreased by $1.1 billion compared to December 31, 2019. We intend to maintain a high level of cash and maximize flexibility as we evaluate the next steps
over time that are needed to execute our deleveraging priorities throughout this period of uncertainty. Additionally, we continue to evaluate the timing of an
orderly sale over time of our remaining stake in Baker Hughes.
GE CAPITAL LIQUIDITY. 	GE Capital’s primary sources of liquidity consist of cash and cash equivalents, cash generated from asset sales and cash flows from
our businesses. We expect to maintain an adequate liquidity position to fund our insurance obligations and debt maturities primarily as a result of cash flows
from our businesses, GE repayments of intercompany loans and capital contributions from GE. See the Segment Operations - Capital section within MD&A for
further information regarding allocation of GE Capital interest expense to the GE Capital businesses.
GE Capital cash, cash equivalents and restricted cash totaled $13.5 billion at March 31, 2020, including $1.3 billion which was subject to regulatory restrictions,
primarily in insurance entities.
*Non-GAAP Financial Measure
2020 1Q FORM 10-Q 	17

-- 18 of 93 --

MD&A 	CAPITAL RESOURCES AND LIQUIDITY
GE Capital provided capital contributions to its insurance subsidiaries of $2.0 billion, $1.9 billion and $3.5 billion in the first quarters of 2020, 2019 and 2018,
respectively, and expects to provide further capital contributions of 	approximately $7 billion through 2024. 	These contributions are subject to ongoing monitoring
by Kansas Insurance Department (KID), and the total amount to be contributed could increase or decrease, or the timing could be accelerated, based upon the
results of reserve adequacy testing or a decision by KID to modify the schedule of contributions set forth in January 2018. We will continue to monitor the volatile
interest rate environment, including the impact of reinvestment rates and our investment portfolio performance, and other factors in determining the related effect
on our expected future capital contributions. See the Critical Accounting Estimates section of MD&A for discussion of the sensitivity of interest rate changes to
our insurance liabilities. GE maintains specified capital levels at these insurance subsidiaries under capital maintenance agreements. Going forward, we
anticipate funding any capital needs for insurance through a combination of GE Capital liquidity, GE Capital asset sales, GE Capital future earnings and capital
contributions from GE.
BORROWINGS. 	Consolidated 	total borrowings were $85.2 billion and $90.9 billion at March 31, 2020 and December 31, 2019, respectively. The reduction was
driven primarily by net repayments of GE Capital debt of $6.2 billion (including $4.7 billion of long-term debt maturities), a reduction in GE commercial paper of
$1.1 billion, and $0.7 billion of foreign exchange due to strengthening US dollar against most currencies, partially offset by an increase of $2.4 billion in fair value
adjustments for GE Capital debt in fair value hedge relationships as a result of lower interest rates.
GE Industrial net debt* was $34.0 billion and $47.9 billion at March 31, 2020 and December 31, 2019, respectively. 	The reduction was driven primarily by a
higher ending cash balance mainly as a result of the proceeds from the sale of the BioPharma business.
In 2015, senior unsecured notes and commercial paper were assumed by GE upon its merger with GE Capital. Under the conditions of the 2015 assumed debt
agreement, GE Capital agreed to continue making required principal and interest payments on behalf of GE, resulting in the establishment of an intercompany
receivable and payable between GE and GE Capital. In addition, GE Capital has periodically made intercompany loans to GE with maturity terms that mirror the
assumed debt. As these loans qualify for right-of-offset presentation, they reduce the assumed debt intercompany receivable and payable between GE and GE
Capital, as noted in the table below.
The following table provides a reconciliation of total short- and long-term borrowings as reported on the respective GE and GE Capital Statements of Financial
Position to borrowings adjusted for assumed debt and intercompany loans:
March 31, 2020 	(In billions) 	GE 	GE Capital 	Consolidated(a)
Total short- and long-term borrowings 	$ 	48.1 	$ 	37.6 	$ 	85.2
Debt assumed by GE from GE Capital 	(29.1) 	29.1 	—
Intercompany loans with right of offset 	12.2 	(12.2) 	—
Total intercompany payable (receivable) between GE and GE Capital 	(16.9) 	16.9 	—
Total borrowings adjusted for assumed debt and intercompany loans 	$ 	31.2 	$ 	54.5 	$ 	85.2
(a) 	Included 	$0.6 billion of eliminations of other GE borrowings from GE Capital, primarily related to timing of cash settlements associated with GE receivables
monetization programs.
When measuring the individual financial positions of GE and GE Capital, assumed debt should be considered a GE Capital debt obligation, and the
intercompany loans with the right of offset mentioned above should be considered a GE debt obligation and a reduction of GE Capital’s total debt obligations.
The following table illustrates the primary components of GE and GE Capital borrowings, adjusted for assumed debt and intercompany loans.
GE 	(In billions) 	March 31, 2020
December 31,
2019 	GE Capital 	(In billions) 	March 31, 2020 	December 31, 2019
Commercial paper 	$ 	1.9 	$ 	3.0 	Senior and subordinated notes 	$ 	35.8 	$ 	36.5
GE senior notes 	15.4 	15.5
Senior and subordinated notes
assumed by GE 	29.1 	31.4
Intercompany loans from
GE Capital 	12.2 	12.2 	Intercompany loans to GE 	(12.2) 	(12.2)
Other GE borrowings 	1.6 	2.2 	Other GE Capital borrowings(a) 	1.8 	3.4
Total GE Capital
Total GE adjusted borrowings 	$ 	31.2 	$ 	32.9 	adjusted borrowings 	$ 	54.5 	$ 	59.0
(a) Included $0.6 billion and $1.7 billion at March 31, 2020 and December 31, 2019, respectively, of non-recourse borrowings of consolidated securitization
entities where GE Capital has securitized financial assets as an alternative source of funding.
The intercompany loans from GE Capital to GE bear the right of offset against amounts owed by GE Capital to GE under the assumed debt agreement and can
be prepaid by GE at any time, in whole or in part, without premium or penalty. These loans are priced at market terms and have a collective weighted average
interest rate of 3.5% and term of approximately 11.8 years at March 31, 2020. On April 1, 2020, GE repaid $6.0 billion of intercompany loans from GE Capital,
decreasing GE borrowings with an offsetting increase to GE Capital borrowings.
*Non-GAAP Financial Measure
18 	2020 1Q FORM 10-Q

-- 19 of 93 --

MD&A 	CAPITAL RESOURCES AND LIQUIDITY
On April 22, 2020, GE issued $6.0 billion of senior notes, comprised of $1.0 billion due 2027, $1.25 billion due 2030, $1.5 billion due 2040, and $2.25 billion due
2050, and used the proceeds to complete a tender offer to purchase $4.2 billion of GE senior notes with maturities ranging from 2020 to 2024. We intend to use
the remaining proceeds to repurchase, redeem or repay GE’s outstanding debt obligations, including other notes or commercial paper. These transactions will
be leverage neutral and liquidity enhancing by extending our near-team industrial debt maturities.
On April 23, 2020, GE Capital completed a tender offer to purchase $5.4 billion of GE Capital senior notes with maturities during 2020 using the proceeds from
the repayment of $6.0 billion of intercompany loans from GE.
GE has in place committed revolving credit lines. The following table provides a summary of committed and available credit lines.
GE COMMITTED AND AVAILABLE REVOLVING CREDIT FACILITIES 	(In billions) 	March 31, 2020 	December 31, 2019
Unused back-up revolving syndicated credit facility 	$ 	20.0 	$ 	20.0
Unused revolving syndicated credit facility 	14.8 	14.8
Bilateral revolving credit facilities 	7.2 	7.2
Total committed revolving credit facilities 	$ 	42.0 	$ 	42.0
Less offset provisions 	6.7 	6.7
Total net available revolving credit facilities 	$ 	35.3 	$ 	35.3
Included in our credit facilities at March 31, 2020, was an unused $20.0 billion back-up revolving syndicated credit facility extended by 36 banks, expiring in
2021, and an unused $14.8 billion revolving syndicated credit facility extended by six banks, expiring on December 31, 2020. The commitments under these
syndicated credit facilities may be reduced by up to $6.7 billion due to offset provisions for any bank that holds a commitment to lend under both facilities.
As part of our ordinary course refinancing processes, on April 17, 2020, we refinanced unused back-up revolving syndicated credit facility. In connection with the
refinancing, we terminated the unused $20.0 billion back-up revolving syndicated credit facility and entered into a new $15.0 billion back-up revolving syndicated
credit facility, expiring in April 2023. This facility does not contain any offset provisions. The new back-up revolving credit facility includes a customary net debt-
to-EBITDA financial covenant.
The closing of the new $15.0 billion facility also terminated the $14.8 billion unused revolving syndicated credit facility that was scheduled to mature in
December 2020, which had an aggregate revolving commitment amount of $4.2 billion effective April 14, 2020, following the sale of the BioPharma business
within our Healthcare segment.
Under the terms of an agreement between GE Capital and GE, GE Capital has the right to compel GE to borrow under all credit facilities in place at March 31,
2020 except the $14.8 billion unused revolving syndicated credit facility expiring on December 31, 2020. Under this agreement, GE would transfer the proceeds
to GE Capital as intercompany loans, which would be subject to the same terms and conditions as those between GE and the lending banks. GE Capital has not
exercised this right.
The following table provides a summary of the activity in the primary external sources of short-term borrowings for GE in the first quarters of 2020 and 2019. GE
uses bilateral revolving credit facilities from time to time to meet its short-term liquidity needs.
(In billions) 	GE Commercial Paper
Bilateral Revolving
Credit Facilities 	Total
2020
Average borrowings during the first quarter 	$ 	2.9 	$ 	1.2 	$ 	4.1
Maximum borrowings outstanding during the first quarter 	3.4 	1.5 	4.7
Ending balance at March 31 	1.9 	— 	1.9
2019
Average borrowings during the first quarter 	$ 	3.2 	$ 	1.3 	$ 	4.4
Maximum borrowings outstanding during the first quarter 	3.6 	1.5 	4.8
Ending balance at March 31 	3.0 	— 	3.0
Total average and maximum borrowings in the table above are calculated based on the daily outstanding balance of the sum of commercial paper and revolving
credit facilities.
GE’s ending commercial paper balance decreased to $1.9 billion at March 31, 2020 from $3.0 billion at December 31, 2019, primarily as a result of market
conditions and our liquidity position.
In addition to these external sources of short-term borrowings, GE and GE Capital may from time to time enter into short-term intercompany loans to utilize
excess cash as an efficient source of liquidity, which are typically repaid within the same quarter.
2020 1Q FORM 10-Q 	19

-- 20 of 93 --

MD&A 	CAPITAL RESOURCES AND LIQUIDITY
CREDIT RATINGS AND CONDITIONS. 	We have relied, and may continue to rely, on the short- and long-term debt capital markets to fund, among other things,
a significant portion of our operations. The cost and availability of debt financing is influenced by our credit ratings. Moody’s Investors Service (Moody’s),
Standard and Poor’s Global Ratings (S&P), and Fitch Ratings (Fitch) currently issue ratings on GE and GE Capital short- and long-term debt. The credit ratings
of GE and GE Capital as of the date of this filing are set forth in the table below.
Moody's 	S&P 	Fitch
GE
Outlook 	Negative 	Negative 	Stable
Short term 	P-2 	A-2 	F3
Long term 	Baa1 	BBB+ 	BBB
GE Capital
Outlook 	Negative 	Negative 	Stable
Short term 	P-2 	A-2 	F3
Long term 	Baa1 	BBB+ 	BBB
On April 10, 2020, S&P affirmed the ratings of GE and GE Capital short- and long-term debt and changed its outlook from Stable to Negative.
On April 12, 2020, Fitch lowered the credit ratings of GE and GE Capital short- and long-term debt from F2 to F3 and BBB+ to BBB, respectively, with a Stable
outlook.
On April 13, 2020, Moody’s affirmed the ratings of GE and GE Capital short- and long-term debt and changed its outlook from Stable to Negative.
We are disclosing our credit ratings and any current quarter updates to these ratings to enhance understanding of our sources of liquidity and the effects of our
ratings on our costs of funds. Our ratings may be subject to a revision or withdrawal at any time by the assigning rating organization, and each rating should be
evaluated independently of any other rating. For a description of some of the potential consequences of a reduction in our credit ratings, see the Financial Risks
section of Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2019.
The following table provides a summary of the estimated potential liquidity impact in the event of further downgrades with regards to the most significant
contractual credit ratings conditions of the Company based on their proximity to our current ratings.
(In billions) 	Triggers Below 	At March 31, 2020
Derivatives
Terminations 	BBB/Baa2 	$ 	(0.4)
Cash margin posting 	BBB/Baa2 	(0.9)
Receivables Sales Programs
Loss of cash commingling 	A-2/P-2/F2 	$ 	(0.6)
Alternative funding sources 	A-2/P-2/F2 	(0.7)
Surety bond cash collateral posting 	BBB-/Baa3 	$ 	(0.8)
The timing within the quarter of the potential liquidity impact of these areas may differ, as described in the following sections which provide additional details
regarding the significant credit rating conditions of the Company.
DEBT CONDITIONS. 	Substantially 	all debt agreements in place at March 31, 2020 do not contain material credit rating covenants. If our short-term credit
ratings were to fall below A-2/P-2/F2, it is possible that we would lose all or part of our access to the tier-2 commercial paper markets, which would reduce our
borrowing capacity in those markets and may result in increased utilization of our revolving credit facilities to fund our intra-quarter operations. As of the date of
this filing, the Fitch downgrade has not interrupted our ability to access the tier-2 market.
DERIVATIVE CONDITIONS. 	Swap, forward and option contracts are executed under standard master agreements that typically contain mutual downgrade
provisions that provide the ability of the counterparty to require termination if the credit ratings of the applicable GE entity were to fall below specified ratings
levels agreed upon with the counterparty, primarily BBB/Baa2. Our master agreements also typically contain provisions that provide termination rights upon the
occurrence of certain other events, such as a bankruptcy or events of default by one of the parties. If an agreement was terminated under any of these
circumstances, the termination amount payable would be determined on a net basis and could also take into account any collateral posted. The net amount of
our derivative liability subject to such termination provisions, after consideration of collateral posted by us and outstanding interest payments was $0.4 billion at
March 31, 2020. This excludes exposure related to embedded derivatives, which are not subject to these provisions.
In addition, certain of our derivatives, primarily interest rate swaps, are subject to additional cash margin posting requirements if our credit ratings were to fall
below BBB/Baa2. The amount of additional margin will vary based on, among other factors, market movements and changes in our positions. At March 31,
2020, the amount of additional margin that we could be required to post if we fell below these ratings levels was approximately $0.9 billion.
20 	2020 1Q FORM 10-Q

-- 21 of 93 --

MD&A 	CAPITAL RESOURCES AND LIQUIDITY
The Fitch downgrades did not result in a breach of any of our required ratings levels relating to derivatives.
See Note 17 to the consolidated financial statements for further information about our risk exposures, our use of derivatives, and the effects of this activity on
our financial statements.
OTHER CONDITIONS. 	Where we provide servicing for third-party investors under certain of our receivable sales programs, GE is contractually permitted to
commingle cash collected from customers on financing receivables sold to third-party investors with our own cash prior to payment to third-party investors,
provided our short-term credit rating does not fall below A-2/P-2. In the event any of our ratings were to fall below such levels, we may be required to segregate
certain of these cash collections owed to third-party investors into restricted bank accounts and would lose the short-term liquidity benefit of commingling with
respect to such collections. The financial impact to our intra-quarter liquidity would vary based on collections activity for a given quarter and may result in
increased utilization of our revolving credit facilities. The loss of cash commingling would have resulted in an estimated maximum reduction of approximately
$0.6 billion to GE intra-quarter liquidity during the first quarter of 2020.
We have relied, and may continue to rely, on securitization programs to provide alternative funding for sales of GE receivables to third-party investors. If any of
our short-term credit ratings were to fall below A-2/P-2/F2, the timing or amount of available liquidity generated by these programs could be adversely impacted.
In the first quarter of 2020, the estimated maximum reduction to our ending available liquidity had our credit ratings fallen below these levels was approximately
$0.7 billion. 	In the event we fall below these ratings levels, these programs contain features that permit continued timely third-party funding subject to additional
restrictions, which we do not expect to have a significant impact to the Company.
In conjunction with ordinary course commercial transactions and certain regulatory requirements, the Company may periodically enter into agreements that
require us to post surety bonds to counterparties. In the first quarter of 2020, we entered into amendments to our agreements with certain of our surety bond
providers that may require us to post cash collateral in the event our credit ratings were to fall below BBB-/Baa3. At March 31, 2020, the maximum amount of
cash collateral we could be required to post if we fell below these levels was approximately $0.8 billion.
FOREIGN EXCHANGE. 	As a result of our global operations, we generate and incur a significant portion of our revenues and expenses in currencies other than
the U.S. dollar. Such principal currencies include the euro, the pound sterling, the Brazilian real and the Chinese renminbi, among others. The effects of foreign
currency fluctuations on earnings, excluding the earnings impact of the underlying hedged item, was less than $0.1 billion for the three months ended March 31,
2020 and less than $0.1 billion for the three months ended March 31, 2019. This analysis excludes any offsetting effect from the forecasted future transactions
that are economically hedged.
See Note 17 to the consolidated financial statements for further information about our risk exposures, our use of derivatives, and the effects of this activity on
our financial statements.
STATEMENT OF CASH FLOWS – THREE MONTHS ENDED MARCH 31, 2020 VERSUS 2019. 	We manage the cash flow performance of our industrial and
financial services businesses separately, in order to enable us and our investors to evaluate the cash from operating activities of our industrial businesses
separately from the cash flows of our financial services business.
See the Intercompany Transactions between GE and GE Capital section and Notes 4 and 20 to the consolidated financial statements for further information
regarding certain transactions affecting our consolidated Statement of Cash Flows.
GE CASH FLOWS FROM CONTINUING OPERATIONS. 	The most significant source of cash in GE CFOA is customer-related activities, the largest of which is
collecting cash resulting from product or services sales. The most significant operating use of cash is to pay our suppliers, employees, tax authorities, contribute
to post retirement plans and pay others for a wide range of material, services and taxes.
GE cash used for operating activities 	was $1.7 billion in 2020, an increase of $1.1 billion compared with 2019, primarily due to: an increase in cash used for
working capital of $1.1 billion; and a general decrease in net income (after adjusting for the gain on the sale of BioPharma and the non-cash loss related to our
interest in Baker Hughes), primarily due to COVID-19 impacts in our Aviation segment; partially offset by a decrease in cash used for contract & other deferred
assets of $0.7 billion, primarily due to higher billings on our long-term equipment contracts and an increased net unfavorable change in estimated profitability,
partially offset by higher revenue recognition, on our long-term service agreements.
The increase in cash used for working capital was due to: an increase in cash used for accounts payable of $1.5 billion, which was primarily as a result of lower
volume in 2020 and higher disbursements related to purchases of materials in prior periods; and higher net utilizations of progress collections of $0.3 billion.
These increases in cash used for working capital were partially offset by an increase in cash generated from current receivables of $0.5 billion, which was
primarily driven by lower volume, partially offset by a higher decrease in sales of receivables; and an decrease in cash used for inventories of $0.1 billion, which
was primarily driven by lower build for anticipated volumes in the year, largely offset by lower liquidations.
2020 1Q FORM 10-Q 	21

-- 22 of 93 --

MD&A 	CAPITAL RESOURCES AND LIQUIDITY
As discussed in the Significant Developments section within the Consolidated Results section of MD&A, the COVID-19 pandemic negatively impacted GE CFOA
and GE Industrial free cash flows* by approximately $1 billion in the first quarter of 2020, primarily as a result of decreased net income and working capital in our
Aviation segment.
GE cash from investing activities 	was $20.0 billion in 2020, an increase of $17.8 billion compared with 2019, primarily due to: net proceeds from the sale of
our BioPharma business of $20.3 billion; and lower cash used in relation to net settlements between our continuing operations and discontinued operations of
$0.4 billion; partially offset by the nonrecurrence of proceeds from the 2019 spin-off of our Transportation business of $2.9 billion. Cash used for additions to
property, plant and equipment and internal-use software, which is a component of GE Industrial free cash flows*, was $0.6 billion in both 2020 and 2019.
GE cash used for financing activities 	was $2.0 billion in 2020, an increase of $0.7 billion compared with 2019, primarily due to higher net repayments of
borrowings.
GE CASH FLOWS FROM DISCONTINUED OPERATIONS. 	GE cash used for operating activities of discontinued operations in 2019 primarily reflects operating
outflows related to Transportation, prior to our disposition of the segment in the first quarter of 2019. GE cash used for financing activities of discontinued
operations in 2019 primarily reflects payments of Baker Hughes dividends to noncontrolling interests.
GE CAPITAL CASH FLOWS FROM CONTINUING OPERATIONS. GE Capital cash from operating activities 	was $1.3 billion in 2020, an increase of $1.2
billion compared with 2019, primarily due to: a net increase in cash collateral received and settlements paid from counterparties on derivative contracts of $0.9
billion and a general increase in cash generated from earnings (loss) from continuing operations.
GE Capital cash used for investing activities 	was $0.1 billion in 2020, an increase of $3.9 billion compared with 2019, primarily due to: lower collections of
financing receivables of $2.2 billion and an increase of net purchases of investment securities of $1.7 billion.
GE Capital cash used for financing activities 	was $6.4 billion in 2020, an increase of $2.9 billion compared with 2019, primarily due to: higher net repayments
of borrowings of $2.8 billion and higher cash settlements on derivatives hedging foreign currency debt of $0.2 billion.
INTERCOMPANY TRANSACTIONS BETWEEN GE AND GE CAPITAL. 	Transactions between related companies are made on arm's length terms and are
reported in the GE and GE Capital columns of our financial statements, which we believe provide useful supplemental information to our consolidated financial
statements. See Note 20 to the consolidated financial statements for further information.
Sales of Receivables. 	In order to manage short-term liquidity and credit exposure, GE may sell current customer receivables to GE Capital and other third
parties. These transactions are made on arm's length terms and any discount related to time value of money, is recognized within the respective GE Industrial
business in the period these receivables were sold to GE Capital or third parties. See Note 4 to the consolidated financial statements for further information.
Supply Chain Finance Programs. GE facilitates voluntary supply chain finance programs with third parties which provide participating GE suppliers the
opportunity to sell their GE receivables to third parties at the sole discretion of both the suppliers and the third parties.
At March 31, 2020 and December 31, 2019, included in GE's accounts payable is $2.6 billion and $2.4 billion, respectively, of supplier invoices that are subject
to the third-party programs. Total GE supplier invoices paid through these third-party programs were $1.1 billion and $0.1 billion for the three months ended
March 31, 2020 and 2019, respectively.
The GE liability associated with the funded participation in the GE Capital program is presented as accounts payable and amounted to $1.3 billion and $2.1
billion at March 31, 2020 and December 31, 2019, respectively.
GE Capital Finance Transactions. 	During the 	three 	months ended 	March 31, 2020 	and 	2019, GE Capital acquired from third parties 	five 	aircraft with a list price
totaling $0.6 	billion and 	13 	aircraft with a list price totaling $1.9 	billion, respectively, that will be leased to others and are powered by engines manufactured by
GE Aviation and affiliates. GE Capital also made payments to GE Aviation and affiliates related to spare engines and engine parts of $0.1 billion and $0.1 billion,
which included $0.1 billion and an insignificant amount to CFM International during the 	three 	months ended 	March 31, 2020 	and 	2019, respectively. Additionally,
GE Capital had $2.1 	billion and $2.0 	billion of net book value of engines, originally manufactured by GE Aviation and affiliates and subsequently leased back to
GE Aviation and affiliates at 	March 31, 2020 	and 	December 31, 2019, respectively.
Also, during the 	three 	months ended 	March 31, 2020 	and 	2019, GE recognized equipment revenues of $0.5 billion and $0.2 billion, respectively, from customers
within our Power and Renewable Energy segments in which GE Capital is an investee or is committed to be an investee in the underlying projects.
For certain of these investments, in order to meet its underwriting criteria, GE Capital may obtain a direct guarantee from GE related to the performance of the
third party. GE guarantees include direct performance or payment guarantees, return on investment guarantees and asset value guarantees. As of 	March 31,
2020, GE had outstanding guarantees to GE Capital on $1.0 	billion of funded exposure and $0.8 	billion of unfunded commitments, which included guarantees
issued by industrial businesses. The recorded contingent liability for these guarantees was insignificant as of 	March 31, 2020 	and is based on individual
transaction level defaults, losses and/or returns.
*Non-GAAP Financial Measure
22 	2020 1Q FORM 10-Q

-- 23 of 93 --

MD&A 	CRITICAL ACCOUNTING ESTIMATES
CRITICAL ACCOUNTING ESTIMATES
Please refer to the Critical Accounting Estimates and Other Items sections within MD&A and Note 1 to the consolidated financial statements of our Annual
Report on Form 10-K for the year ended December 31, 2019, for a further discussion of our accounting policies and critical accounting estimates. COVID-19
related market events may have an effect on our Insurance business and pension assumptions.
INSURANCE AND INVESTMENT CONTRACTS. 	At March 31, 2020, our insurance liabilities and annuity benefits of $38.2 billion are primarily supported by
investment securities of $37.6 billion and commercial mortgage loans of $1.9 billion, net of their allowance for losses, respectively.
Future policy benefit reserves. 	Future changes in the discount rate assumption used in our annual premium deficiency testing performed in the third quarter
across our run-off insurance portfolio may be required. A lower discount rate, holding all other assumptions constant, will result in an increase in our future policy
benefit reserves on a GAAP basis. Furthermore, a lower discount rate may be required under statutory asset adequacy testing that is relevant for determining
the amount of capital to be contributed to our insurance subsidiaries.
Our GAAP discount rate is based upon the actual yields on our investment portfolio and our forecasted reinvestment rates, which comprise the future rates at
which we expect to invest proceeds from investment maturities, net of operating cash flows, and projected future capital contributions. Although the movement in
market rates impacts the reinvestment rate, it does not materially impact the actual yield on our existing investments. While credit spreads on fixed-income
securities widened during the quarter, benchmark interest rates in the U.S. have been lowered which may impact other discount rate assumptions, including the
period over which the reinvestment rate increases to the expected long-term average investment yield and the expected long-term average investment yield
(including changes to expected default rates). Furthermore, expected returns on higher yielding asset classes may change.
For further information on our overall discount rate, reinvestment rate and mortality assumptions, refer to the GAAP Reserve Sensitivities included in Other Items
within MD&A of our Annual Report on Form 10-K for the year ended December 31, 2019.
Investments. 	Our investment security portfolio may experience higher gross unrealized losses, downgrades in credit ratings and higher default rates and result
in an increase to the allowance for losses on assets supporting our insurance liabilities. See Note 3 to the consolidated financial statements for further
information about our investment securities.
PENSION ASSUMPTIONS. 	As discussed in Critical Accounting Estimates in our Annual Report on Form 10-K for the year ended December 31, 2019, our
defined benefit pension plans are accounted for on an actuarial basis and measured annually as of December 31. Accounting for defined benefit plans requires
the selection of certain assumptions and actual results in any given year will often differ from actuarial assumptions because of economic or other factors.
During the first quarter of 2020, financial markets and interest rates have experienced volatility, which could result in a change in the discount rate used to
measure our pension benefit obligation or our pension assets may realize less than our expected long-term rate of return, either of which could result in a
material change in the funded status of our pension plans when we measure them at December 31, 2020. Our discount rate is determined using the weighted
average of market-observed yields for high-quality fixed income securities with maturities that correspond to the payments of benefits and while benchmark
interest rates in the U.S. have been lowered credit spreads on high-quality fixed incomes securities have widened.
As disclosed in our Annual Report on Form 10-K for the year ended December 31, 2019, changes in key assumptions for our principal pension plans would
have the following effects.
• 	Discount rate - A 25 basis point decrease in the discount rate would increase pension cost in the following year by about $0.2 billion and would increase the
pension benefit obligation by about $2.3 billion.
• 	Expected return on assets - A 50 basis point decrease in the expected return on assets would increase pension cost in the following year by about $0.3
billion.
OTHER ITEMS
NEW ACCOUNTING STANDARDS. 	The Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2018-12, 	Financial
Services - Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts with an effective date for periods beginning after
December 31, 2021, with an election to adopt early. We are evaluating the effect of the standard on our consolidated financial statements and anticipate that its
adoption will significantly change the accounting for measurements of our long-duration insurance liabilities. The ASU requires cash flow assumptions used in
the measurement of various insurance liabilities to be reviewed at least annually and updated if actual experience or other evidence indicates previous
assumptions need to be revised with any required changes recorded in earnings. Under the current accounting guidance, the discount rate is based on expected
investment yields, while under the ASU the discount rate will be equivalent to the upper-medium grade (i.e., single A) fixed-income instrument yield reflecting the
duration characteristics of the liability and is required to be updated in each reporting period with changes recorded in other comprehensive income. In
measuring the insurance liabilities under the new standard, contracts shall not be grouped together from different issue years. These changes result in the
elimination of premium deficiency testing and shadow adjustments. While we continue to evaluate the effect of the standard on our ongoing financial reporting,
we anticipate that the adoption of the ASU will materially affect our financial statements. As the ASU is only applicable to the measurements of our long-duration
insurance liabilities under GAAP, it will not affect the accounting for our insurance reserves or the levels of capital and surplus under statutory accounting
practices.
2020 1Q FORM 10-Q 	23

-- 24 of 93 --

MD&A 	NON-GAAP FINANCIAL MEASURES
NON-GAAP FINANCIAL MEASURES
We believe that presenting non-GAAP financial measures provides management and investors useful measures to evaluate performance and trends of the total
company and its businesses. 	This includes adjustments in recent periods to GAAP financial measures to increase period-to-period comparability following
actions to strengthen our overall financial position and how we manage our business.
In addition, management recognizes that certain non-GAAP terms may be interpreted differently by other companies under different circumstances. In various
sections of this report we have made reference to the following non-GAAP financial measures in describing our (1) revenues, specifically GE Industrial organic
revenues by segment; BioPharma organic revenues, GE Industrial organic revenues, and GE Industrial equipment and services organic revenues (2) profit,
specifically GE Industrial organic profit and profit margin by segment; BioPharma organic profit and profit margin, Adjusted GE Industrial profit and profit margin
(excluding certain items); Adjusted GE Industrial organic profit and profit margin; Adjusted earnings (loss); and Adjusted earnings (loss) per share (EPS), (3)
cash flows, specifically GE Industrial free cash flows (FCF), and (4) debt balances, specifically GE Industrial net debt.
The reasons we use these non-GAAP financial measures and the reconciliations to their most directly comparable GAAP financial measures follow.
GE INDUSTRIAL ORGANIC REVENUES, PROFIT (LOSS) AND PROFIT MARGIN BY SEGMENT (NON-GAAP)
Revenues 	Segment profit (loss) 	Profit margin
Three months ended March 31 	(In millions) 	2020 	2019 	V% 	2020 	2019 	V% 	2020 	2019 	V pts
Power (GAAP) 	$ 	4,025 	$ 	4,617 	(13)% 	$ 	(129) 	$ 	110 	U 	(3.2)% 	2.4 	% 	(5.6)pts
Less: acquisitions 	16 	— 	2 	—
Less: business dispositions 	15 	35 	2 	—
Less: foreign currency effect 	(46) 	— 	2 	—
Power organic (Non-GAAP) 	$ 	4,040 	$ 	4,583 	(12)% 	$ 	(135) 	$ 	110 	U 	(3.3)% 	2.4 	% 	(5.7)pts
Renewable Energy (GAAP) 	$ 	3,194 	$ 	2,538 	26 	% 	$ 	(302) 	$ 	(187) 	(61)% 	(9.5)% 	(7.4)% 	(2.1)pts
Less: acquisitions 	— 	— 	— 	—
Less: business dispositions 	— 	— 	— 	—
Less: foreign currency effect 	(64) 	— 	7 	—
Renewable Energy organic (Non-GAAP) 	$ 	3,258 	$ 	2,538 	28 	% 	$ 	(310) 	$ 	(187) 	(66)% 	(9.5)% 	(7.4)% 	(2.1)pts
Aviation (GAAP) 	$ 	6,892 	$ 	7,954 	(13)% 	$ 	1,005 	$ 	1,660 	(39)% 	14.6 	% 	20.9 	% 	(6.3)pts
Less: acquisitions 	— 	— 	— 	—
Less: business dispositions 	13 	180 	(2) 	19
Less: foreign currency effect 	(2) 	— 	4 	—
Aviation organic (Non-GAAP) 	$ 	6,882 	$ 	7,774 	(11)% 	$ 	1,003 	$ 	1,641 	(39)% 	14.6 	% 	21.1 	% 	(6.5)pts
Healthcare (GAAP) 	$ 	4,727 	$ 	4,683 	1 	% 	$ 	896 	$ 	781 	15 	% 	19.0 	% 	16.7 	% 	2.3pts
Less: acquisitions 	14 	21 	— 	(4)
Less: business dispositions 	— 	3 	— 	(32)
Less: foreign currency effect 	(52) 	— 	(5) 	—
Healthcare organic (Non-GAAP) 	$ 	4,765 	$ 	4,659 	2 	% 	$ 	901 	$ 	817 	10 	% 	18.9 	% 	17.5 	% 	1.4pts
Less: BioPharma organic (Non-GAAP) 	839 	762 	380 	311
Healthcare excluding BioPharma organic
(Non-GAAP) 	$ 	3,926 	$ 	3,897 	1 	% 	$ 	521 	$ 	506 	3 	% 	13.3 	% 	13.0 	% 	0.3pts
We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established,
ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, as these activities can obscure underlying trends. We also believe
presenting organic revenues* and organic profit* separately for our industrial businesses provides management and investors with useful information about the
trends of our industrial businesses and enables a more direct comparison to other non-financial companies.
BIOPHARMA ORGANIC REVENUES, PROFIT (LOSS) AND PROFIT MARGIN (NON-GAAP)
Revenues 	Segment profit (loss) 	Profit margin
Three months ended March 31 	(In millions) 	2020 	2019 	V% 	2020 	2019 	V% 	2020 	2019 	V pts
BioPharma (GAAP) 	$ 	830 	$ 	765 	9% 	$ 	382 	$ 	312 	22% 	46.0% 	40.8% 	5.2pts
Less: acquisitions 	— 	— 	— 	—
Less: business dispositions 	— 	3 	— 	1
Less: foreign currency effect 	(9) 	— 	2 	—
BioPharma organic (Non-GAAP) 	$ 	839 	$ 	762 	10% 	$ 	380 	$ 	311 	22% 	45.3% 	40.8% 	4.5pts

-- 25 of 93 --

*Non-GAAP Financial Measure
24 	2020 1Q FORM 10-Q

-- 26 of 93 --

MD&A 	NON-GAAP FINANCIAL MEASURES
GE INDUSTRIAL ORGANIC REVENUES (NON-GAAP) 	Three months ended March 31
(In millions) 	2020 	2019 	V%
GE Industrial revenues (GAAP) 	$ 	18,844 	$ 	20,324 	(7)%
Adjustments:
Less: acquisitions 	42 	21
Less: business dispositions(a) 	28 	380
Less: foreign currency effect(b) 	(166) 	—
GE Industrial organic revenues (Non-GAAP) 	$ 	18,941 	$ 	19,923 	(5)%
Less: BioPharma organic revenue (Non-GAAP) 	839 	762
GE Industrial organic revenues excluding BioPharma organic revenues (Non-GAAP) 	$ 	18,101 	$ 	19,162 	(6)%
(a) Dispositions impact in 2019 primarily related to our Aviation business including the Middle River and Hamble site dispositions, with revenues of $125 million
and $55 million, respectively, and Current within our Corporate segment, with revenues of $155 million.
(b) Foreign currency impact primarily driven by U.S. Dollar appreciation against Euro, Brazilian Real and Chinese Yen.
We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established,
ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, as these activities can obscure underlying trends.
GE INDUSTRIAL EQUIPMENT AND SERVICES ORGANIC 	Three months ended March 31
REVENUES (NON-GAAP) 	Equipment 	Services
(In millions) 	2020 	2019 	V% 	2020 	2019 	V%
GE Industrial revenues (GAAP) 	$ 	9,177 	$ 	9,608 	(4)% 	$ 	9,668 	$ 	10,716 	(10)%
Adjustments:
Less: acquisitions 	11 	— 	31 	21
Less: business dispositions 	11 	314 	18 	66
Less: foreign currency effect 	(111) 	— 	(55) 	—
GE Industrial organic revenues (Non-GAAP) 	$ 	9,266 	$ 	9,294 	— 	% 	$ 	9,674 	$ 	10,629 	(9)%
We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established,
ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, as these activities can obscure underlying trends.
ADJUSTED GE INDUSTRIAL PROFIT AND PROFIT MARGIN 	Three months ended March 31
(EXCLUDING CERTAIN ITEMS) (NON-GAAP) 	(In millions) 	2020 	2019
GE total revenues (GAAP) 	$ 	18,844 	$ 	20,324
Costs
GE total costs and expenses (GAAP) 	$ 	19,133 	$ 	20,101
Less: GE interest and other financial charges 	370 	520
Less: non-operating benefit costs 	616 	564
Less: restructuring & other(a) 	207 	267
Add: noncontrolling interests 	36 	23
Adjusted GE Industrial costs (Non-GAAP) 	$ 	17,976 	$ 	18,773
Other Income
GE other income (GAAP) 	$ 	6,874 	$ 	852
Less: unrealized gains (losses)(b) 	(5,794) 	13
Less: restructuring & other 	— 	9
Less: gains (losses) and impairments for disposed or held for sale businesses(b) 	12,439 	365
Adjusted GE other income (Non-GAAP) 	$ 	228 	$ 	465
GE Industrial profit (GAAP) 	$ 	6,585 	$ 	1,076
GE Industrial profit margin (GAAP) 	34.9% 	5.3%
Adjusted GE Industrial profit (Non-GAAP) 	$ 	1,096 	$ 	2,017
Adjusted GE Industrial profit margin (Non-GAAP) 	5.8% 	9.9%
(a) See the Corporate Items and Eliminations - Restructuring section for further information.
(b) See the Corporate Items and Eliminations section for further information.

-- 27 of 93 --

We believe these measures are meaningful because they increase the comparability of period-to-period results.
2020 1Q FORM 10-Q 	25

-- 28 of 93 --

MD&A 	NON-GAAP FINANCIAL MEASURES
ADJUSTED GE INDUSTRIAL ORGANIC PROFIT 	Three months ended March 31
(NON-GAAP) 	(In millions) 	2020 	2019 	V%
Adjusted GE Industrial profit (Non-GAAP) 	$ 	1,096 	$ 	2,017 	(46) 	%
Adjustments:
Less: acquisitions 	2 	(4)
Less: business dispositions 	(1) 	(21)
Less: foreign currency effect 	11 	—
Adjusted GE Industrial organic profit (Non-GAAP) 	$ 	1,084 	$ 	2,041 	(47) 	%
Adjusted GE Industrial profit margin (Non-GAAP) 	5.8% 	9.9% 	(410) bps
Adjusted GE Industrial organic profit margin (Non-GAAP) 	5.7% 	10.2% 	(450) bps
We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established,
ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, as these activities can obscure underlying trends.
ADJUSTED EARNINGS (LOSS) (NON-GAAP) 	Three months ended March 31
(In millions) 	2020 	2019 	V%
Consolidated earnings (loss) from continuing operations attributable to GE common shareholders (GAAP) 	$ 	6,332 	$ 	920 	F
Less: GE Capital earnings (loss) from continuing operations attributable to GE common shareholders (GAAP) 	(30) 	135
GE Industrial earnings (loss) (Non-GAAP) 	6,362 	785 	F
Non-operating benefits costs (pre-tax) (GAAP) 	(616) 	(564)
Tax effect on non-operating benefit costs 	129 	118
Less: non-operating benefit costs (net of tax) 	(487) 	(446)
Gains (losses) and impairments for disposed or held for sale businesses (pre-tax)(a) 	12,439 	365
Tax effect on gains (losses) and impairments for disposed or held for sale businesses 	(1,265) 	35
Less: gains (losses) and impairments for disposed or held for sale businesses (net of tax) 	11,174 	400
Restructuring & other (pre-tax)(b) 	(207) 	(258)
Tax effect on restructuring & other 	43 	53
Less: restructuring & other (net of tax) 	(164) 	(205)
Unrealized gains (losses)(a) 	(5,794) 	13
Tax on unrealized gains (losses) 	1,096 	(3)
Less: unrealized gains (losses) 	(4,697) 	10
BioPharma deal expense (pre-tax) 	— 	—
Tax on BioPharma deal expense 	— 	(14)
Less: BioPharma deal expense (net of tax) 	— 	(14)
Less: GE Industrial U.S. tax reform enactment adjustment 	— 	(101)
Adjusted GE Industrial earnings (loss) (Non-GAAP) 	$ 	536 	$ 	1,140 	(53)%
GE Capital earnings (loss) from continuing operations attributable to GE common shareholders (GAAP) 	(30) 	135 	U
Less: GE Capital U.S. tax reform enactment adjustment 	— 	99
Less: GE Capital tax benefit related to BioPharma sale 	88 	—
Adjusted GE Capital earnings (loss) (Non-GAAP) 	$ 	(118) 	$ 	36 	U
Adjusted GE Industrial earnings (loss) (Non-GAAP) 	$ 	536 	$ 	1,140 	(53)%
Add: Adjusted GE Capital earnings (loss) (Non-GAAP) 	(118) 	36 	U
Adjusted earnings (loss) (Non-GAAP) 	$ 	418 	$ 	1,177 	(64)%
(a) See the Corporate Items and Eliminations section for further information.
(b) See the Corporate Items and Eliminations - Restructuring section for further information.

-- 29 of 93 --

26 	2020 1Q FORM 10-Q

-- 30 of 93 --

MD&A 	NON-GAAP FINANCIAL MEASURES
ADJUSTED EARNINGS (LOSS) PER SHARE (EPS) 	Three months ended March 31
(NON-GAAP) 	2020 	2019 	V%
Consolidated EPS from continuing operations attributable to GE common shareholders (GAAP) 	$ 	0.72 	$ 	0.10 	F
Less: GE Capital EPS from continuing operations attributable to GE common shareholders (GAAP) 	— 	0.02
GE Industrial EPS (Non-GAAP) 	0.73 	0.09 	F
Non-operating benefits costs (pre-tax) (GAAP) 	(0.07) 	(0.06)
Tax effect on non-operating benefit costs 	0.01 	0.01
Less: non-operating benefit costs (net of tax) 	(0.06) 	(0.05)
Gains (losses) and impairments for disposed or held for sale businesses (pre-tax)(a) 	1.42 	0.04
Tax effect on gains (losses) and impairments for disposed or held for sale businesses 	(0.14) 	—
Less: gains (losses) and impairments for disposed or held for sale businesses (net of tax) 	1.28 	0.04
Restructuring & other (pre-tax)(b) 	(0.02) 	(0.03)
Tax effect on restructuring & other 	— 	0.01
Less: restructuring & other (net of tax) 	(0.02) 	(0.02)
Unrealized gains (losses)(a) 	(0.66) 	—
Tax on unrealized gains (losses) 	0.13 	—
Less: unrealized gains (losses) 	(0.54) 	—
BioPharma deal expense (pre-tax) 	— 	—
Tax on BioPharma deal expense 	— 	—
Less: BioPharma deal expense (net of tax) 	— 	—
Less: GE Industrial U.S. tax reform enactment adjustment 	— 	(0.01)
Adjusted GE Industrial EPS (Non-GAAP) 	$ 	0.06 	$ 	0.13 	(54)%
GE Capital EPS from continuing operations attributable to GE common shareholders (GAAP) 	— 	0.02 	(100)%
Less: GE Capital U.S. tax reform enactment adjustment 	— 	0.01
Less: GE Capital tax benefit related to BioPharma sale 	0.01 	—
Adjusted GE Capital EPS (Non-GAAP) 	$ 	(0.01) 	$ 	— 	U
Adjusted GE Industrial EPS (Non-GAAP) 	$ 	0.06 	$ 	0.13 	(54)%
Add: Adjusted GE Capital EPS (Non-GAAP) 	(0.01) 	— 	U
Adjusted EPS (Non-GAAP) 	$ 	0.05 	$ 	0.13 	(62)%
(a) See the Corporate Items and Eliminations section for further information.
(b) See the Corporate Items and Eliminations - Restructuring section for further information.
Earnings-per-share amounts are computed independently. As a result, the sum of per-share amounts may not equal the total.
The service cost for our pension and other benefit plans are included in adjusted earnings*, which represents the ongoing cost of providing pension benefits to
our employees. The components of non-operating benefit costs are mainly driven by capital allocation decisions and market performance. We believe the
retained costs in Adjusted earnings* and Adjusted EPS* provides management and investors a useful measure to evaluate the performance of the total
company, and increases period-to-period comparability. We also use Adjusted EPS* as a performance metric at the company level for our annual executive
incentive plan for 2020. We believe presenting Adjusted Industrial earnings* and Adjusted Industrial EPS* separately for our financial services businesses also
provides management and investors with useful information about the relative size of our industrial and financial services businesses in relation to the total
company.
GE INDUSTRIAL FREE CASH FLOWS (FCF) (NON-GAAP) 	Three months ended March 31
(In millions) 	2020 	2019
GE CFOA (GAAP) 	$ 	(1,662) 	$ 	(607)
Add: gross additions to property, plant and equipment 	(504) 	(552)
Add: gross additions to internal-use software 	(58) 	(66)
Less: taxes related to business sales 	(17) 	(8)
GE Industrial free cash flows (Non-GAAP) 	$ 	(2,207) 	$ 	(1,216)
We believe investors may find it useful to compare GE's Industrial free cash flows* performance without the effects of cash used for taxes related to business
sales. We believe this measure will better allow management and investors to evaluate the capacity of our industrial operations to generate free cash flows.

-- 31 of 93 --

*Non-GAAP Financial Measure
2020 1Q FORM 10-Q 	27

-- 32 of 93 --

MD&A 	NON-GAAP FINANCIAL MEASURES
GE INDUSTRIAL NET DEBT (NON-GAAP) 	(In millions) 	March 31, 2020 	December 31, 2019
Total GE short- and long-term borrowings (GAAP) 	$ 	48,132 	$ 	52,059
Less: GE Capital short- and long-term debt assumed by GE 	29,136 	31,368
Add: intercompany loans from GE Capital 	12,226 	12,226
Total adjusted GE borrowings 	$ 	31,222 	$ 	32,917
Total pension and principal retiree benefit plan liabilities (pre-tax)(a) 	27,773 	27,773
Less: taxes at 21% 	5,832 	5,832
Total pension and principal retiree benefit plan liabilities (net of tax) 	$ 	21,941 	$ 	21,941
GE operating lease liabilities 	3,266 	3,369
GE preferred stock 	5,782 	5,738
Less: 50% of GE preferred stock 	2,891 	2,869
50% of preferred stock 	$ 	2,891 	$ 	2,869
Deduction for total GE cash, cash equivalents and restricted cash 	(33,810) 	(17,613)
Less: 25% of GE cash, cash equivalents and restricted cash 	(8,453) 	(4,403)
Deduction for 75% of GE cash, cash equivalents and restricted cash 	$ 	(25,358) 	$ 	(13,210)
Total GE Industrial net debt (Non-GAAP) 	$ 	33,962 	$ 	47,886
(a) Represents the total net deficit status of principal pension plans, other pension plans and retiree benefit plans at December 31, 2019. The funded status of
our benefit plans is updated annually in the fourth quarter.
In this document we use GE Industrial net debt*, which is calculated based on rating agency methodologies. We are including the calculation of GE industrial
net debt* to provide investors more clarity regarding how the credit rating agencies measure GE Industrial leverage.
CONTROLS AND PROCEDURES
Under the direction of our Chief Executive Officer and Chief Financial Officer, we evaluated our disclosure controls and procedures and internal control over
financial reporting and concluded that (i) our disclosure controls and procedures were effective as of
March 31, 2020, and (ii) no change in internal control over financial reporting occurred during the quarter ended 	March 31, 2020, that has materially affected, or
is reasonably likely to materially affect, such internal control over financial reporting.
RISK FACTORS
The risk factor set forth below updates the risk factors in our Annual Report on Form 10-K for the year ended December 31, 2019. These risk factors could
materially affect our business, financial position and results of operations.
The global Coronavirus Disease 2019 (COVID-19) pandemic is having a material adverse impact on our operations and financial performance, as well
as on the operations and financial performance of many of the customers and suppliers in industries that we serve. We are unable to predict the
extent to which the pandemic and related impacts will continue to adversely impact our business operations, financial performance, results of
operations, financial position and the achievement of our strategic objectives. 	Our operations and financial performance have been negatively impacted
by the COVID-19 pandemic that has caused, and is expected to continue to cause, the global slowdown of economic activity (including the decrease in demand
for a broad variety of goods and services), disruptions in global supply chains and significant volatility and disruption of financial markets. Because the severity,
magnitude and duration of the COVID-19 pandemic and its economic consequences are uncertain, rapidly changing and difficult to predict, the pandemic’s
impact on our operations and financial performance, as well as its impact on our ability to successfully execute our business strategies and initiatives, remains
uncertain and difficult to predict. Further, the ultimate impact of the COVID-19 pandemic on our operations and financial performance depends on many factors
that are not within our control, including, but not limited, to: governmental, business and individuals’ actions that have been and continue to be taken in response
to the pandemic (including restrictions on travel and transport and workforce pressures); the impact of the pandemic and actions taken in response on global
and regional economies, travel, and economic activity; the availability of federal, state, local or non-U.S. funding programs; general economic uncertainty in key
global markets and financial market volatility; global economic conditions and levels of economic growth; and the pace of recovery when the COVID-19
pandemic subsides.
The COVID-19 pandemic has subjected our operations, financial performance and financial condition to a number of risks, including, but not limited to those
discussed below:
Operations-related risks: 	Across all of our businesses, we are facing increased operational challenges from the need to protect employee health and safety, site
shutdowns, workplace disruptions and restrictions on the movement of people, raw materials and goods, both at our own facilities and at customers and
suppliers. We are also experiencing, and expect to continue experiencing, lower demand and volume for products and services, customer requests for potential
payment deferrals or other contract modifications, supply chain under-liquidation, delays of deliveries and the achievement of other billing milestones, delays or
cancellations of new projects and related down payments and other factors related directly and indirectly to the COVID-19 pandemic that adversely impact our
businesses. We expect that the longer the period of economic and global supply chain and disruption continues, the more material the adverse impact will be on
our business operations, financial performance and results of operations, and this could include additional charges, impairments and other adverse financial
impacts in future periods.
*Non-GAAP Financial Measure
28 	2020 1Q FORM 10-Q

-- 33 of 93 --

RISK FACTORS
Customer-related risks: 	In particular, the interruption of regional and international air travel from COVID-19 has resulted in the loss of business and leisure traffic
and is having a material adverse effect on our airline and airframer customers, the viability of their businesses and their demand for our services and products.
Changes in passenger air travel trends arising from COVID-19 may continue to develop or persist over time and further contribute to this adverse effect. We are
also observing a significant increase in the number of requests for payment deferrals, contract modifications, aircraft lease restructurings and similar actions
across the aviation sector, and these trends may lead to additional charges, impairments and other adverse financial impacts at GE Aviation and GE Capital
Aviation Services over time. We have depended on the strength of our Aviation business as we have been working to improve the operations and execution of
other GE businesses and strengthen the company’s balance sheet. As a result, disruption of the aviation industry, which could continue for an uncertain period
of time, is particularly significant for GE. Across our businesses, to varying degrees, we anticipate that some existing or potential customers will continue to
delay or cancel plans to purchase our products and services, or may not be able to fulfill prior obligations in a timely fashion, as a result of ongoing effects
related to the COVID-19 pandemic and adverse economic conditions more broadly.
Leverage- and market-related risks: 	The current financial market dynamics and volatility pose heightened risks to our timelines for decreasing our leverage, and
we now expect to achieve our prior targets over a longer period than previously announced as we seek to maintain appropriate liquidity to compensate for lower
cash flows from operations or as variables impacting our leverage ratios fluctuate with extreme market volatility. For example, lower discount rates and lower
asset valuations at the time of remeasurement can materially impact the calculation of long-term liabilities such as our pension deficit, GAAP insurance reserve
and insurance statutory calculations. In addition, extreme volatility in financial and commodities markets has had and may continue to have adverse impacts on
other asset valuations such as the market value of our remaining equity interest in Baker Hughes and the value of the investment portfolios supporting our
pension and long-term insurance liabilities. Our long-term liabilities are sensitive to numerous factors and assumptions that can move in offsetting directions and
should be considered as of the time of a relevant measurement event.
Liquidity- and funding-related risks: 	While we have significant sources of cash and liquidity and access to committed credit lines, a prolonged period of
generating lower cash from operations could adversely affect our financial condition and the achievement of our strategic objectives. As described in the Capital
Resources and Liquidity section of this report, in April 2020, Moody's and S&P changed their credit rating outlooks for GE and GE Capital from Stable to
Negative, and Fitch lowered its credit ratings for GE and GE Capital. There can also be no assurance that we will not face additional credit rating downgrades as
a result of weaker than anticipated performance of our businesses, slower progress in decreasing our leverage or other factors. Future downgrades could further
adversely affect our cost of funds and related margins, liquidity, competitive position and access to capital markets, and a significant downgrade could have an
adverse commercial impact on our industrial businesses. Conditions in the financial and credit markets may also limit the availability of funding or increase the
cost of funding (including for receivables monetization or supply chain finance programs), which could adversely affect our business, financial position and
results of operations. Although the U.S. federal and other governments have announced a number of funding programs to support businesses, our ability or
willingness to access funding under such programs may be limited by regulations or other guidance, or by further change or uncertainty related to the terms of
these programs.
As the COVID-19 pandemic continues to adversely affect our operating and financial results, it may also have the effect of heightening many of the other risks
described in the risk factors in our Annual Report on Form 10-K for the year ended December 31, 2019. In particular, see the risk factors regarding “Global
macro-environment,” “Supply chain,” “Leverage and borrowings,” “Liquidity” and “Economy, customers & counterparties," as updated by the information in this
risk factor. Refer also to the Critical Accounting Estimates section of this report for additional details about how COVID-19 related market events may affect our
insurance business and pension assumptions. Further, the COVID-19 pandemic may also affect our operating and financial results in a manner that is not
presently known to us or that we currently do not expect to present significant risks to our operations or financial results.
LEGAL PROCEEDINGS
Refer to Legal Matters and Environmental, Health and Safety Matters in Note 19 to the consolidated financial statements for information relating to legal
proceedings. The information in those sections supplements and amends the discussion set forth in the corresponding sections of Note 23 to the consolidated
financial statements in our Annual Report on Form 10-K for the year ended December 31, 2019.
2020 1Q FORM 10-Q 	29

-- 34 of 93 --

FINANCIAL STATEMENTS
FINANCIAL STATEMENTS
STATEMENT OF EARNINGS (LOSS) 	Three months ended March 31
(UNAUDITED) 	Consolidated
(In millions; per-share amounts in dollars) 	2020 	2019
Sales of goods 	$ 	12,364 	$ 	13,249
Sales of services 	6,450 	7,008
GE Capital revenues from services 	1,709 	1,945
Total revenues (Note 9) 	20,524 	22,202
Cost of goods sold 	10,540 	10,974
Cost of services sold 	5,156 	5,234
Selling, general and administrative expenses 	3,065 	3,402
Interest and other financial charges 	794 	1,065
Insurance losses and annuity benefits 	636 	611
Non-operating benefit costs 	619 	569
Other costs and expenses 	109 	72
Total costs and expenses 	20,918 	21,927
Other income (Note 23) 	6,869 	847
GE Capital earnings (loss) from continuing operations 	— 	—
Earnings (loss) from continuing operations before income taxes 	6,475 	1,122
Benefit (provision) for income taxes 	(63) 	(140)
Earnings (loss) from continuing operations 	6,412 	983
Earnings (loss) from discontinued operations, net of taxes (Note 2) 	(178) 	2,663
Net earnings (loss) 	6,233 	3,645
Less net earnings (loss) attributable to noncontrolling interests 	34 	57
Net earnings (loss) attributable to the Company 	6,199 	3,588
Preferred stock dividends 	(43) 	(40)
Net earnings (loss) attributable to GE common shareholders 	$ 	6,156 	$ 	3,549
Amounts attributable to GE common shareholders
Earnings (loss) from continuing operations 	$ 	6,412 	$ 	983
Less net earnings (loss) attributable to noncontrolling interests,
continuing operations 	36 	23
Earnings (loss) from continuing operations attributable to the Company 	6,375 	960
Preferred stock dividends 	(43) 	(40)
Earnings (loss) from continuing operations attributable
to GE common shareholders 	6,332 	920
Earnings (loss) from discontinued operations, net of taxes 	(178) 	2,663
Less net earnings (loss) attributable to
noncontrolling interests, discontinued operations 	(2) 	34
Net earnings (loss) attributable to GE common shareholders 	$ 	6,156 	$ 	3,549
Earnings (loss) per share from continuing operations (Note 16)
Diluted earnings (loss) per share 	$ 	0.72 	$ 	0.10
Basic earnings (loss) per share 	$ 	0.72 	$ 	0.10
Net earnings (loss) per share (Note 16)
Diluted earnings (loss) per share 	$ 	0.70 	$ 	0.40
Basic earnings (loss) per share 	$ 	0.70 	$ 	0.41
Dividends declared per common share 	$ 	0.01 	$ 	0.01

-- 35 of 93 --

30 	2020 1Q FORM 10-Q

-- 36 of 93 --

FINANCIAL STATEMENTS
STATEMENT OF EARNINGS (LOSS) (CONTINUED) 	Three months ended March 31
(UNAUDITED) 	GE(a) 	GE Capital
(In millions; per-share amounts in dollars) 	2020 	2019 	2020 	2019
Sales of goods 	$ 	12,359 	$ 	13,315 	$ 	24 	$ 	16
Sales of services 	6,486 	7,009 	— 	—
GE Capital revenues from services 	— 	— 	1,899 	2,210
Total revenues 	18,844 	20,324 	1,923 	2,227
Cost of goods sold 	10,541 	11,049 	17 	13
Cost of services sold 	4,657 	4,781 	535 	486
Selling, general and administrative expenses 	2,949 	3,196 	203 	267
Interest and other financial charges 	370 	520 	504 	677
Insurance losses and annuity benefits 	— 	— 	653 	633
Non-operating benefit costs 	616 	564 	2 	5
Other costs and expenses 	— 	(8) 	119 	99
Total costs and expenses 	19,133 	20,101 	2,033 	2,180
Other income (Note 23) 	6,874 	852 	— 	—
GE Capital earnings (loss) from continuing operations 	(30) 	135 	— 	—
Earnings (loss) from continuing operations before income taxes 	6,555 	1,211 	(110) 	47
Benefit (provision) for income taxes 	(187) 	(268) 	123 	128
Earnings (loss) from continuing operations 	6,368 	943 	13 	175
Earnings (loss) from discontinued operations, net of taxes (Note 2) 	(178) 	2,663 	(164) 	35
Net earnings (loss) 	6,190 	3,606 	(151) 	210
Less net earnings (loss) attributable to noncontrolling interests 	34 	57 	— 	—
Net earnings (loss) attributable to the Company 	6,156 	3,549 	(151) 	210
Preferred stock dividends 	— 	— 	(43) 	(40)
Net earnings (loss) attributable to GE common shareholders 	$ 	6,156 	$ 	3,549 	$ 	(194) 	$ 	171
Amounts attributable to GE common shareholders:
Earnings (loss) from continuing operations 	$ 	6,368 	$ 	943 	$ 	13 	$ 	175
Less net earnings (loss) attributable to noncontrolling interests,
continuing operations 	36 	23 	— 	—
Earnings (loss) from continuing operations attributable to the Company 	6,332 	920 	13 	175
Preferred stock dividends 	— 	— 	(43) 	(40)
Earnings (loss) from continuing operations attributable
to GE common shareholders 	6,332 	920 	(30) 	135
Earnings (loss) from discontinued operations, net of taxes 	(178) 	2,663 	(164) 	35
Less net earnings (loss) attributable to
noncontrolling interests, discontinued operations 	(2) 	34 	— 	—
Net earnings (loss) attributable to GE common shareholders 	$ 	6,156 	$ 	3,549 	$ 	(194) 	$ 	171
(a) Represents the adding together of all GE Industrial affiliates and GE Capital continuing operations on a one-line basis. See Note 1.
2020 1Q FORM 10-Q 	31

-- 37 of 93 --

FINANCIAL STATEMENTS
STATEMENT OF FINANCIAL POSITION (UNAUDITED) 	Consolidated
(In millions, except share amounts) 	March 31, 2020 	December 31, 2019
Cash, cash equivalents and restricted cash 	$ 	47,286 	$ 	36,394
Investment securities (Note 3) 	42,299 	48,521
Current receivables (Note 4) 	16,925 	16,769
Financing receivables – net (Note 5) 	2,998 	3,134
Inventories (Note 6) 	15,457 	14,104
Other GE Capital receivables 	7,505 	7,144
Property, plant and equipment – net (Note 7)(a) 	45,979 	46,186
Receivable from GE Capital 	— 	—
Investment in GE Capital 	— 	—
Goodwill (Note 8) 	26,598 	26,734
Other intangible assets – net (Note 8) 	10,381 	10,653
Contract and other deferred assets (Note 10) 	16,136 	16,801
All other assets 	15,841 	16,461
Deferred income taxes (Note 14) 	10,457 	9,889
Assets of businesses held for sale (Note 2) 	506 	9,149
Assets of discontinued operations (Note 2) 	3,653 	4,109
Total assets 	$ 	262,021 	$ 	266,048
Short-term borrowings (Note 11) 	$ 	18,122 	$ 	22,072
Short-term borrowings assumed by GE (Note 11) 	— 	—
Accounts payable, principally trade accounts 	15,212 	15,926
Progress collections and deferred income (Note 10) 	19,818 	20,508
Other GE current liabilities 	16,290 	15,753
Non-recourse borrowings of consolidated securitization entities (Note 11) 	644 	1,655
Long-term borrowings (Note 11) 	66,388 	67,155
Long-term borrowings assumed by GE (Note 11) 	— 	—
Insurance liabilities and annuity benefits (Note 12) 	38,241 	39,826
Non-current compensation and benefits 	31,104 	31,687
All other liabilities(a) 	18,985 	19,745
Liabilities of businesses held for sale (Note 2) 	219 	1,658
Liabilities of discontinued operations (Note 2) 	139 	203
Total liabilities 	225,162 	236,187
Preferred stock (5,939,875 shares outstanding at both March 31, 2020
and December 31, 2019) 	6 	6
Common stock (8,747,092,000 and 8,738,434,000 shares outstanding
at March 31, 2020 and December 31, 2019, respectively) 	702 	702
Accumulated other comprehensive income (loss) – net attributable to GE 	(10,819) 	(11,732)
Other capital 	34,296 	34,405
Retained earnings 	93,615 	87,732
Less common stock held in treasury 	(82,516) 	(82,797)
Total GE shareholders’ equity 	35,284 	28,316
Noncontrolling interests 	1,575 	1,545
Total equity 	36,859 	29,861
Total liabilities and equity 	$ 	262,021 	$ 	266,048
(a) Included operating lease right of use assets. The related liabilities are included in All Other Liabilities.
32 	2020 1Q FORM 10-Q

-- 38 of 93 --

FINANCIAL STATEMENTS
STATEMENT OF FINANCIAL POSITION (CONTINUED) 	GE(a) 	GE Capital
(UNAUDITED) 	(In millions, except share amounts)
March 31,
2020
December 31,
2019
March 31,
2020
December 31,
2019
Cash, cash equivalents and restricted cash 	$ 	33,810 	$ 	17,613 	$ 	13,475 	$ 	18,781
Investment securities (Note 3) 	4,184 	10,008 	38,117 	38,514
Current receivables (Note 4) 	13,076 	13,883 	— 	—
Financing receivables - net (Note 5) 	— 	— 	7,457 	6,979
Inventories (Note 6) 	15,457 	14,104 	— 	—
Other GE Capital receivables 	— 	— 	10,764 	11,767
Property, plant and equipment – net (Note 7)(b) 	17,088 	17,447 	30,058 	29,886
Receivable from GE Capital 	16,909 	19,142 	— 	—
Investment in GE Capital 	14,965 	15,299 	— 	—
Goodwill (Note 8) 	25,759 	25,895 	839 	839
Other intangible assets – net (Note 8) 	10,212 	10,461 	169 	192
Contract and other deferred assets (Note 10) 	16,168 	16,833 	— 	—
All other assets 	8,380 	8,399 	8,200 	8,648
Deferred income taxes (Note 14) 	8,654 	8,189 	1,803 	1,700
Assets of businesses held for sale (Note 2) 	43 	8,626 	247 	241
Assets of discontinued operations (Note 2) 	156 	202 	3,497 	3,907
Total assets 	$ 	184,861 	$ 	186,100 	$ 	114,626 	$ 	121,454
Short-term borrowings (Note 11) 	$ 	3,999 	$ 	5,606 	$ 	8,833 	$ 	12,030
Short-term borrowings assumed by GE (Note 11) 	5,888 	5,473 	2,519 	2,104
Accounts payable, principally trade accounts 	16,004 	17,702 	1,054 	886
Progress collections and deferred income (Note 10) 	19,986 	20,694 	— 	—
Other GE current liabilities 	17,186 	16,833 	— 	—
Non-recourse borrowings of consolidated securitization entities (Note 11) 	— 	— 	644 	1,655
Long-term borrowings (Note 11) 	14,997 	15,085 	28,144 	26,175
Long-term borrowings assumed by GE (Note 11) 	23,247 	25,895 	14,390 	17,038
Insurance liabilities and annuity benefits (Note 12) 	— 	— 	38,729 	40,232
Non-current compensation and benefits 	30,649 	31,208 	447 	472
All other liabilities(b) 	15,911 	16,156 	4,664 	5,278
Liabilities of businesses held for sale (Note 2) 	181 	1,620 	52 	52
Liabilities of discontinued operations (Note 2) 	108 	106 	31 	97
Total liabilities 	148,157 	156,379 	99,507 	106,016
Preferred stock (5,939,875 shares outstanding at both March 31, 2020
and December 31, 2019) 	6 	6 	6 	6
Common stock (8,747,092,000 and 8,738,434,000 shares outstanding
at March 31, 2020 and December 31, 2019, respectively) 	702 	702 	— 	—
Accumulated other comprehensive income (loss) - net attributable to GE 	(10,819) 	(11,732) 	(986) 	(852)
Other capital 	34,296 	34,405 	17,003 	17,001
Retained earnings 	93,615 	87,732 	(1,058) 	(857)
Less common stock held in treasury 	(82,516) 	(82,797) 	— 	—
Total GE shareholders’ equity 	35,284 	28,316 	14,965 	15,299
Noncontrolling interests 	1,421 	1,406 	154 	139
Total equity 	36,705 	29,721 	15,119 	15,438
Total liabilities and equity 	$ 	184,861 	$ 	186,100 	$ 	114,626 	$ 	121,454
(a) Represents the adding together of all GE Industrial affiliates and GE Capital continuing operations on a one-line basis. See Note 1.
(b) Included operating lease right of use assets. The related liabilities are included in All Other Liabilities.

-- 39 of 93 --

2020 1Q FORM 10-Q 	33

-- 40 of 93 --

FINANCIAL STATEMENTS
STATEMENT OF CASH FLOWS 	Three months ended March 31
(UNAUDITED) 	Consolidated
(In millions) 	2020 	2019
Net earnings (loss) 	$ 	6,233 	$ 	3,645
(Earnings) loss from discontinued operations 	178 	(2,663)
Adjustments to reconcile net earnings (loss)
to cash provided from operating activities
Depreciation and amortization of property, plant and equipment (Note 7) 	991 	995
Amortization of intangible assets (Note 8) 	340 	367
(Earnings) loss from continuing operations retained by GE Capital 	— 	—
(Gains) losses on purchases and sales of business interests (Note 23) 	(12,372) 	(253)
(Gains) losses on equity securities (Note 23) 	5,874 	(20)
Principal pension plans cost (Note 13) 	877 	868
Principal pension plans employer contributions 	(70) 	(65)
Other postretirement benefit plans (net) 	(254) 	(289)
Provision (benefit) for income taxes 	63 	140
Cash recovered (paid) during the year for income taxes 	(310) 	(280)
Decrease (increase) in contract and other deferred assets 	(12) 	(680)
Decrease (increase) in GE current receivables 	(503) 	545
Decrease (increase) in inventories 	(978) 	(1,165)
Increase (decrease) in accounts payable 	(601) 	215
Increase (decrease) in GE progress collections 	(655) 	(331)
All other operating activities 	1,050 	(609)
Cash from (used for) operating activities – continuing operations 	(148) 	420
Cash from (used for) operating activities – discontinued operations 	(67) 	(298)
Cash from (used for) operating activities 	(214) 	122
Additions to property, plant and equipment 	(1,027) 	(1,395)
Dispositions of property, plant and equipment 	731 	1,068
Additions to internal-use software 	(60) 	(69)
Net decrease (increase) in financing receivables 	(50) 	353
Proceeds from sale of discontinued operations 	— 	2,865
Proceeds from principal business dispositions 	20,488 	569
Net cash from (payments for) principal businesses purchased 	(6) 	—
All other investing activities 	(856) 	305
Cash from (used for) investing activities – continuing operations 	19,221 	3,696
Cash from (used for) investing activities – discontinued operations 	(134) 	(206)
Cash from (used for) investing activities 	19,086 	3,490
Net increase (decrease) in borrowings (maturities of 90 days or less) 	(1,905) 	(445)
Newly issued debt (maturities longer than 90 days) 	125 	731
Repayments and other debt reductions (maturities longer than 90 days) 	(5,903) 	(3,546)
Dividends paid to shareholders 	(89) 	(88)
All other financing activities 	(147) 	(113)
Cash from (used for) financing activities – continuing operations 	(7,919) 	(3,461)
Cash from (used for) financing activities – discontinued operations 	— 	(274)
Cash from (used for) financing activities 	(7,919) 	(3,735)
Effect of currency exchange rate changes on cash, cash equivalents and
restricted cash 	(256) 	78
Increase (decrease) in cash, cash equivalents and restricted cash 	10,697 	(45)
Cash, cash equivalents and restricted cash at beginning of year 	37,077 	35,548
Cash, cash equivalents and restricted cash at March 31 	47,774 	35,503
Less cash, cash equivalents and restricted cash of discontinued operations at March 31 	437 	3,671
Cash, cash equivalents and restricted cash of continuing operations at March 31 	$ 	47,338 	$ 	31,832

-- 41 of 93 --

34 	2020 1Q FORM 10-Q

-- 42 of 93 --

FINANCIAL STATEMENTS
STATEMENT OF CASH FLOWS (CONTINUED) 	Three months ended March 31
(UNAUDITED) 	GE(a) 	GE Capital
(In millions) 	2020 	2019 	2020 	2019
Net earnings (loss) 	$ 	6,190 	$ 	3,606 	$ 	(151) 	$ 	210
(Earnings) loss from discontinued operations 	178 	(2,663) 	164 	(35)
Adjustments to reconcile net earnings (loss)
to cash provided from operating activities
Depreciation and amortization of property, plant and equipment (Note 7) 	453 	505 	536 	488
Amortization of intangible assets (Note 8) 	315 	353 	25 	13
(Earnings) loss from continuing operations retained by GE Capital 	30 	(135) 	— 	—
(Gains) losses on purchases and sales of business interests (Note 23) 	(12,372) 	(253) 	— 	—
(Gains) losses on equity securities (Note 23) 	5,789 	(20) 	86 	(1)
Principal pension plans cost (Note 13) 	877 	868 	— 	—
Principal pension plans employer contributions 	(70) 	(65) 	— 	—
Other postretirement benefit plans (net) 	(247) 	(292) 	(8) 	3
Provision (benefit) for income taxes 	187 	268 	(123) 	(128)
Cash recovered (paid) during the year for income taxes 	(278) 	(272) 	(32) 	(8)
Decrease (increase) in contract and other deferred assets 	(12) 	(680) 	— 	—
Decrease (increase) in GE current receivables 	487 	(57) 	— 	—
Decrease (increase) in inventories 	(966) 	(1,088) 	— 	—
Increase (decrease) in accounts payable 	(1,468) 	(2) 	(5) 	(41)
Increase (decrease) in GE progress collections 	(673) 	(343) 	— 	—
All other operating activities 	(82) 	(336) 	784 	(451)
Cash from (used for) operating activities – continuing operations 	(1,662) 	(607) 	1,276 	50
Cash from (used for) operating activities – discontinued operations 	29 	(528) 	(95) 	(86)
Cash from (used for) operating activities 	(1,633) 	(1,135) 	1,181 	(36)
Additions to property, plant and equipment 	(504) 	(552) 	(541) 	(911)
Dispositions of property, plant and equipment 	29 	79 	709 	993
Additions to internal-use software 	(58) 	(66) 	(1) 	(3)
Net decrease (increase) in financing receivables 	— 	— 	(506) 	1,673
Proceeds from sale of discontinued operations 	— 	2,865 	— 	—
Proceeds from principal business dispositions 	20,505 	561 	(16) 	396
Net cash from (payments for) principal businesses purchased 	(6) 	(396) 	— 	—
All other investing activities 	81 	(245) 	300 	1,655
Cash from (used for) investing activities – continuing operations 	20,046 	2,246 	(56) 	3,802
Cash from (used for) investing activities – discontinued operations 	(33) 	(42) 	(101) 	152
Cash from (used for) investing activities 	20,013 	2,204 	(157) 	3,954
Net increase (decrease) in borrowings (maturities of 90 days or less) 	(1,881) 	(1,170) 	(514) 	(612)
Newly issued debt (maturities longer than 90 days) 	1 	248 	124 	483
Repayments and other debt reductions (maturities longer than 90 days) 	(64) 	(290) 	(5,840) 	(3,255)
Dividends paid to shareholders 	(89) 	(88) 	(42) 	(38)
All other financing activities 	(12) 	(18) 	(135) 	(95)
Cash from (used for) financing activities – continuing operations 	(2,045) 	(1,318) 	(6,406) 	(3,518)
Cash from (used for) financing activities – discontinued operations 	— 	(273) 	— 	(1)
Cash from (used for) financing activities 	(2,045) 	(1,592) 	(6,406) 	(3,519)
Effect of currency exchange rate changes on cash, cash equivalents and restricted cash 	(143) 	68 	(113) 	10
Increase (decrease) in cash, cash equivalents and restricted cash 	16,193 	(455) 	(5,495) 	409
Cash, cash equivalents and restricted cash at beginning of year 	17,617 	20,528 	19,460 	15,020
Cash, cash equivalents and restricted cash at March 31 	33,810 	20,073 	13,964 	15,429
Less cash, cash equivalents and restricted cash of discontinued operations
at March 31 	— 	3,078 	437 	593

-- 43 of 93 --

Cash, cash equivalents and restricted cash of continuing operations
at March 31 	$ 	33,810 	$ 	16,996 	$ 	13,527 	$ 	14,836
(a) Represents the adding together of all GE Industrial affiliates and the impact of GE Capital dividends on a one-line basis. See Note 1.
2020 1Q FORM 10-Q 	35

-- 44 of 93 --

FINANCIAL STATEMENTS
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) 	Three months ended March 31
(In millions, net of tax) 	2020 	2019
Net earnings (loss) 	$ 	6,233 	$ 	3,645
Less net earnings (loss) attributable to noncontrolling interests 	34 	57
Net earnings (loss) attributable to the Company 	$ 	6,199 	$ 	3,588
Investment securities 	$ 	(41) 	$ 	24
Currency translation adjustments 	135 	423
Cash flow hedges 	(211) 	38
Benefit plans 	1,035 	545
Other comprehensive income (loss) 	918 	1,031
Less: other comprehensive income (loss) attributable to noncontrolling interests 	5 	101
Other comprehensive income (loss) attributable to the Company 	$ 	913 	$ 	930
Comprehensive income (loss) 	$ 	7,152 	$ 	4,675
Less: comprehensive income (loss) attributable to noncontrolling interests 	39 	158
Comprehensive income (loss) attributable to the Company 	$ 	7,113 	$ 	4,517
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) 	Three months ended March 31
(In millions) 	2020 	2019
Preferred stock issued 	$ 	6 	$ 	6
Common stock issued 	$ 	702 	$ 	702
Beginning balance 	(11,732) 	(14,414)
Investment securities 	(41) 	23
Currency translation adjustments 	133 	324
Cash flow hedges 	(211) 	35
Benefit plans 	1,032 	547
Accumulated other comprehensive income (loss) ending balance 	$ 	(10,819) 	$ 	(13,485)
Beginning balance 	34,405 	35,504
Gains (losses) on treasury stock dispositions 	(249) 	(507)
Stock-based compensation 	105 	137
Other changes 	35 	(788)
Other capital ending balance 	$ 	34,296 	$ 	34,345
Beginning balance 	87,732 	93,109
Net earnings (loss) attributable to the Company 	6,199 	3,588
Dividends and other transactions with shareholders 	(142) 	(145)
Changes in accounting (Note 1) 	(175) 	368
Retained earnings ending balance 	$ 	93,615 	$ 	96,921
Beginning balance 	(82,797) 	(83,925)
Purchases 	(14) 	(38)
Dispositions 	295 	636
Common stock held in treasury ending balance 	$ 	(82,516) 	$ 	(83,328)
GE shareholders' equity balance 	35,284 	35,161
Noncontrolling interests balance (Note 15) 	1,575 	20,485
Total equity balance at March 31(a) 	$ 	36,859 	$ 	55,646
(a) 	Total equity balance decreased by 	$(18,787) 	million in the last twelve months from March 31, 2019, primarily due to reduction of non-controlling interest
balance of 	$(19,271) 	million attributable to Baker Hughes Class A shareholders at March 31, 2019, after-tax loss of 	$(8,238) million 	in discontinued
operations due to deconsolidation of Baker Hughes in the third quarter of 2019, 	after-tax change in unrealized loss on our remaining interest in Baker
Hughes 	$(4,631) million, 	partially offset by after-tax gain of 	$11,145 million 	due to 	the sale of our BioPharma business within our Healthcare segment. 	See
Notes 2 and 3 for further information.

-- 45 of 93 --

36 	2020 1Q FORM 10-Q

-- 46 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
We present our financial statements in a three-column format, which allows investors to see our GE industrial operations separately from our financial services
operations. We believe that this provides useful supplemental information to our consolidated financial statements. To the extent that we have transactions
between GE and GE Capital, these transactions are made on arm's length terms, are reported in the respective columns of our financial statements and are
eliminated in consolidation. See Note 20 for further information.
Our financial statements are prepared in conformity with U.S. generally accepted accounting principles (GAAP), which requires us to make estimates based on
assumptions about current and, for some estimates, future economic and market conditions which affect reported amounts and related disclosures in our
financial statements. Although our current estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual
conditions could differ from our expectations, which could materially affect our results of operations and financial position. In particular, a number of estimates
have been and will continue to be affected by the ongoing Coronavirus Disease 2019 (COVID-19) pandemic. The severity, magnitude and duration, as well as
the economic consequences of the COVID-19 pandemic, are uncertain, rapidly changing and difficult to predict. As a result, our accounting estimates and
assumptions may change over time in response to COVID-19. Such changes could result in future impairments of goodwill, intangibles, long-lived assets and
investment securities, revisions to estimated profitability on long-term product service agreements, incremental credit losses on receivables and debt securities,
a decrease in the carrying amount of our tax assets, or an increase in our insurance liabilities and pension obligations as of the time of a relevant measurement
event.
In preparing our Statement of Cash Flows, we make certain adjustments to reflect cash flows that cannot otherwise be calculated by changes in our Statement
of Financial Position. These adjustments may include, but are not limited to, the effects of currency exchange, acquisitions and dispositions of businesses,
businesses classified as held for sale, the timing of settlements to suppliers for property, plant and equipment, non-cash gains/losses and other balance sheet
reclassifications.
We have reclassified certain prior-period amounts to conform to the current-period’s presentation. Certain columns and rows may not add due to the use of
rounded numbers. Percentages presented are calculated from the underlying numbers in millions. Unless otherwise indicated, information in these notes to the
consolidated financial statements relates to continuing operations. Certain of our operations have been presented as discontinued. We present businesses
whose disposal represents a strategic shift that has, or will have, a major effect on our operations and financial results as discontinued operations when the
components meet the criteria for held for sale, are sold, or spun-off. See Note 2 for further information.
The accompanying consolidated financial statements and notes are unaudited. The results reported in these consolidated financial statements should not be
regarded as necessarily indicative of results that may be expected for the entire year. These consolidated financial statements should be read in conjunction
with the financial statements and notes included in our Annual Report on Form 10-K for the year ended 	December 31, 2019.
Our significant accounting policies are described in Note 1 to the consolidated financial statements of our aforementioned Annual Report. We include herein
certain updates to those policies.
Allowance for credit losses. 	When we record customer receivables, contract assets and financing receivables arising from revenue transactions, as well as
commercial mortgage loans and reinsurance recoveries in GE Capital’s run-off insurance operations, financial guarantees and certain commitments, we record
an allowance for credit losses for the current expected credit losses (CECL) inherent in the asset over its expected life. The allowance for credit losses is a
valuation account deducted from the amortized cost basis of the assets to present their net carrying value at the amount expected to be collected. Each period
the allowance for credit losses is adjusted through earnings to reflect expected credit losses over the remaining lives of the assets.
We estimate expected credit losses based on relevant information about past events, including historical experience, current conditions, and reasonable and
supportable forecasts that affect the collectability of the reported amount. When measuring expected credit losses, we pool assets with similar country risk and
credit risk characteristics. Changes in the relevant information may significantly affect the estimates of expected credit losses.
ACCOUNTING CHANGES. 	On January 1, 2020, we adopted ASU No. 2016-13, 	Financial Instruments - Credit Losses (ASU 2016-13). ASU 2016-13 requires
us to prospectively record an allowance for credit losses for the current expected credit losses inherent in the asset over its expected life, replacing the incurred
loss model that recognized losses only when they became probable and estimable. We recorded a 	$221 million 	increase in our allowance for credit losses and a
$175 million 	decrease to retained earnings, net of tax, reflecting the cumulative effect on retained earnings.
In the three months ended March 31, 2020, we increased our CECL reserves by recording a charge to earnings of 	$111 million 	to reflect higher expected credit
losses in our Aviation and GE Capital segments.
On January 1, 2020 we adopted ASU 2017-04, 	Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The ASU eliminates
Step 2 of the goodwill impairment test and the qualitative assessment for any reporting unit with a zero or negative carrying amount. The ASU also requires an
entity to disclose the amount of goodwill allocated to each reporting unit with a zero or negative carrying amount. The adoption did not have an impact on our
financial statements.
2020 1Q FORM 10-Q 	37

-- 47 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2. BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS
ASSETS AND LIABILITIES OF BUSINESSES HELD FOR SALE. 	On March 31, 2020, we completed the sale of our BioPharma business within our Healthcare
segment for total consideration of $21,141 million 	(after certain working capital adjustments). 	The consideration consisted of 	$20,724 million 	in cash and 	$417
million 	of pension liabilities that were assumed by Danaher. We received cash of 	$20,321 million 	on March 31st 	and an additional 	$403 million 	on April 1st. In
addition, we expect to incur approximately 	$200 million 	of cash payments directly associated with the transaction in the second quarter. As a result, we
recognized a pretax gain of 	$12,292 million 	($11,145 million 	after tax) in our consolidated Statement of Earnings (Loss).
Assets and liabilities of businesses held for sale primarily comprise the remaining Lighting business within Corporate and the remaining PK AirFinance business
within our Capital segment.
ASSETS AND LIABILITIES OF BUSINESSES HELD FOR SALE 	(In millions) 	March 31, 2020 	December 31, 2019
Current receivables 	$ 	217 	$ 	499
Inventories 	160 	712
Financing receivables held for sale 	197 	197
Property, plant, and equipment 	77 	958
Goodwill and Other intangible assets - net 	169 	6,286
Valuation allowance 	(412) 	(719)
Deferred income taxes 	— 	815
All other assets 	97 	400
Assets of businesses held for sale 	$ 	506 	$ 	9,149
Accounts payable & Progress collections and deferred income 	$ 	135 	$ 	843
Non-current compensation and benefits 	— 	466
All other liabilities 	84 	349
Liabilities of businesses held for sale 	$ 	219 	$ 	1,658
DISCONTINUED OPERATIONS. Discontinued operations primarily include our Baker Hughes and Transportation segments, and certain businesses in our GE
Capital segment (our mortgage portfolio in Poland and trailing liabilities associated with the sale of our GE Capital businesses). Results of operations, financial
position and cash flows for these businesses are reported as discontinued operations for all periods presented.
In September 2019, we reduced our ownership interest in Baker Hughes from 	50.2% 	to 	36.8% 	and reclassified its results to discontinued operations for all
periods presented.
We have continuing involvement with Baker Hughes primarily through our remaining interest, ongoing purchases and sales of products and services, transition
services that we provide to Baker Hughes as well as an aeroderivative joint venture, which we formed with Baker Hughes and currently consolidate. In the first
quarter of 2020, we had sales and purchases of products and services with Baker Hughes and affiliates of 	$290 million 	and 	$36 million, respectively. We have
collected net cash of 	$415 million 	from Baker Hughes related to these activities, including 	$106 million 	of repayments on the promissory note. In addition, in the
first quarter of 2020 we received a dividend of 	$68 million 	from Baker Hughes.
In February 2019, we completed the spin-off and subsequent merger of our Transportation business with Wabtec. 	As a result, we recorded a gain of 	$3,471
million 	($2,508 million 	after-tax) in discontinued operations.
38 	2020 1Q FORM 10-Q

-- 48 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
RESULTS OF DISCONTINUED OPERATIONS
(In millions) 	Baker Hughes 	Transportation 	GE Capital 	Total
Three months ended March 31 	2020 	2019 	2020 	2019 	2020 	2019 	2020 	2019
Operations
Sales of goods and services 	$ 	— 	$ 	5,616 	$ 	— 	$ 	549 	$ 	— 	$ 	— 	$ 	— 	$ 	6,165
GE Capital revenues from services 	— 	— 	— 	— 	(76) 	39 	(76) 	39
Cost of goods and services sold 	— 	(4,677) 	— 	(478) 	— 	— 	— 	(5,155)
Other costs and expenses 	— 	(787) 	(4) 	(9) 	(85) 	(74) 	(89) 	(870)
Earnings (loss) of discontinued operations before income taxes 	— 	152 	(4) 	62 	(161) 	(35) 	(165) 	179
Benefit (provision) for income taxes 	(13) 	(82) 	7 	(12) 	(3) 	25 	(9) 	(70)
Earnings (loss) of discontinued operations, net of taxes(a) 	$ 	(13) 	$ 	70 	$ 	3 	$ 	50 	$ 	(164) 	$ 	(10) 	$ 	(174) 	$ 	109
Disposal
Gain (loss) on disposal before income taxes 	(4) 	— 	— 	3,471 	— 	47 	(4) 	3,518
Benefit (provision) for income taxes 	— 	— 	— 	(963) 	— 	(2) 	— 	(964)
Gain (loss) on disposal, net of taxes 	$ 	(4) 	$ 	— 	$ 	— 	$ 	2,508 	$ 	— 	$ 	45 	$ 	(4) 	$ 	2,553
Earnings (loss) from discontinued operations, net of taxes 	$ 	(17) 	$ 	70 	$ 	3 	$ 	2,558 	$ 	(164) 	$ 	35 	$ 	(178) 	$ 	2,663
(a) Earnings (loss) of discontinued operations attributable to the Company after income taxes was 	$(172) million 	and 	$76 million 	for the three months ended
March 31, 2020 and 2019 respectively.
ASSETS AND LIABILITIES OF DISCONTINUED OPERATIONS 	(In millions) 	March 31, 2020 	December 31, 2019
Cash, cash equivalents and restricted cash 	$ 	437 	$ 	638
Investment securities 	170 	202
Current receivables 	63 	81
Financing receivables held for sale (Polish mortgage portfolio) 	2,371 	2,485
Property, plant, and equipment 	117 	123
Deferred income taxes 	211 	264
All other assets 	285 	317
Assets of discontinued operations 	$ 	3,653 	$ 	4,109
Accounts payable & Progress collections and deferred income 	$ 	22 	$ 	40
All other liabilities (a) 	117 	163
Liabilities of discontinued operations 	$ 	139 	$ 	203
(a) 	Included within All other liabilities of discontinued operations at March 31, 2020 and December 31, 2019 are intercompany tax receivables in the amount of
$880 million 	and 	$839 million, respectively, primarily related to the financial services businesses that were part of the GE Capital Exit Plan, which are offset
within All other liabilities of consolidated GE.
NOTE 3. INVESTMENT SECURITIES
All of our debt securities are classified as available-for-sale and substantially all are investment-grade debt securities supporting obligations to annuitants and
policyholders in our run-off insurance operations. Changes in fair value of our debt securities are recorded in other comprehensive income. Equity securities with
readily determinable fair values are included within this caption and changes in their fair value are recorded in earnings.
March 31, 2020 	December 31, 2019
(In millions)
Amortized
cost
Gross
unrealized
gains
Gross
unrealized
losses
Estimated
fair value
Amortized
cost
Gross
unrealized
gains
Gross
unrealized
losses
Estimated
fair value
Debt
U.S. corporate 	$ 	23,167 	$ 	3,795 	$ 	(493) 	$ 	26,470 	$ 	23,037 	$ 	4,636 	$ 	(11) 	$ 	27,661
Non-U.S. corporate 	2,155 	150 	(60) 	2,246 	2,161 	260 	(1) 	2,420
State and municipal 	3,090 	638 	(21) 	3,708 	3,086 	598 	(15) 	3,669
Mortgage and asset-backed 	3,296 	51 	(143) 	3,205 	3,117 	116 	(4) 	3,229
Government and agencies 	1,269 	157 	— 	1,427 	1,391 	126 	— 	1,516
Equity 	5,245 	— 	— 	5,245 	10,025 	— 	— 	10,025

-- 49 of 93 --

Total 	$ 	38,223 	$ 	4,792 	$ 	(716) 	$ 	42,299 	$ 	42,816 	$ 	5,736 	$ 	(31) 	$ 	48,521
2020 1Q FORM 10-Q 	39

-- 50 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The amortized cost of debt securities as of March 31, 2020 excludes accrued interest of 	$432 million, which is reported in Other GE Capital receivables.
The estimated fair values of investment securities at March 31, 2020 decreased since December 31, 2019, primarily due to the mark-to-market effects on our
remaining interest in Baker Hughes, as well as an increase in market interest rates as a result of a significant widening in credit spreads, a significant decline in
oil prices and a challenging liquidity environment. The fair value of remaining Baker Hughes interest 	and promissory note receivable was 	$4,083 million 	at March
31, 2020.
Gross unrealized losses of 	$(685) million 	and 	$(31) million 	are associated with debt securities with a fair value of 	$6,253 million 	and 	$173 million 	that have been
in a loss position for less than 12 months and 12 months or more, respectively, at March 31, 2020. Gross unrealized losses of 	$(11) million 	and 	$(20) million 	are
associated with debt securities with a fair value of 	$724 million 	and 	$274 million 	that have been in a loss position for less than 12 months and 12 months or
more, respectively, at December 31, 2019.
At March 31, 2020, gross unrealized losses of 	$(716) million 	included 	$(493) million 	related to U.S. corporate securities and 	$(114) million 	related to commercial
mortgage-backed securities (CMBS). Of the U.S. corporate securities in an unrealized loss position, 	$(313) million 	and 	$(57) million 	related to the energy and
consumer industries, respectively. Substantially all of our CMBS in an unrealized loss position have received investment-grade credit ratings from the major
rating agencies and are collateralized by pools of commercial mortgage loans on real estate.
With respect to our debt securities that are in an unrealized loss position at March 31, 2020, our current intention is to hold them at least until such time as their
individual fair values exceed their amortized cost and based upon the long duration of our insurance liabilities, we have the ability to hold all such debt securities
until their maturities. 	We assessed debt securities in an unrealized loss position for credit losses and recognized an allowance for credit losses on investment
securities of 	$(24) million 	for the three months ending March 31, 2020. 	In addition to our qualitative and quantitative evaluation criteria, our credit loss
assessment at March 31, 2020 considered the continuing market deterioration that resulted in the lack of liquidity and the historic levels of price volatility and
credit spreads in the fixed income market. With respect to corporate bonds, we evaluated the credit quality of the issuers. With respect to CMBS, we evaluated
the cash flows from the underlying collateral.
Net unrealized gains (losses) for equity securities with readily determinable fair values, which are recorded in Other income within continuing operations, were
$(5,772) million 	and 	an insignificant amount 	for the three months ended March 31, 2020 and 2019, respectively. The amount recognized in the three months
ended March 31, 2020 primarily included a loss of 	$(5,710) million 	related to our interest in Baker Hughes and 	$(85) million 	at GE Capital, predominantly from
fixed income exchange traded funds supporting our insurance liabilities and annuity benefits.
Proceeds from debt and equity securities sales, early redemptions by issuers and principal payments on the Baker Hughes promissory note totaled 	$1,250
million 	and 	$1,421 	million for the three months ended March 31, 2020 and 2019, respectively. 	Gross realized gains on investment securities were 	$46 million
and 	$44 million 	and gross realized losses and impairments were 	$(17) million 	and 	$(39) million 	for the three months ended 	March 31, 2020 	and 2019,
respectively.
Contractual maturities of investments in debt securities (excluding mortgage and asset-backed securities) at March 31, 2020 are as follows:
(In millions)
Amortized
cost
Estimated
fair value
Due
Within one year 	$ 	610 	$ 	621
After one year through five years 	2,328 	2,400
After five years through ten years 	6,616 	7,226
After ten years 	20,128 	23,603
We expect actual maturities to differ from contractual maturities because issuers have the right to call or prepay certain obligations.
Substantially all our equity securities are classified within Level 1 and substantially all our debt securities are classified within Level 2 as their valuation is
determined based on significant observable inputs. Investments with a fair value of $5,046 	million and 	$5,210 million 	were classified within Level 3 as significant
inputs to the valuation model are unobservable at 	March 31, 2020 	and December 31, 2019, respectively. During the 	three 	months ended 	March 31, 2020 	and
2019, there were no significant transfers into or out of Level 3.
In addition to the equity securities described above, we hold 	$429 million 	and 	$517 million 	of equity securities without readily determinable fair value at 	March
31, 2020 	and December 31, 2019, respectively, that are classified within All other assets in our consolidated Statement of Financial Position. Fair value
adjustments, including impairments, recorded in earnings were 	$(93) million 	and an insignificant amount for the three months ended March 31, 2020 and 2019,
respectively.
40 	2020 1Q FORM 10-Q

-- 51 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 4. CURRENT AND LONG-TERM RECEIVABLES
CURRENT RECEIVABLES 	Consolidated 	GE
(In millions) 	March 31, 2020 	December 31, 2019 	March 31, 2020 	December 31, 2019
Customer receivables(a) 	$ 	12,877 	$ 	12,594 	$ 	8,920 	$ 	9,507
Sundry receivables(b) 	4,976 	5,049 	5,082 	5,247
Allowance for losses 	(929) 	(874) 	(926) 	(872)
Total current receivables 	$ 	16,925 	$ 	16,769 	$ 	13,076 	$ 	13,883
(a) Includes receivables from Boeing due to 737 MAX temporary fleet grounding of 	$1,407 million 	and 	$1,397 million 	as of March 31, 2020 and December 31,
2019, respectively.
(b) 	Includes 	supplier advances, revenue sharing programs receivables, other non-income based tax receivables, certain intercompany balances that eliminate
upon consolidation and deferred purchase price. 	The deferred purchase price represents our retained risk with respect to current customer receivables sold
to third parties through one of the receivable facilities. 	The balance of the deferred purchase price held by GE Capital at 	March 31, 2020 	and December 31,
2019 was $502 	million and $421 	million, respectively.
Sales of GE current customer receivables. 	When GE sells customer receivables to GE Capital or third parties it accelerates the receipt of cash that would
otherwise have been collected from customers. In any given period, the amount of cash received from sales of customer receivables compared to the cash GE
would have otherwise collected had those customer receivables not been sold represents the cash generated or used in the period relating to this activity. GE
sales of customer receivables to GE Capital or third parties are made on arm's length terms and any discount related to time value of money is recognized by
GE when the customer receivables are sold. 	As of 	March 31, 2020 	and 2019, GE sold approximately 	49% 	and 	65%, respectively, of its gross customer
receivables to GE Capital or third parties. 	Activity related to customer receivables sold by GE is as follows:
(In millions) 	2020 	2019
GE Capital 	Third Parties 	GE Capital 	Third Parties
Balance at January 1 	$ 	3,087 	$ 	6,757 	$ 	4,386 	$ 	7,880
GE sales to GE Capital 	9,225 	— 	9,690 	—
GE sales to third parties 	— 	515 	— 	1,376
GE Capital sales to third parties 	(5,253) 	5,253 	(6,591) 	6,591
Collections and other 	(3,224) 	(8,005) 	(3,967) 	(8,123)
Reclassification from long-term customer receivables 	123 	— 	140 	—
Balance at March 31 	$ 	3,958 	(a)(b) 	$ 	4,519 	$ 	3,657 	(a) 	$ 	7,724
(a) 	At March 31, 2020 and 2019, $557 	million and $1,248 	million, respectively, of the current receivables purchased and retained by GE Capital had been sold
by GE to GE Capital with recourse (i.e., GE retains all or some risk of default). The effect on GE CFOA of claims by GE Capital on receivables sold with
recourse was insignificant for the three months ended March 31, 2020 and 2019.
(b) 	The 	$871 million 	increase in GE current receivables purchased and retained by GE Capital in the quarter was driven by a plan to use excess liquidity in GE
Capital to purchase and retain GE current receivables. GE Aviation receivables were substantially all of the increase and approximately 	$288 million 	of that
increase can be attributed to lower third-party demand for certain GE Aviation receivables.
LONG-TERM RECEIVABLES. 	In certain circumstances, GE provides customers, primarily within our Power, Renewable Energy and Aviation businesses, with
extended payment terms for the purchase of new equipment, purchases of upgrades and spare parts for our long-term service agreements. These long-term
customer receivables are initially recorded at present value and have an average remaining duration of approximately 	three 	years and are included in All other
assets in the consolidated Statement of Financial Position.
Consolidated 	GE
(In millions) 	March 31, 2020 	December 31, 2019 	March 31, 2020 	December 31, 2019
Long-term customer receivables(a) 	$ 	756 	$ 	906 	$ 	492 	$ 	506
Long-term sundry receivables(b) 	1,437 	1,504 	1,647 	1,834
Allowance for losses 	(131) 	(128) 	(131) 	(128)
Total long-term receivables 	$ 	2,063 	$ 	2,282 	$ 	2,008 	$ 	2,212
(a) At March 31, 2020 and December 31, 2019, GE Capital held 	$265 million 	and 	$400 million, respectively, of GE long-term customer receivables, of which
$222 million 	and 	$312 million 	had been purchased with recourse (i.e., GE retains all or some risk of default). The effect on GE cash flows from operating
activities (CFOA) of claims on long-term receivables sold with recourse was insignificant for the three months ended March 31, 2020 and the year ended
December 31, 2019.
(b) 	Includes supplier advances, revenue sharing programs receivables, other non-income based tax receivables and certain intercompany balances that
eliminate upon consolidation.
Sales of GE long-term customer receivables. 	Similar to sales of current customer receivables, sales of long-term customer receivables can result in cash
generation or use in our consolidated Statement of Cash Flows. 	During the three months ended March 31, 2020 and 2019, GE Capital did not purchase any GE
long-term customer receivables. Reductions in GE Capital outstanding GE long-term customer receivables were attributable to collections and reclassification to
short-term receivables.

-- 52 of 93 --

2020 1Q FORM 10-Q 	41

-- 53 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
UNCONSOLIDATED RECEIVABLES FACILITIES. GE Capital has 	two 	revolving receivables facilities, under which customer receivables purchased from GE
are sold to third parties. In the first facility, which has a program size of 	$3,100 million, upon the sale of receivables, we receive proceeds of cash and deferred
purchase price and the Company’s remaining risk with respect to the sold receivables is limited to the balance of the deferred purchase price. In the second
facility, which has a program size of 	$600 million, upon the sale of receivables, we receive proceeds of cash only and therefore the Company has no remaining
risk with respect to the sold receivables. The program size of the second facility reduced from 	$1,200 million 	to 	$600 million 	in March 2020. Current receivables
that would otherwise have been sold to third parties were retained by GE Capital to utilize available funding.
Activity related to these facilities is included in the GE Capital sales to third parties line in the sales of GE current customer receivables table above and is as
follows:
Three months ended March 31 	(In millions) 	2020 	2019
Customer receivables sold to receivables facilities 	$ 	4,307 	$ 	5,175
Total cash purchase price for customer receivables 	4,120 	5,071
Cash collections re-invested to purchase customer receivables 	3,723 	4,253
Non-cash increases to deferred purchase price 	$ 	160 	$ 	44
Cash payments received on deferred purchase price 	78 	61
CONSOLIDATED SECURITIZATION ENTITIES. GE Capital consolidates 	three 	variable interest entities (VIEs) that purchased customer receivables and long-
term customer receivables from GE. At March 31, 2020 and December 31, 2019 these VIEs held current customer receivables of 	$1,619 million 	and 	$2,080
million 	and long-term customer receivables of 	$251 million 	and 	$375 million, respectively. At March 31, 2020 and December 31, 2019, the outstanding non-
recourse debt under their respective debt facilities was 	$644 million 	and 	$1,655 million, respectively.
NOTE 5. FINANCING RECEIVABLES AND ALLOWANCES
Consolidated 	GE Capital
(In millions) 	March 31, 2020 	December 31, 2019 	March 31, 2020 	December 31, 2019
Loans, net of deferred income 	$ 	1,141 	$ 	1,098 	$ 	5,568 	$ 	4,927
Investment in financing leases, net of deferred income 	1,921 	2,070 	1,921 	2,070
3,062 	3,168 	7,489 	6,996
Allowance for losses 	(65) 	(33) 	(33) 	(17)
Financing receivables – net 	$ 	2,998 	$ 	3,134 	$ 	7,457 	$ 	6,979
Consolidated finance lease income was 	$43 million 	and 	$46 million 	in the three months ended March 31, 2020 and 2019, respectively.
We manage our GE Capital financing receivables portfolio using delinquency and nonaccrual data as key performance indicators. At March 31, 2020, 	6.2%,
2.8% 	and 	5.7% 	of financing receivables were over 30 days past due, over 90 days past due and on nonaccrual, respectively, with the vast majority of
nonaccrual financing receivables secured by collateral. At December 31, 2019, 	4.2%, 	2.9% 	and 	6.1% 	of financing receivables were over 30 days past due, over
90 days past due and on nonaccrual, respectively.
GE Capital financing receivables that comprise receivables purchased from GE are reclassified to either Current receivables or All other assets in the
consolidated Statement of Financial Position. To the extent these receivables are purchased with full or limited recourse, they are excluded from the delinquency
and nonaccrual data above. See Note 4 for further information.
NOTE 6. INVENTORIES
(In millions) 	March 31, 2020 	December 31, 2019
Raw materials and work in process 	$ 	9,192 	$ 	8,771
Finished goods 	6,265 	5,333
Total inventories 	$ 	15,457 	$ 	14,104
NOTE 7. PROPERTY, PLANT AND EQUIPMENT
PROPERTY, PLANT AND EQUIPMENT 	(In millions) 	March 31, 2020 	December 31, 2019
Original cost 	$ 	75,619 	$ 	75,187
Less accumulated depreciation and amortization 	(32,453) 	(31,897)
Property, plant and equipment – net 	$ 	43,166 	$ 	43,290

-- 54 of 93 --

Consolidated depreciation and amortization on property, plant and equipment was 	$991 million 	and 	$995 million 	for the three months ended 	March 31, 2020 	and
2019, respectively.
42 	2020 1Q FORM 10-Q

-- 55 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Operating lease income on our equipment leased to others, primarily from our GECAS business, was 	$876 million 	and 	$932 million 	for the three months ended
March 31, 2020 and 2019, respectively, and comprises fixed lease income of 	$705 million 	and 	$764 million 	and variable lease income of 	$171 million 	and 	$168
million, respectively.
Operating Lease Assets and Liabilities. 	Our consolidated Right of use operating lease (ROU) assets, included within property, plant and equipment in our
Statement of Financial Position were 	$2,813 million 	and 	$2,896 million, as of March 31, 2020 and December 31, 2019, respectively. Our consolidated operating
lease liabilities, included in All other liabilities in our Statement of Financial Position, were 	$3,067 million 	and 	$3,162 million, as of March 31, 2020 and December
31, 2019, respectively, which included GE Industrial operating lease liabilities of 	$3,266 million 	and 	$3,369 million, respectively.
OPERATING LEASE EXPENSE 	Three months ended March 31
(In millions) 	2020 	2019
Long-term (fixed) 	$ 	177 	$ 	225
Long-term (variable) 	21 	44
Short-term 	68 	47
Total operating lease expense 	$ 	266 	$ 	317
NOTE 8. GOODWILL AND OTHER INTANGIBLE ASSETS
GOODWILL 	(In millions) 	January 1, 2020
Dispositions and
classification to held
for sale
Currency
exchange
and other
Balance at
March 31, 2020
Power 	$ 	145 	$ 	— 	$ 	— 	$ 	145
Renewable Energy 	3,290 	— 	(74) 	3,216
Aviation 	9,859 	— 	(41) 	9,818
Healthcare 	11,728 	— 	(17) 	11,711
Capital 	839 	— 	— 	839
Corporate 	873 	— 	(5) 	869
Total 	$ 	26,734 	$ 	— 	$ 	(136) 	$ 	26,598
In assessing the possibility that a reporting unit’s fair value has been reduced below its carrying amount due to the occurrence of events or circumstances
between annual impairment testing dates, we consider all available evidence, including (i) the results of our impairment testing from the most recent testing date
(in particular, the magnitude of the excess of fair value over carrying value observed), (ii) downward revisions to internal forecasts or decreases in market
multiples (and the magnitude thereof), if any, and (iii) declines in market capitalization below book value (and the magnitude and duration of those declines), if
any.
In the first quarter of 2020, we performed 	an analysis of the impact of recent events, including business and industry specific considerations, on the fair values 	of
our Additive reporting unit in our Aviation segment, our GECAS reporting unit in our Capital segment, and our Grid Solutions software reporting unit in our Digital
business within Corporate. We did not identify any reporting units that required an interim impairment test. While the goodwill of these reporting units is not
currently impaired there can be no assurances that goodwill will not be impaired in future periods. We will continue to monitor the operating results, cash flow
forecasts and challenges from declines in current market conditions, as well as impacts of COVID-19 for these reporting units as their fair values are not
significantly in excess of their respective carrying values. At March 31, 2020, goodwill in our Additive, GECAS, and Grid Solutions software reporting units was
$1,091 million, 	$839 million 	and 	$869 million, respectively.
OTHER INTANGIBLE ASSETS - NET 	(In millions) 	March 31, 2020 	December 31, 2019
Intangible assets subject to amortization 	$ 	10,381 	$ 	10,653
Intangible assets decreased in the first quarter of 2020, primarily as a result of amortization. Consolidated amortization expense was 	$340 million 	and 	$367
million 	in the three months ended March 31, 2020 and 2019, respectively.
2020 1Q FORM 10-Q 	43

-- 56 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 9. REVENUES
The equipment and services revenues classification in the table below is consistent with our segment MD&A presentation.
EQUIPMENT & SERVICES REVENUES 	Three months ended March 31
(In millions) 	2020 	2019
Equipment 	Services 	Total 	Equipment 	Services 	Total
Power 	$ 	1,506 	$ 	2,518 	$ 	4,025 	$ 	1,576 	$ 	3,041 	$ 	4,617
Renewable Energy 	2,576 	618 	3,194 	1,982 	557 	2,538
Aviation 	2,444 	4,449 	6,892 	3,113 	4,841 	7,954
Healthcare 	2,699 	2,029 	4,727 	2,653 	2,029 	4,683
Corporate items and industrial eliminations 	(48) 	54 	6 	284 	248 	532
Total GE Industrial revenues 	$ 	9,177 	$ 	9,668 	$ 	18,844 	$ 	9,608 	$ 	10,716 	$ 	20,324
REVENUES 	Three months ended March 31
(In millions) 	2020 	2019
Gas Power 	$ 	2,859 	$ 	3,263
Power Portfolio 	1,165 	1,355
Power 	$ 	4,025 	$ 	4,617
Onshore Wind 	$ 	2,124 	$ 	1,441
Grid Solutions equipment and services 	839 	917
Hydro, Offshore Wind and other 	230 	180
Renewable Energy 	$ 	3,194 	$ 	2,538
Commercial Engines & Services 	$ 	4,777 	$ 	5,949
Military 	960 	1,036
Systems & Other 	1,156 	969
Aviation 	$ 	6,892 	$ 	7,954
Healthcare Systems 	$ 	3,448 	$ 	3,433
Life Sciences(a) 	1,280 	1,251
Healthcare 	$ 	4,727 	$ 	4,683
Corporate items and industrial eliminations 	6 	532
Total GE Industrial revenues 	$ 	18,844 	$ 	20,324
Capital 	1,923 	2,227
GE Capital-GE eliminations 	$ 	(244) 	$ 	(349)
Consolidated revenues 	$ 	20,524 	$ 	22,202
(a) Includes revenues of $830 million and $765 million from BioPharma 	for the 	three 	months ended 	March 31, 2020 	and 	2019, respectively.
REMAINING PERFORMANCE OBLIGATION. 	As of March 31, 2020, the aggregate amount of the contracted revenues allocated to our unsatisfied (or partially
unsatisfied) performance obligations was 	$240,381 	million. We expect to recognize revenue as we satisfy our remaining performance obligations as follows: 	1)
equipment-related remaining performance obligation of 	$45,171 	million, of which 	61%, 	81% 	and 	96% 	is expected to be satisfied within 	1, 	2 	and 	5 years,
respectively, and the remaining thereafter; 	and 2) 	services-related remaining performance obligation of 	$195,211 	million, of which 	12%, 	44%, 	71% 	and 	82% 	is
expected to be recognized within 	1, 	5, 	10 	and 	15 years, respectively, and the remaining thereafter. 	Contract modifications could affect both the timing to
complete as well as the amount to be received as we fulfill the related remaining performance obligations.
NOTE 10. CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME
Contract and other deferred assets 	decreased 	$665 million 	in 	2020. Our long-term service agreements 	decreased primarily due to billings of 	$2,544 million
and a net unfavorable change in estimated profitability of 	$193 million 	at Aviation and 	$72 million 	at Power, offset by revenues recognized of 	$2,688 million. The
change in estimated profitability at Aviation included a 	$100 million 	non-cash pre-tax charge (reduction in revenues and profit) to reflect the cumulative impacts
of changes to assumptions for certain long-term service agreements. Additional adjustments are likely to occur in future periods and could be material as
conditions related to COVID-19 continue to evolve.
44 	2020 1Q FORM 10-Q

-- 57 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2020 	(In millions) 	Power 	Aviation
Renewable
Energy 	Healthcare 	Other 	Total
Revenues in excess of billings 	$ 	5,197 	$ 	4,909 	$ 	— 	$ 	— 	$ 	— 	$ 	10,106
Billings in excess of revenues 	(1,586) 	(3,660) 	— 	— 	— 	(5,247)
Long-term service agreements(a) 	3,611 	1,248 	— 	— 	— 	4,859
Short-term and other service agreements 	155 	389 	33 	174 	45 	795
Equipment contract revenues(b) 	2,425 	60 	1,185 	278 	133 	4,081
Total contract assets 	6,191 	1,696 	1,217 	452 	178 	9,735
Deferred inventory costs 	887 	481 	1,148 	342 	1 	2,859
Nonrecurring engineering costs 	49 	2,306 	43 	33 	— 	2,431
Customer advances and other(c) 	— 	1,143 	— 	— 	(32) 	1,111
Contract and other deferred assets 	$ 	7,127 	$ 	5,627 	$ 	2,409 	$ 	827 	$ 	146 	$ 	16,136
December 31, 2019 	(In millions)
Revenues in excess of billings 	$ 	5,342 	$ 	4,996 	$ 	— 	$ 	— 	$ 	— 	$ 	10,338
Billings in excess of revenues 	(1,561) 	(3,719) 	— 	— 	— 	(5,280)
Long-term service agreements(a) 	3,781 	1,278 	— 	— 	— 	5,058
Short-term and other service agreements 	190 	316 	43 	169 	— 	717
Equipment contract revenues(b) 	2,508 	82 	1,217 	324 	106 	4,236
Total contract assets 	6,478 	1,675 	1,260 	492 	106 	10,011
Deferred inventory costs 	943 	287 	1,677 	359 	— 	3,267
Nonrecurring engineering costs 	44 	2,257 	47 	35 	8 	2,391
Customer advances and other(c) 	— 	1,165 	— 	— 	(32) 	1,133
Contract and other deferred assets 	$ 	7,465 	$ 	5,384 	$ 	2,985 	$ 	886 	$ 	82 	$ 	16,801
(a) 	Included amounts due from customers at Aviation for the sales of engines, spare parts and services, which we will collect through higher usage-based fees
from servicing equipment under long-term service agreements, totaling 	$1,777 million 	and 	$1,712 million 	as of 	March 31, 2020 	and 	December 31, 2019,
respectively. The corresponding discount is recorded within liabilities as Deferred income and amounted to 	$332 million 	and 	$308 million 	as of 	March 31,
2020 	and 	December 31, 2019, respectively.
(b) 	Included are amounts due from customers at Power for the sale of services upgrades, which we collect through incremental fixed or usage-based fees from
servicing the equipment under long-term service agreements, totaling 	$877 million 	and 	$909 million 	as of 	March 31, 2020 	and 	December 31, 2019,
respectively.
(c) 	Included advances to and amounts due from customers at Aviation for the sale of engines, spare parts and services, which we will collect through
incremental fees for goods and services to be delivered in future periods, totaling 	$961 million 	and 	$986 million 	as of 	March 31, 2020 	and 	December 31,
2019, respectively. The corresponding discount is recorded within liabilities as Deferred income and amounted to 	$268 million 	and 	$256 million 	as of 	March
31, 2020 	and 	December 31, 2019, respectively.
Progress collections and deferred income 	decreased 	$708 million 	in the first quarter of 	2020 	primarily due to the timing of revenue recognition in excess of
new collections received, primarily at Power and Renewable Energy. These decreases were partially offset by milestone payments received, primarily at
Aviation.
Revenues recognized for contracts included in liability position at the beginning of the year were 	$3,898 million 	and 	$4,608 million 	for the 	three 	months ended
March 31, 2020 	and 	2019, respectively.
March 31, 2020 	(In millions) 	Power 	Aviation
Renewable
Energy 	Healthcare 	Other 	Total
Progress collections on equipment contracts 	$ 	5,418 	$ 	144 	$ 	1,146 	$ 	— 	$ 	— 	$ 	6,709
Other progress collections 	317 	4,791 	3,999 	312 	170 	9,589
Total progress collections 	5,735 	4,935 	5,145 	312 	170 	16,298
Deferred income(a) 	41 	1,569 	316 	1,654 	109 	3,689
GE Progress collections and deferred income 	$ 	5,776 	$ 	6,504 	$ 	5,461 	$ 	1,966 	$ 	279 	$ 	19,986
December 31, 2019 	(In millions)
Progress collections on equipment contracts 	$ 	5,857 	$ 	115 	$ 	1,268 	$ 	— 	$ 	— 	$ 	7,240
Other progress collections 	413 	4,748 	4,193 	305 	189 	9,849
Total progress collections 	6,270 	4,863 	5,461 	305 	189 	17,089

-- 58 of 93 --

Deferred income(a) 	49 	1,528 	284 	1,647 	98 	3,606
GE Progress collections and deferred income 	$ 	6,319 	$ 	6,391 	$ 	5,745 	$ 	1,952 	$ 	287 	$ 	20,694
(a) 	Included in this balance are finance discounts associated with customer advances at Aviation of 	$600 million 	and 	$564 million 	as of 	March 31, 2020 	and
December 31, 2019, respectively.
2020 1Q FORM 10-Q 	45

-- 59 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 11. BORROWINGS
(In millions) 	March 31, 2020 	December 31, 2019
Short-term borrowings
Commercial paper 	$ 	1,946 	$ 	3,008
Current portion of long-term borrowings 	764 	766
Current portion of long-term borrowings assumed by GE 	5,888 	5,473
Other 	1,288 	1,832
Total GE short-term borrowings 	$ 	9,887 	$ 	11,079
Current portion of long-term borrowings 	$ 	8,542 	$ 	11,226
Intercompany payable to GE 	2,519 	2,104
Other 	292 	804
Total GE Capital short-term borrowings 	$ 	11,353 	$ 	14,134
Eliminations 	(3,118) 	(3,140)
Total short-term borrowings 	$ 	18,122 	$ 	22,072
Long-term borrowings
Senior notes 	$ 	14,717 	$ 	14,762
Senior notes assumed by GE 	21,590 	23,024
Subordinated notes assumed by GE 	1,658 	2,871
Other 	281 	324
Total GE long-term borrowings 	$ 	38,244 	$ 	40,980
Senior notes 	$ 	27,373 	$ 	25,371
Subordinated notes 	177 	178
Intercompany payable to GE 	14,390 	17,038
Other 	593 	626
Total GE Capital long-term borrowings 	$ 	42,534 	$ 	43,213
Eliminations 	(14,390) 	(17,038)
Total long-term borrowings 	$ 	66,388 	$ 	67,155
Non-recourse borrowings of consolidated securitization entities 	644 	1,655
Total borrowings 	$ 	85,154 	$ 	90,882
At 	March 31, 2020, the outstanding GE Capital borrowings that had been assumed by GE as part of the GE Capital Exit Plan was 	$29,136 million 	($5,888 million
short term and 	$23,247 	million long term), for which GE has an offsetting Receivable from GE Capital of 	$16,909 million. The difference of 	$12,226 million
($3,369 million 	in short-term borrowings and 	$8,857 million 	in long-term borrowings) represents the amount of borrowings GE Capital had funded with available
cash to GE via intercompany loans in lieu of GE issuing borrowings externally. During the first quarter of 2020, GE had not repaid any intercompany loans from
GE Capital.
At 	March 31, 2020, total GE borrowings of 	$31,222 million 	comprised of GE-issued borrowings of 	$18,996 million 	and intercompany loans from GE Capital to GE
of 	$12,226 million 	as described above.
GE has provided a full and unconditional guarantee on the payment of the principal and interest on all tradable senior and subordinated outstanding long-term
debt securities issued by GE Capital. This guarantee applies to 	$33,077 million 	and 	$34,683 million 	of GE Capital debt at March 31, 2020 and December 31,
2019, respectively.
Non-recourse borrowings of consolidated securitization entities included 	$644 million 	and 	$1,569 million 	of current portion of long-term borrowings at March 31,
2020 and December 31, 2019, respectively. See Notes 4 and 18 for further information.
On April 22, 2020, GE issued a total of 	$6,000 million 	in aggregate principal amount of senior unsecured debt, comprised of 	$1,000 million 	of 	3.450% 	Notes due
2027, 	$1,250 million 	of 	3.625% 	Notes due 2030, 	$1,500 million 	of 	4.250% 	Notes due 2040, and 	$2,250 million 	of 	4.350% 	Notes due 2050, and used the
proceeds to complete a tender offer to purchase 	$4,237 million 	in aggregate principal amount of certain GE unsecured debt, comprising 	$2,046 million 	of
2.700% 	Notes due 2022, 	€934 million 	($1,011 million 	equivalent) of 	0.375% 	Notes due 2022, 	€425 million 	($460 million 	equivalent) of 	1.250% 	Notes due 2023,
€376 million 	($407 million 	equivalent) of floating-rate Notes due 2020, and 	$312 million 	of 	3.375% 	Notes due 2024. The total carrying amount of the purchased
notes was approximately 	$4,228 million. We intend to use the remaining proceeds to repurchase, redeem or repay GE’s outstanding debt obligations, including
other notes or commercial paper.
46 	2020 1Q FORM 10-Q

-- 60 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
On April 23, 2020, GE Capital completed a tender offer to purchase 	$5,443 million 	in aggregate principal amount of certain senior unsecured debt, comprising
$3,858 million 	of 	2.342% 	Notes due 2020, 	€575 million 	($623 million 	equivalent) of 	2.250% 	Notes due 2020, 	$460 million 	of 	4.375% 	Notes due 2020, and 	£404
million 	($503 million 	of 	5.875% 	Notes due 2020. The total carrying amount of the purchased notes was approximately 	$5,427 million.
See Note 17 for further information about borrowings and associated interest rate swaps.
NOTE 12. INSURANCE LIABILITIES AND ANNUITY BENEFITS
Insurance liabilities and annuity benefits comprise mainly obligations to annuitants and insureds in our run-off insurance activities.
March 31, 2020 	(In millions)
Long-term care
insurance contracts
Structured settlement
annuities & life
insurance contracts
Other
contracts 	Other adjustments(a) 	Total
Future policy benefit reserves 	$ 	16,785 	$ 	9,491 	$ 	181 	$ 	4,051 	$ 	30,508
Claim reserves 	4,314 	253 	1,099 	— 	5,666
Investment contracts 	— 	1,112 	1,057 	— 	2,169
Unearned premiums and other 	26 	194 	165 	— 	385
21,125 	11,050 	2,502 	4,051 	38,729
Eliminations 	— 	— 	(488) 	— 	(488)
Total 	$ 	21,125 	$ 	11,050 	$ 	2,014 	$ 	4,051 	$ 	38,241
December 31, 2019 	(In millions)
Future policy benefit reserves 	$ 	16,755 	$ 	9,511 	$ 	183 	$ 	5,655 	$ 	32,104
Claim reserves 	4,238 	252 	1,125 	— 	5,615
Investment contracts 	— 	1,136 	1,055 	— 	2,191
Unearned premiums and other 	30 	196 	96 	— 	322
21,023 	11,095 	2,459 	5,655 	40,232
Eliminations 	— 	— 	(406) 	— 	(406)
Total 	$ 	21,023 	$ 	11,095 	$ 	2,053 	$ 	5,655 	$ 	39,826
(a) To the extent that unrealized gains on specific investment securities supporting our insurance contracts would result in a premium deficiency should those
gains be realized, an increase in future policy benefit reserves is recorded, with an after-tax reduction of net unrealized gains recognized through
Accumulated other comprehensive income (loss) in our consolidated Statement of Earnings (Loss).
The decrease in insurance liabilities and annuity benefits of 	$1,586 million 	from December 31, 2019 to March 31, 2020, is primarily due to an adjustment of
$1,604 million 	resulting from a decrease in unrealized gains on investment securities that would result in a premium deficiency should those gains be realized.
Claim reserves included incurred claims of 	$507 million 	and 	$473 million, 	of which 	insignificant amounts related to the recognition of adjustments to prior year
claim reserves arising from our periodic reserve evaluation for the three months ended March 31, 2020 and 2019, respectively. Paid claims were 	$405 million
and 	$421 million 	in the three months ended March 31, 2020 and 2019, respectively.
Reinsurance recoverables are recorded when we cede insurance risk to third parties but are not relieved from our primary obligation to policyholders and
cedents. These amounts, net of allowances of 	$1,374 million 	and 	$1,355 million, are included in Other GE Capital receivables in our consolidated Statement of
Financial Position and amounted to 	$2,463 million 	and 	$2,416 million 	at March 31, 2020 and December 31, 2019, respectively.
2020 1Q FORM 10-Q 	47

-- 61 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 13. POSTRETIREMENT BENEFIT PLANS
We sponsor a number of pension and retiree health and life insurance benefit plans that we present in 	three 	categories, principal pension plans, other pension
plans and principal retiree benefit plans. Principal pension plans represent the GE Pension Plan and the GE Supplementary Pension Plan. Other pension plans
include U.S. and non-U.S. pension plans with pension assets or obligations greater than 	$50 million. Principal retiree benefit plans provide health and life
insurance benefits to certain eligible participants and these participants share in the cost of the healthcare benefits. Smaller pension plans with pension assets
or obligations less than 	$50 million 	and other retiree benefit plans are not presented.
EFFECT ON OPERATIONS OF BENEFIT PLANS. 	The components of benefit plans costs other than the service cost are included in the caption Non-operating
benefit costs in our consolidated Statement of Earnings (Loss).
Principal pension plans 	Other pension plans
Three months ended March 31 	Three months ended March 31
(In millions) 	2020 	2019 	2020 	2019
Service cost for benefits earned 	$ 	153 	$ 	158 	$ 	65 	$ 	63
Prior service cost amortization 	37 	33 	— 	—
Expected return on plan assets 	(748) 	(863) 	(274) 	(284)
Interest cost on benefit obligations 	587 	726 	108 	139
Net actuarial loss amortization 	848 	763 	112 	80
Curtailment/settlement loss (gain) 	— 	51 	(a) 	(1) 	9
Benefit plans cost 	$ 	877 	$ 	868 	$ 	10 	$ 	7
(a) Curtailment loss in the three months ended March 31, 2019, resulted from the spin-off and subsequent merger of our Transportation segment with Wabtec,
which is included in Earnings (loss) from discontinued operations in our consolidated Statement of Earnings (Loss).
Principal retiree benefit plans income was 	$32 million 	and 	$61 million 	for the three months ended March 31, 2020 and 2019, respectively, which includes a
curtailment gain of 	$33 million 	in 2019 resulting from the Transportation transaction, which is included in Earnings (loss) from discontinued operations in our
consolidated Statement of Earnings (Loss).
We also have a defined contribution plan for eligible U.S. employees that provides discretionary contributions. Defined contribution plan costs were 	$95 million
and 	$101 million 	for the three months ended March 31, 2020 and 2019, respectively.
NOTE 14. INCOME TAXES
Our consolidated effective income tax rate was 	1.0% 	and 	12.5% 	during the three months ended March 31, 2020 and 2019, respectively. The rate for 2020 is
lower than the U.S. statutory rate primarily due to the lower tax rate on the sale of our BioPharma business. The low tax rate on the sale reflects gain outside the
U.S. taxed at lower than 	21% 	and because we recorded 	$633 million 	of the tax associated with preparatory steps for the transaction in the fourth quarter of
2019. The rate for 2019 is lower than the U.S. statutory rate primarily due to favorable audit resolutions, the benefit of the lower-taxed disposition of our Digital
ServiceMax business and U.S. business credits. This was partially offset by the cost of the base erosion and global intangible low tax income provisions in
excess of the benefit from other global activities.
The Internal Revenue Service (IRS) is currently auditing our consolidated U.S. income tax returns for 2014-2015 and 2016-2018. It is possible the 2014-2015
audit will be completed in the next 12 months. The United Kingdom tax authorities disallowed interest deductions claimed by GE Capital for the years 2004-2015
that could result in a potential impact of approximately 	$1 billion, which includes a possible assessment of tax and reduction of deferred tax assets, not including
interest and penalties. We are contesting the disallowance. We comply with all applicable tax laws and judicial doctrines of the United Kingdom and believe that
the entire benefit is more likely than not to be sustained on its technical merits.
48 	2020 1Q FORM 10-Q

-- 62 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 15. SHAREHOLDERS’ EQUITY
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) 	Three months ended March 31
(In millions) 	2020 	2019
Beginning balance 	$ 	61 	$ 	(39)
Other comprehensive income (loss) (OCI) before reclassifications – net of deferred taxes of $0 and $38(a) 	6 	28
Reclassifications from OCI – net of deferred taxes of $(12) and $(1) 	(47) 	(4)
Other comprehensive income (loss) 	(41) 	24
Less OCI attributable to noncontrolling interests 	— 	1
Investment securities ending balance 	$ 	20 	$ 	(16)
Beginning balance 	$ 	(4,818) 	$ 	(6,134)
OCI before reclassifications – net of deferred taxes of $(5) and $26 	(554) 	307
Reclassifications from OCI – net of deferred taxes of $0 and $(4)(b) 	690 	117
Other comprehensive income (loss) 	135 	423
Less OCI attributable to noncontrolling interests 	2 	100
Currency translation adjustments ending balance 	$ 	(4,685) 	$ 	(5,810)
Beginning balance 	$ 	49 	$ 	13
OCI before reclassifications – net of deferred taxes of $(45) and $11 	(262) 	34
Reclassifications from OCI – net of deferred taxes of $8 and $(4)(b) 	51 	3
Other comprehensive income (loss) 	(211) 	38
Less OCI attributable to noncontrolling interests 	— 	2
Cash flow hedges ending balance 	$ 	(163) 	$ 	49
Beginning balance 	$ 	(7,024) 	$ 	(8,254)
OCI before reclassifications – net of deferred taxes of $30 and $48 	219 	(116)
Reclassifications from OCI – net of deferred taxes of $239 and $183(b) 	817 	662
Other comprehensive income (loss) 	1,035 	545
Less OCI attributable to noncontrolling interests 	3 	(2)
Benefit plans ending balance 	$ 	(5,991) 	$ 	(7,708)
Accumulated other comprehensive income (loss) at March 31 	$ 	(10,819) 	$ 	(13,485)
(a) Included adjustments of 	$1,267 million 	and 	$(957) million 	for the three months ended March 31, 2020 and 2019, respectively related to insurance liabilities
and annuity benefits in our run-off insurance operations to reflect the effects that would have been recognized had the related unrealized investment security
gains been realized. See Note 12 for further information.
(b) Included 	$836 million, including currency translation of 	$688 million, net of taxes, for the three months ended March 31, 2020, related to the sale of our
BioPharma business within our Healthcare segment.
In 2016, we issued 	$5,694 million 	of GE Series D preferred stock, which are callable on January 21, 2021. In addition to Series D, 	$250 million 	of existing GE
Series A, B and C preferred stock are also outstanding. The total carrying value of GE preferred stock at March 31, 2020 was 	$5,782 million 	and will increase to
$5,944 million 	by the respective call dates through periodic accretion. See our Annual Report on Form 10-K for the year ended December 31, 2019 for further
information.
Noncontrolling interests in equity of consolidated affiliates amounted to 	$1,575 million 	and 	$1,545 million 	at March 31, 2020 and December 31, 2019,
respectively. Net earnings (loss) attributable to noncontrolling interests were 	$7 million 	and 	$30 million 	for the three months ended March 31, 2020 and 2019,
respectively. Dividends attributable to noncontrolling interests were 	$(3) million 	and 	$(106) million 	for the three months ended March 31, 2020 and 2019,
respectively.
Redeemable noncontrolling interests presented within All other liabilities in our consolidated Statement of Financial Position include common shares issued by
our affiliates that are redeemable at the option of the holder of those interests and amounted to 	$470 million 	and 	$439 million 	as of March 31, 2020 and
December 31, 2019, respectively. Net earnings (loss) attributable to redeemable noncontrolling interests was 	$27 million 	and 	$27 million 	for the three months
ended March 31, 2020 and 2019, respectively.
2020 1Q FORM 10-Q 	49

-- 63 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 16. EARNINGS PER SHARE INFORMATION
Three months ended March 31 	2020 	2019
(In millions; per-share amounts in dollars) 	Diluted 	Basic 	Diluted 	Basic
Earnings from continuing operations for per-share calculation 	$ 	6,358 	$ 	6,358 	$ 	936 	$ 	954
Preferred stock dividends 	(43) 	(43) 	(40) 	(40)
Earnings from continuing operations attributable to
common shareholders for per-share calculation 	6,315 	6,315 	897 	915
Earnings (loss) from discontinued operations
for per-share calculation 	(175) 	(175) 	2,604 	2,622
Net earnings (loss) attributable to GE common
shareholders for per-share calculation 	$ 	6,140 	$ 	6,140 	$ 	3,519 	$ 	3,537
Shares of GE common stock outstanding 	8,742 	8,742 	8,711 	8,711
Employee compensation-related shares (including stock options) 	7 	— 	15 	—
Total average equivalent shares 	8,749 	8,742 	8,726 	8,711
Earnings per share from continuing operations 	$ 	0.72 	$ 	0.72 	$ 	0.10 	$ 	0.10
Earnings (loss) per share from discontinued operations 	(0.02) 	(0.02) 	0.30 	0.30
Net earnings (loss) per share 	0.70 	0.70 	0.40 	0.41
Potentially dilutive securities(a) 	422 	471
(a) Outstanding stock awards not included in the computation of diluted earnings per share because their effect was antidilutive.
Our unvested restricted stock unit awards that contain non-forfeitable rights to dividends or dividend equivalents are considered participating securities, and,
therefore, are included in the computation of earnings per share pursuant to the two-class method. For the three months ended March 31, 2020 and 2019,
application of this treatment had an insignificant effect.
Earnings per share amounts are computed independently for earnings from continuing operations, earnings from discontinued operations and net earnings. As a
result, the sum of per-share amounts from continuing operations and discontinued operations may not equal the total per-share amounts for net earnings.
NOTE 17. FINANCIAL INSTRUMENTS
The following table provides information about assets and liabilities not carried at fair value and excludes finance leases, equity securities without readily
determinable fair value and non-financial assets and liabilities. Substantially all of these assets are considered to be Level 3 and the vast majority of our
liabilities’ fair value are considered Level 2.
March 31, 2020 	December 31, 2019
(In millions)
Carrying
amount
(net)
Estimated
fair value
Carrying
amount
(net)
Estimated
fair value
Assets
Loans and other receivables 	$ 	3,912 	$ 	3,777 	$ 	4,113 	$ 	4,208
Liabilities
Borrowings (Note 11) 	85,154 	85,033 	90,882 	97,754
Investment contracts (Note 12) 	2,169 	2,485 	2,191 	2,588
The lower fair value in relation to carrying value for borrowings at March 31, 2020 compared to December 31, 2019 was driven primarily by widening GE credit
spreads, partially offset by a decline in market interest rates. Unlike the carrying amount, estimated fair value of borrowings included 	$913 million 	and 	$1,106
million 	of accrued interest at March 31, 2020 and December 31, 2019, respectively.
Assets and liabilities that are reflected in the accompanying financial statements at fair value are not included in the above disclosures; such items include cash
and equivalents, investment securities and derivative financial instruments.
DERIVATIVES AND HEDGING. 	Our policy requires that derivatives are used solely for managing risks and not for speculative purposes. Total gross notional
was 	$101,209 million 	($53,808 million 	in GE Capital and 	$47,401 million 	in GE) and 	$98,018 million 	($55,704 million 	in GE Capital and 	$42,314 million 	in GE) at
March 31, 2020 and December 31, 2019, respectively. GE Capital notional relates primarily to managing interest rate and currency risk between financial assets
and liabilities, and GE notional relates primarily to managing currency risk.
50 	2020 1Q FORM 10-Q

-- 64 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FAIR VALUE OF DERIVATIVES 	March 31, 2020 	December 31, 2019
(In millions) 	Gross Notional 	All other assets
All other
liabilities 	Gross Notional 	All other assets
All other
liabilities
Interest rate contracts 	$ 	23,617 	$ 	2,191 	$ 	9 	$ 	23,918 	$ 	1,636 	$ 	11
Currency exchange contracts 	7,307 	170 	277 	7,044 	99 	46
Derivatives accounted for as hedges 	$ 	30,924 	$ 	2,361 	$ 	287 	$ 	30,961 	$ 	1,734 	$ 	57
Interest rate contracts 	$ 	2,447 	$ 	29 	$ 	7 	$ 	3,185 	$ 	18 	$ 	12
Currency exchange contracts 	66,240 	1,105 	1,477 	62,165 	697 	744
Other contracts 	1,598 	5 	103 	1,706 	123 	40
Derivatives not accounted for as hedges 	$ 	70,285 	$ 	1,139 	$ 	1,587 	$ 	67,056 	$ 	838 	$ 	796
Gross derivatives 	$ 	101,209 	$ 	3,500 	$ 	1,874 	$ 	98,018 	$ 	2,572 	$ 	853
Netting and credit adjustments 	$ 	(1,145) 	$ 	(1,155) 	$ 	(546) 	$ 	(546)
Cash collateral adjustments 	(1,297) 	(198) 	(1,286) 	(105)
Net derivatives recognized in statement of
financial position 	$ 	1,058 	$ 	520 	$ 	740 	$ 	202
Net accrued interest 	$ 	71 	$ 	1 	$ 	182 	$ 	1
Securities held as collateral 	(693) 	— 	(469) 	—
Net amount 	$ 	436 	$ 	521 	$ 	452 	$ 	203
Fair value of derivatives in our consolidated Statement of Financial Position excluded accrued interest. Cash collateral adjustments excluded excess collateral
received and posted of 	$198 million 	and 	$995 million 	at March 31, 2020, respectively, and 	$104 million 	and 	$603 million 	at December 31, 2019, respectively.
Securities held as collateral excluded excess collateral received of 	$45 million 	and 	$27 million 	at March 31, 2020 and December 31, 2019 respectively.
FAIR VALUE HEDGES. 	We use derivatives to hedge the effects of interest rate and currency exchange rate changes on our borrowings. At March 31, 2020, the
cumulative amount of hedging adjustments of 	$6,527 million 	(including 	$2,348 million 	on discontinued hedging relationships) was included in the carrying
amount of the hedged liability of 	$53,272 million. At March 31, 2019, the cumulative amount of hedging adjustments of 	$3,712 million 	(including 	$2,685 million
on discontinued hedging relationships) was included in the carrying amount of the hedged liability of 	$58,885 million. The cumulative amount of hedging
adjustments was primarily recorded in long-term borrowings.
CASH FLOW HEDGES. 	Changes in the fair value of cash flow hedges are recorded in Accumulated Other Comprehensive Income (AOCI) and recorded in
earnings in the period in which the hedged transaction occurs. The gain (loss) recognized in AOCI was 	$(313) million 	and 	$47 million 	for the three months ended
March 31, 2020 	and 2019, respectively. The gain (loss) reclassified from AOCI to earnings was 	$(59) million 	and 	zero 	for the three months ended 	March 31,
2020 	and 2019, respectively. These amounts were primarily related to currency exchange and interest rate contracts.
The total amount in AOCI related to cash flow hedges of forecasted transactions was a 	$183 million 	loss at 	March 31, 2020. We expect to reclassify 	$125 million
of loss to earnings in the next 12 months contemporaneously with the earnings effects of the related forecasted transactions. For the three months ended 	March
31, 2020 	and 2019, we recognized 	$18 million 	of loss, primarily as a result of the disposition of BioPharma, and insignificant gains and losses, respectively,
related to hedged forecasted transactions and firm commitments that did not occur by the end of the originally specified period. At 	March 31, 2020 	and 2019, the
maximum term of derivative instruments that hedge forecasted transactions was 	15 years 	and 	14 years, respectively.
NET INVESTMENT HEDGES. 	For these hedges, the portion of the fair value changes of the derivatives or debt instruments that relates to changes in spot
currency exchange rates is recorded in a separate component of AOCI. The portion of the fair value changes of the derivatives related to differences between
spot and forward rates is recorded in earnings each period. The amounts recorded in AOCI affect earnings if the hedged investment is sold, substantially
liquidated, or control is lost.
The total gain (loss) recognized in AOCI on hedging instruments for the three months ended March 31, 2020 and 2019 was 	$158 million 	and 	$(68) million,
respectively, comprising 	$109 million 	and 	$(27) million 	on currency exchange contracts and 	$48 million 	and 	$(41) million 	on foreign currency debt, respectively.
The total gain (loss) excluded from assessment and recognized in earnings was 	$2 million 	and 	$8 million 	for the three months ended March 31, 2020 and 2019,
respectively.
The carrying value of foreign currency debt designated as net investment hedges was 	$9,145 million 	and 	$12,502 million 	at
March 31, 2020 	and 2019, respectively. 	The gain (loss) reclassified from AOCI into earnings 	was 	zero 	and 	$6 million 	for the three months ended March 31, 2020
and 2019, respectively.
EFFECTS OF DERIVATIVES ON EARNINGS. 	All derivatives are marked to fair value on our balance sheet, whether they are designated in a hedging
relationship for accounting purposes or are used as economic hedges. For derivatives not designated as hedging instruments, substantially all of the gain or loss
recognized in earnings is offset by either the current period change in value of underlying exposures, which is recorded in earnings in the current period or a
future period when the recording of the exposures occur.
2020 1Q FORM 10-Q 	51

-- 65 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The table below presents the effect of our derivative financial instruments in the consolidated Statement of Earnings:
Three months ended March 31, 2020 	Three months ended March 31, 2019
(In millions) 	Revenues
Cost of
sales
Interest
Expense 	SG&A
Other
Income 	Revenues
Cost of
sales
Interest
Expense 	SG&A
Other
Income
Total amounts presented in the
consolidated Statement of Earnings 	$ 	20,524 	$ 	15,695 	$ 	794 	$ 	3,065 	$ 	6,869 	$ 	22,202 	$ 	16,208 	$ 	1,065 	$ 	3,402 	$ 	847
Total effect of cash flow hedges 	$ 	(21) 	$ 	(25) 	$ 	(10) 	$ 	(3) 	$ 	— 	$ 	20 	$ 	(9) 	$ 	(10) 	$ 	(1) 	$ 	—
Hedged items 	$ 	(2,480) 	$ 	(527)
Derivatives designated as hedging
instruments 	2,511 	515
Total effect of fair value hedges 	$ 	31 	$ 	(11)
Interest rate contracts 	$ 	(23) 	$ 	— 	$ 	(9) 	$ 	— 	$ 	— 	$ 	(4) 	$ 	— 	$ 	(16) 	$ 	— 	$ 	—
Currency exchange contracts 	(521) 	13 	— 	54 	11 	390 	9 	— 	(45) 	3
Other 	— 	— 	— 	(160) 	(22) 	— 	— 	96 	— 	13
Total effect of derivatives not
designated as hedges 	$ 	(545) 	$ 	13 	$ 	(9) 	$ 	(106) 	$ 	(12) 	$ 	386 	$ 	9 	$ 	80 	$ 	(45) 	$ 	16
The amount excluded for cash flow hedges which is recognized in earnings was 	$15 million 	and 	zero 	for the three months ended March 31, 2020 and 2019,
respectively.
COUNTERPARTY CREDIT RISK. 	Fair values of our derivatives can change significantly from period to period based on, among other factors, market
movements and changes in our positions. We manage counterparty credit risk (the risk that counterparties will default and not make payments to us according to
the terms of our agreements) on an individual counterparty basis. Where we have agreed to netting of derivative exposures with a counterparty, we net our
exposures with that counterparty and apply the value of collateral posted to us to determine the exposure. We actively monitor these net exposures against
defined limits and take appropriate actions in response, including requiring additional collateral. Our exposures to counterparties (including accrued interest), net
of collateral we held, was 	$270 million 	and 	$368 million 	at March 31, 2020 and December 31, 2019, respectively. Counterparties' exposures to our derivative
liability (including accrued interest), net of collateral posted by us, was 	$463 million 	and 	$159 million 	at March 31, 2020 and December 31, 2019, respectively.
NOTE 18. 	VARIABLE INTEREST ENTITIES
In addition to the 	three 	VIEs detailed in Note 4, in our consolidated Statement of Financial Position, we have assets of 	$2,106 million 	and 	$2,134 million 	and
liabilities of 	$1,103 million 	and 	$1,233 million 	at March 31, 2020, and December 31, 2019, respectively, from other consolidated VIEs. These entities were
created to help our customers facilitate or finance the purchase of GE goods and services. These entities have no features that could expose us to losses that
would significantly exceed the difference between the consolidated assets and liabilities. Substantially all the assets of our consolidated VIEs at March 31, 2020,
can only be used to settle the liabilities of those VIEs.
Our investments in unconsolidated VIEs were 	$1,939 	million and 	$1,937 million 	at March 31, 2020, and December 31, 2019, respectively. These investments
are primarily owned by GE Capital businesses, 	$506 	million and 	$621 	million of which were owned by Energy Financial Services, comprising equity method
investments, and 	$1,040 	million and 	$896 million 	of which were owned by our run-off insurance operations, primarily comprising investment securities at March
31, 2020 and December 31, 2019, respectively. The increase in investments in unconsolidated VIEs in our run-off insurance operations reflects implementation
of our revised reinvestment plan, which incorporates the introduction of strategic initiatives to invest in higher-yielding asset classes. Our maximum exposure to
loss in respect of unconsolidated VIEs is increased by our commitments to make additional investments in these entities described in Note 19.
NOTE 19. COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES
COMMITMENTS. 	The GECAS business within the Capital segment has placed multiple-year orders for various Boeing, Airbus and other aircraft manufacturers
with list prices approximating $35,772 	million 	(including 	358 	new aircraft with estimated delivery dates of 	10% 	in 2020, 	18% 	in 2021 and 	72% 	in 2022 through
2026) and secondary orders with airlines for used aircraft approximating $2,297 	million (including 	53 	used aircraft with estimated delivery dates of 	21% 	in 2020,
64% 	in 2021 and 	15% 	in 2022) at 	March 31, 2020. When we purchase aircraft, it is at a contractual price, which is usually less than the aircraft manufacturer’s
list price and excludes any pre-delivery payments made in advance. As of 	March 31, 2020, we have made 	$2,963 million 	of pre-delivery payments to aircraft
manufacturers.
During April 2020, GECAS agreed with Boeing to restructure its 737 MAX orderbook including previously canceled positions, resulting in the cancellation of 	69
orders with 	82 	orders now remaining.
52 	2020 1Q FORM 10-Q

-- 66 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
GE Capital had total investment commitments of 	$2,786 million 	at March 31, 2020. The commitments primarily comprise project financing investments in thermal
and wind energy projects of 	$1,149 million 	and investments by our run-off insurance operations in investment securities and other assets of 	$1,608 million,
included within these commitments are obligations to make additional investments in unconsolidated VIEs of 	$260 million 	and 	$1,090 million, respectively. See
Note 18 for further information.
As of 	March 31, 2020, in our Aviation segment, we have committed to provide financing assistance of $2,072 	million for future customer acquisitions of aircraft
equipped with our engines.
GUARANTEES. 	At 	March 31, 2020, we were committed under the following guarantee arrangements:
Credit Support. 	At 	March 31, 2020, we have provided $1,483 	million of credit support on behalf of certain customers' predominantly joint ventures and
partnerships, such as standby letters of credit and performance guarantees. The liability was $33 	million at 	March 31, 2020.
Indemnification Agreements – Continuing Operations. 	At 	March 31, 2020, we have $1,544 	million of indemnifications, including representations and
warranties in sales of businesses or assets, for which we recorded a liability of $144 	million.
Indemnification Agreements – Discontinued Operations. 	At 	March 31, 2020, 	we have provided specific indemnities to buyers of GE Capital’s assets that, in
the aggregate, represent a maximum potential claim of 	$1,019 	million with related reserves of 	$139 	million.
PRODUCT WARRANTIES. 	We provide for estimated product warranty expenses when we sell the related products. Because warranty estimates are forecasts
that are based on the best available information, mostly historical claims experience, claims costs may differ from amounts provided. The liability for product
warranties was 	$2,081 million 	and 	$2,165 million 	at March 31, 2020 and December 31, 2019, respectively.
LEGAL MATTERS. 	The following information supplements and amends the discussion of Legal Matters in Note 23 to the consolidated financial statements in
our Annual Report on Form 10-K for the year ended December 31, 2019; refer to that discussion for information about previously reported legal matters that are
not updated below. 	In the normal course of our business, we are involved from time to time in various arbitrations, class actions, commercial litigation,
investigations and other legal, regulatory or governmental actions, including the significant matters described below that could have a material impact on our
results of operations. In many proceedings, including the specific matters described below, it is inherently difficult to determine whether any loss is probable or
even reasonably possible or to estimate the size or range of the possible loss, and accruals for legal matters are not recorded until a loss for a particular matter
is considered probable and reasonably estimable. Given the nature of legal matters and the complexities involved, it is often difficult to predict and determine a
meaningful estimate of loss or range of loss until we know, among other factors, the particular claims involved, the likelihood of success of our defenses to those
claims, the damages or other relief sought, how discovery or other procedural considerations will affect the outcome, the settlement posture of other parties and
other factors that may have a material effect on the outcome. For these matters, unless otherwise specified, we do not believe it is possible to provide a
meaningful estimate of loss at this time. Moreover, it is not uncommon for legal matters to be resolved over many years, during which time relevant
developments and new information must be continuously evaluated.
Alstom legacy matters. 	In November 2015, we acquired the Thermal, Renewables and Grid businesses from Alstom. Prior to the acquisition, the seller was the
subject of 	two 	significant cases involving anti-competitive activities and improper payments: (1) in January 2007, Alstom was fined 	€65 million 	by the European
Commission for participating in a gas insulated switchgear cartel that operated from 1988 to 2004 (that fine was later reduced to 	€59 million), and (2) in
December 2014, Alstom pled guilty in the United States to multiple violations of the Foreign Corrupt Practices Act and paid a criminal penalty of 	$772 million. As
part of GE’s accounting for the acquisition, we established a reserve amounting to 	$858 million 	for legal and compliance matters related to the legacy business
practices that were the subject of these and related cases in various jurisdictions, including the previously reported legal proceedings in Israel that are described
below. The reserve balance was 	$846 million 	and 	$875 million 	at March 31, 2020 and December 31, 2019, respectively.
Regardless of jurisdiction, the allegations relate to claimed anti-competitive conduct or improper payments in the pre-acquisition period as the source of legal
violations and/or damages. Given the significant litigation and compliance activity related to these matters and our ongoing efforts to resolve them, it is difficult to
assess whether the disbursements will ultimately be consistent with the reserve established. The estimation of this reserve involved significant judgment and
may not reflect the full range of uncertainties and unpredictable outcomes inherent in litigation and investigations of this nature, and at this time we are unable to
develop a meaningful estimate of the range of reasonably possible additional losses beyond the amount of this reserve. Damages sought may include
disgorgement of profits on the underlying business transactions, fines and/or penalties, interest, or other forms of resolution. Factors that can affect the ultimate
amount of losses associated with these and related matters include the way cooperation is assessed and valued, prosecutorial discretion in the determination of
damages, formulas for determining fines and penalties, the duration and amount of legal and investigative resources applied, political and social influences
within each jurisdiction, and tax consequences of any settlements or previous deductions, among other considerations. Actual losses arising from claims in
these and related matters could exceed the amount provided.
2020 1Q FORM 10-Q 	53

-- 67 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In September 2013, the Israeli Antitrust Authority issued a decision whereby Alstom, Siemens AG and ABB Ltd. were held liable for an alleged anti-competitive
arrangement in the gas-insulated switchgears market in Israel. While there was no fine in connection with that decision, claimants brought two civil actions in
2013 seeking damages of approximately 	$950 million 	and 	$600 million, respectively, related to the alleged conduct underlying the decision that are pending
before the Central District Court in Israel. The 	court in March 2020 approved a settlement agreement reached by the parties, but the settlement remains subject
to appeal to the Supreme Court of Israel.
Shareholder and related lawsuits. 	In December 2018, a putative class action (the Varga case) was filed in the U.S. District Court for the Northern District of
New York naming GE and a former GE executive officer as defendants in connection with the oversight of the GE RSP. It alleges that the defendants breached
fiduciary duties under the Employee Retirement Income Security Act of 1974 (ERISA) by failing to advise GE RSP participants that GE Capital insurance
subsidiaries were allegedly under-reserved and continued to retain a GE stock fund as an investment option in the GE RSP. The plaintiffs seek unspecified
damages on behalf of a class of GE RSP participants and beneficiaries from January 1, 2010 through January 19, 2018 or later. 	In March 2020 the court
granted GE’s motion to dismiss the case, and in April 2020 the plaintiffs filed an appeal with the Second Circuit.
In August 2019, a putative class action (the Tri-State case) was filed in the Delaware Court of Chancery naming as defendants GE and the former Board of
Directors of Baker Hughes Incorporated (BHI). It alleges fraud, aiding and abetting breaches of fiduciary duty, and aiding and abetting breaches of duty of
disclosure by GE based on allegations regarding financial statements that GE provided the former BHI board, management and shareholders in connection with
BHI’s merger with GE’s Oil and Gas Business in July 2017. The plaintiff seeks damages on behalf of BHI shareholders during the period between October 7,
2016 and July 5, 2017. In October 2019, the City of Providence filed a complaint containing allegations substantially similar to those in the Tri-State complaint.
The cases were consolidated in November 2019, and in December 2019, the plaintiffs filed an amended consolidated complaint which is similar to the prior
complaints but does not include fraud claims against GE. 	In February 2020, GE and the other defendants filed a motion to dismiss the amended consolidated
complaint.
These cases are at an early stage; we believe we have defenses to the claims and are responding accordingly.
Bank BPH. 	As previously reported, GE Capital’s subsidiary Bank BPH, along with other Polish banks, has been subject to ongoing litigation in Poland related to
its portfolio of floating rate residential mortgages, with cases brought by individual borrowers seeking relief related to their foreign currency-denominated
mortgages in various courts throughout Poland. Approximately 	86% 	of the Bank BPH portfolio is indexed to or denominated in foreign currencies (primarily
Swiss francs), and the total portfolio had a carrying value of 	$2.4 billion 	at March 31, 2020. In October 2019, the European Court of Justice (ECJ) issued a
decision about the approach to remedy in a case involving another Polish bank’s foreign currency loans, and in January 2020, a pending case involving a Bank
BPH loan was referred to the ECJ. While there remains significant uncertainty as to how the prior ECJ decision, or a future decision on the Bank BPH case, will
influence the Polish courts as they consider individual cases, we are observing an increase in the number of lawsuits brought against Bank BPH and other
banks in Poland with similar portfolios that may continue in future reporting periods. 	We have observed more findings of liability and more severe remedies being
ordered against Polish banks. 	We also believe there is a potential for unifying rules of decision to emerge regarding both the finding of liability and approach to
remedy that could change our estimate of the potential effects of borrower litigation. Future adverse developments in the potential for legislative relief or in
litigation across the Polish banking industry as a result of ECJ decisions or otherwise could result in losses related to these loans in future reporting periods.
ENVIRONMENTAL, HEALTH AND SAFETY MATTERS. 	Our operations, like operations of other companies engaged in similar businesses, involve the use,
disposal and cleanup of substances regulated under environmental protection laws and nuclear decommissioning regulations. Additionally, like many other
industrial companies, we and our subsidiaries are defendants in various lawsuits related to alleged worker exposure to asbestos or other hazardous materials.
Liabilities for environmental remediation, nuclear decommissioning and worker exposure claims exclude possible insurance recoveries. It is reasonably possible
that our exposure will exceed amounts accrued. However, due to uncertainties about the status of laws, regulations, technology and information related to
individual sites and lawsuits, such amounts are not reasonably estimable. For further information, see our Annual Report on Form 10-K for the year ended
December 31, 2019.
54 	2020 1Q FORM 10-Q

-- 68 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 20. INTERCOMPANY TRANSACTIONS
Presented below is a walk of intercompany eliminations from the combined GE and GE Capital totals to the consolidated cash flows.
Three months ended March 31
(In millions) 	2020 	2019
Combined GE and GE Capital cash from (used for) operating activities - continuing operations 	$ 	(385) 	$ 	(557)
GE current receivables sold to GE Capital 	(997) 	538
GE long-term receivables sold to GE Capital 	135 	174
Supply chain finance programs(a) 	884 	310
Other reclassifications and eliminations 	216 	(45)
Consolidated cash from (used for) operating activities - continuing operations 	$ 	(148) 	$ 	420
Combined GE and GE Capital cash from (used for) investing activities - continuing operations 	$ 	19,991 	$ 	6,048
GE current receivables sold to GE Capital 	945 	(1,306)
GE long-term receivables sold to GE Capital 	(135) 	(174)
Supply chain finance programs(a) 	(884) 	(310)
Other reclassifications and eliminations 	(695) 	(562)
Consolidated cash from (used for) investing activities - continuing operations 	$ 	19,221 	$ 	3,696
Combined GE and GE Capital cash from (used for) financing activities - continuing operations 	$ 	(8,451) 	$ 	(4,837)
GE current receivables sold to GE Capital 	52 	768
Other reclassifications and eliminations 	480 	607
Consolidated cash from (used for) financing activities - continuing operations 	$ 	(7,919) 	$ 	(3,461)
(a) 	Represents the reduction of the GE liability associated with the funded participation in a supply chain finance program with GE Capital, primarily as a result
of GE Capital's sale of the program platform to MUFG Union Bank, N.A. (MUFG) in 2019.
Cash payments received on the Receivable facility deferred purchase price are reflected as Cash from investing activities in the GE Capital and Consolidated
columns of our consolidated Statement of Cash Flows. Sales of customer receivables from GE to GE Capital are classified as Cash from operating activities in
the GE column of our Statement of Cash Flows. See Note 4 for further information.
NOTE 21. GUARANTOR FINANCIAL INFORMATION
GE Capital International Funding Company Unlimited Company (the Issuer) previously issued senior unsecured registered notes that are fully and
unconditionally, jointly and severally guaranteed by both the Company and GE Capital International Holdings Limited (each a Guarantor, and together, the
Guarantors).
CONDENSED CONSOLIDATING STATEMENT OF EARNINGS (LOSS) AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED MARCH 31, 2020 (UNAUDITED)
(In millions)
Parent
Company
Guarantor
Subsidiary
Issuer
Subsidiary
Guarantor
Non-
Guarantor
Subsidiaries
Consolidating
Adjustments 	Consolidated
Sales of goods and services 	$ 	6,217 	$ 	— 	$ 	— 	$ 	29,404 	$ 	(16,806) 	$ 	18,814
GE Capital revenues from services 	— 	238 	2 	1,983 	(513) 	1,709
Total revenues 	6,217 	238 	2 	31,386 	(17,319) 	20,524
Interest and other financial charges 	295 	258 	313 	337 	(409) 	794
Other costs and expenses 	6,898 	— 	— 	32,294 	(19,068) 	20,124
Total costs and expenses 	7,192 	258 	313 	32,631 	(19,477) 	20,918
Other income (loss) 	705 	— 	— 	18,294 	(12,129) 	6,869
Equity in earnings (loss) of affiliates 	6,615 	— 	278 	17,098 	(23,991) 	—
Earnings (loss) from continuing operations
before income taxes 	6,344 	(20) 	(34) 	34,148 	(33,963) 	6,475
Benefit (provision) for income taxes 	20 	2 	— 	421 	(506) 	(63)
Earnings (loss) from continuing operations 	6,363 	(17) 	(34) 	34,568 	(34,469) 	6,412
Earnings (loss) from discontinued operations, net
of taxes 	(164) 	— 	(15) 	— 	1 	(178)
Net earnings (loss) 	6,199 	(17) 	(49) 	34,568 	(34,468) 	6,233
Less net earnings (loss) attributable to
noncontrolling interests 	— 	— 	— 	1 	33 	34
Net earnings (loss) attributable to the

-- 69 of 93 --

Company 	6,199 	(17) 	(49) 	34,567 	(34,501) 	6,199
Other comprehensive income (loss) 	913 	— 	(12) 	(823) 	835 	913
Comprehensive income (loss) attributable to
the Company 	$ 	7,113 	$ 	(17) 	$ 	(61) 	$ 	33,744 	$ 	(33,666) 	$ 	7,113
2020 1Q FORM 10-Q 	55

-- 70 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
CONDENSED CONSOLIDATING STATEMENT OF EARNINGS (LOSS) AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED MARCH 31, 2019 (UNAUDITED)
(In millions)
Parent
Company
Guarantor
Subsidiary
Issuer
Subsidiary
Guarantor
Non-
Guarantor
Subsidiaries
Consolidating
Adjustments 	Consolidated
Sales of goods and services 	$ 	4,580 	$ 	— 	$ 	— 	$ 	38,456 	$ 	(22,779) 	$ 	20,257
GE Capital revenues from services 	— 	233 	75 	2,580 	(943) 	1,945
Total revenues 	4,580 	233 	75 	41,035 	(23,722) 	22,202
Interest and other financial charges 	379 	231 	379 	577 	(501) 	1,065
Other costs and expenses 	8,494 	— 	— 	38,880 	(26,512) 	20,862
Total costs and expenses 	8,873 	231 	380 	39,457 	(27,013) 	21,927
Other income (loss) 	(6,743) 	— 	— 	16,963 	(9,372) 	847
Equity in earnings (loss) of affiliates 	14,929 	— 	375 	11,013 	(26,318) 	—
Earnings (loss) from continuing operations
before income taxes 	3,893 	3 	71 	29,555 	(32,399) 	1,122
Benefit (provision) for income taxes 	(335) 	— 	— 	(658) 	854 	(140)
Earnings (loss) from continuing operations 	3,558 	2 	71 	28,896 	(31,545) 	983
Earnings (loss) from discontinued operations, net
of taxes 	30 	— 	— 	— 	2,632 	2,663
Net earnings (loss) 	3,588 	2 	71 	28,896 	(28,912) 	3,645
Less net earnings (loss) attributable to
noncontrolling interests 	— 	— 	— 	(1) 	58 	57
Net earnings (loss) attributable to the
Company 	3,588 	2 	71 	28,897 	(28,970) 	3,588
Other comprehensive income (loss) 	929 	— 	(1,082) 	(443) 	1,524 	930
Comprehensive income (loss) attributable to
the Company 	$ 	4,517 	$ 	2 	$ 	(1,011) 	$ 	28,454 	$ 	(27,446) 	$ 	4,517
CONDENSED CONSOLIDATING STATEMENT OF FINANCIAL POSITION MARCH 31, 2020 (UNAUDITED)
(In millions)
Parent
Company
Guarantor
Subsidiary
Issuer
Subsidiary
Guarantor
Non-
Guarantor
Subsidiaries
Consolidating
Adjustments 	Consolidated
Cash, cash equivalents and restricted cash 	$ 	27,463 	$ 	— 	$ 	— 	$ 	20,390 	$ 	(567) 	$ 	47,286
Receivables - net 	41,752 	17,970 	84 	56,003 	(88,382) 	27,427
Investment in subsidiaries 	198,819 	— 	40,645 	441,860 	(681,324) 	—
All other assets 	27,445 	1,431 	— 	304,108 	(145,676) 	187,308
Total assets 	$ 	295,479 	$ 	19,401 	$ 	40,729 	$ 	822,360 	$ 	(915,949) 	$ 	262,021
Short-term borrowings 	$ 	150,985 	$ 	6,024 	$ 	3,598 	$ 	6,511 	$ 	(148,996) 	$ 	18,122
Long-term and non-recourse borrowings 	37,967 	12,028 	23,954 	31,336 	(38,255) 	67,032
All other liabilities 	64,455 	337 	68 	138,217 	(63,069) 	140,008
Total liabilities 	253,408 	18,390 	27,620 	176,064 	(250,320) 	225,162
Total liabilities and equity 	$ 	295,479 	$ 	19,401 	$ 	40,729 	$ 	822,360 	$ 	(915,949) 	$ 	262,021
CONDENSED CONSOLIDATING STATEMENT OF FINANCIAL POSITION DECEMBER 31, 2019
(In millions)
Parent
Company
Guarantor
Subsidiary
Issuer
Subsidiary
Guarantor
Non-
Guarantor
Subsidiaries
Consolidating
Adjustments 	Consolidated
Cash, cash equivalents and restricted cash 	$ 	10,591 	$ 	— 	$ 	— 	$ 	26,438 	$ 	(636) 	$ 	36,394
Receivables - net 	47,170 	17,726 	230 	61,026 	(99,104) 	27,047
Investment in subsidiaries 	147,397 	— 	40,408 	421,613 	(609,418) 	—
All other assets 	28,377 	236 	— 	291,995 	(118,000) 	202,607
Total assets 	$ 	233,535 	$ 	17,961 	$ 	40,638 	$ 	801,071 	$ 	(827,158) 	$ 	266,048

-- 71 of 93 --

Short-term borrowings 	$ 	135,172 	$ 	5,991 	$ 	2,981 	$ 	9,712 	$ 	(131,783) 	$ 	22,072
Long-term and non-recourse borrowings 	40,660 	10,780 	24,417 	34,262 	(41,310) 	68,809
All other liabilities 	66,808 	161 	70 	146,972 	(68,705) 	145,306
Total liabilities 	242,640 	16,932 	27,468 	190,946 	(241,799) 	236,187
Total liabilities and equity 	$ 	233,535 	$ 	17,961 	$ 	40,638 	$ 	801,071 	$ 	(827,158) 	$ 	266,048
56 	2020 1Q FORM 10-Q

-- 72 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS THREE MONTHS ENDED MARCH 31, 2020 (UNAUDITED)
(In millions)
Parent
Company
Guarantor
Subsidiary
Issuer
Subsidiary
Guarantor
Non-
Guarantor
Subsidiaries
Consolidating
Adjustments 	Consolidated
Cash from (used for)
operating activities 	$ 	2,339 	$ 	558 	$ 	(819) 	$ 	30,587 	$ 	(32,879) 	$ 	(214)
Cash from (used for) investing activities 	$ 	(584) 	$ 	(558) 	$ 	14 	$ 	(21,387) 	$ 	41,601 	$ 	19,086
Cash from (used for) financing activities 	$ 	15,117 	$ 	— 	$ 	805 	$ 	(15,188) 	$ 	(8,653) 	$ 	(7,919)
Effect of currency exchange rate changes on
cash, cash equivalents and restricted cash 	— 	— 	— 	(256) 	— 	(256)
Increase (decrease) in cash, cash
equivalents and restricted cash 	16,872 	— 	— 	(6,243) 	69 	10,697
Cash, cash equivalents and restricted cash
at beginning of year 	10,591 	— 	— 	27,121 	(636) 	37,077
Cash, cash equivalents and restricted cash
at March 31 	27,463 	— 	— 	20,878 	(567) 	47,774
Less cash, cash equivalents and restricted
cash of discontinued operations at
March 31 	— 	— 	— 	437 	— 	437
Cash, cash equivalents and restricted cash
of continuing operations at March 31 	$ 	27,463 	$ 	— 	$ 	— 	$ 	20,441 	$ 	(567) 	$ 	47,338
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS THREE MONTHS ENDED MARCH 31, 2019 (UNAUDITED)
(In millions)
Parent
Company
Guarantor
Subsidiary
Issuer
Subsidiary
Guarantor
Non-
Guarantor
Subsidiaries
Consolidating
Adjustments 	Consolidated
Cash from (used for)
operating activities(a) 	$ 	(6,665) 	$ 	611 	$ 	(1,063) 	$ 	(22,734) 	$ 	29,973 	$ 	122
Cash from (used for) investing activities 	$ 	7,201 	$ 	(611) 	$ 	(61) 	$ 	48,313 	$ 	(51,352) 	$ 	3,490
Cash from (used for) financing activities 	$ 	(555) 	$ 	— 	$ 	1,124 	$ 	(26,436) 	$ 	22,133 	$ 	(3,735)
Effect of currency exchange rate changes on
cash, cash equivalents and restricted cash 	— 	— 	— 	78 	— 	78
Increase (decrease) in cash, cash equivalents
and restricted cash 	(20) 	— 	— 	(779) 	753 	(45)
Cash, cash equivalents and restricted cash
at beginning of year 	9,561 	— 	1 	30,398 	(4,412) 	35,548
Cash, cash equivalents and restricted cash
at March 31 	9,541 	— 	— 	29,620 	(3,658) 	35,503
Less cash, cash equivalents and restricted
cash of discontinued operations at
March 31 	— 	— 	— 	3,671 	— 	3,671
Cash, cash equivalents and restricted cash
of continuing operations at March 31 	$ 	9,541 	$ 	— 	$ 	— 	$ 	25,949 	$ 	(3,658) 	$ 	31,832
(a) 	Parent Company Guarantor cash flows included cash from (used for) operating activities of discontinued operations of 	$(2,984) million.
2020 1Q FORM 10-Q 	57

-- 73 of 93 --

FINANCIAL STATEMENTS 	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 22. BAKER HUGHES SUMMARIZED FINANCIAL INFORMATION
We account for our remaining interest in Baker Hughes (comprising 	377.4 million 	shares and a promissory note receivable) at fair value. At March 31, 2020, the
fair value of our interest in Baker Hughes was 	$4,083 million. Since the date of deconsolidation, we have not sold any shares of Baker Hughes and recognized
an unrealized loss of 	$5,710 million 	($4,631 million 	after-tax) for the three months ended March 31, 2020 based on a share price of 	$10.50. See Notes 2 and 3
for further information.
Summarized financial information of Baker Hughes is as follows.
For the three months ended March 31, 2020 	(In millions)
Revenues 	$ 	5,425
Gross profit 	755
Net income (loss) 	(16,098)
Net income (loss) attributable to the entity 	(10,210)
Baker Hughes is a SEC registrant with separate filing requirements, and its financial information can be obtained from www.sec.gov or www.bakerhughes.com.
NOTE 23. OTHER INCOME
Three months ended March 31
(In millions) 	2020 	2019
Purchases and sales of business interests(a) 	$ 	12,372 	$ 	253
Licensing and royalty income 	42 	40
Associated companies 	39 	39
Net interest and investment income(b) 	(5,632) 	137
Other items 	53 	384
GE 	6,874 	852
Eliminations 	(4) 	(5)
Total 	$ 	6,869 	$ 	847
(a) 	Included a pre-tax gain of 	$12,292 million 	on the sale of BioPharma in 2020. Included a pre-tax gain of 	$224 million 	on the sale of ServiceMax in 2019. See
Note 2 for further information.
(b) 	Included unrealized loss of 	$(5,710) million 	related to our interest in Baker Hughes in 2020. See Note 3 for further information.
58 	2020 1Q FORM 10-Q

-- 74 of 93 --

FORWARD LOOKING STATEMENTS
FORWARD-LOOKING STATEMENTS
Our public communications and SEC filings may contain statements related to future, not past, events. These forward-looking statements often address our
expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe,"
"seek," "see," "will," "would," "estimate," "forecast," "target," "preliminary," or "range." Forward-looking statements by their nature address matters that are, to
different degrees, uncertain, such as statements about the potential impacts of the COVID-19 pandemic on our business operations, financial results and
financial position and on the world economy; our expected financial performance, including cash flows, revenues, organic growth, margins, earnings and
earnings per share; macroeconomic and market conditions and volatility; planned and potential business or asset dispositions; our de-leveraging plans, including
leverage ratios and targets, the timing and nature of actions to reduce indebtedness and our credit ratings and outlooks; GE's and GE Capital's funding and
liquidity; our businesses’ cost structures and plans to reduce costs; restructuring, goodwill impairment or other financial charges; or tax rates.
For us, particular uncertainties that could cause our actual results to be materially different than those expressed in our forward-looking statements include:
• 	the severity, magnitude and duration of the COVID-19 pandemic, including impacts of the pandemic and of businesses’ and governments’ responses to the
pandemic on our operations and personnel, and on commercial activity and demand across our and our customers’ businesses, and on global supply
chains;
• 	our inability to predict the extent to which the COVID-19 pandemic and related impacts will continue to adversely impact our business operations, financial
performance, results of operations, financial position, the prices of our securities and the achievement of our strategic objectives;
• 	changes in macroeconomic and market conditions and market volatility (including developments and volatility arising from the COVID-19 pandemic),
including interest rates, the value of securities and other financial assets (including our equity ownership position in Baker Hughes), oil and other commodity
prices and exchange rates, and the impact of such changes and volatility on our financial position;
• 	our de-leveraging and capital allocation plans, including with respect to actions to reduce our indebtedness, the timing and amount of GE dividends, organic
investments, and other priorities;
• 	further downgrades of our current short- and long-term credit ratings or ratings outlooks, or changes in rating application or methodology, and the related
impact on our liquidity, funding profile, costs and competitive position;
• 	GE’s liquidity and the amount and timing of our GE Industrial cash flows and earnings, which may be impacted by customer, supplier, competitive,
contractual and other dynamics and conditions;
• 	GE Capital's capital and liquidity needs, including in connection with GE Capital’s run-off insurance operations and discontinued operations, the amount and
timing of required capital contributions to the insurance operations and any strategic actions that we may pursue; the impact of conditions in the financial
and credit markets on GE Capital's ability to sell financial assets; the availability and cost of funding; and GE Capital's exposure to particular counterparties
and markets;
• 	our success in executing and completing asset dispositions or other transactions, including our plan to exit our equity ownership position in Baker Hughes,
the timing of closing for such transactions and the expected proceeds and benefits to GE;
• 	global economic trends, competition and geopolitical risks, including changes in the rates of investment or economic growth in key markets we serve, or an
escalation of trade tensions such as those between the U.S. and China;
• 	market developments or customer actions that may affect levels of demand and the financial performance of the major industries and customers we serve,
such as secular, cyclical and competitive pressures in our Power business, pricing and other pressures in the renewable energy market, levels of demand
for air travel and other customer dynamics such as early aircraft retirements, conditions in key geographic markets and other shifts in the competitive
landscape for our products and services;
• 	operational execution by our businesses, including our ability to improve the operations and execution of our Power and Renewable Energy businesses,
and the performance of our Aviation business;
• 	changes in law, regulation or policy that may affect our businesses, such as trade policy and tariffs, regulation related to climate change, and the effects of
U.S. tax reform and other tax law changes;
• 	our decisions about investments in new products, services and platforms, and our ability to launch new products in a cost-effective manner;
• 	our ability to increase margins through implementation of operational changes, restructuring and other cost reduction measures;
• 	the impact of regulation and regulatory, investigative and legal proceedings and legal compliance risks, including the impact of Alstom, SEC and other
investigative and legal proceedings;
• 	the impact of actual or potential failures of our products or third-party products with which our products are integrated, such as the fleet grounding of the
Boeing 737 MAX, and the timing of its return to service and return to delivery, and related reputational effects;
• 	the impact of potential information technology, cybersecurity or data security breaches; and
• 	the other factors that are described in the "Risk Factors" section of this report and of our Annual Report on Form 10-K for the year ended December 31,
2019, as such descriptions may be updated or amended in any future reports we file with the SEC.
These or other uncertainties may cause our actual future results to be materially different than those expressed in our forward-looking statements. We do not
undertake to update our forward-looking statements. This document includes certain forward-looking projected financial information that is based on current
estimates and forecasts. Actual results could differ materially.
2020 1Q FORM 10-Q 	59

-- 75 of 93 --

OTHER ITEMS
EXHIBITS
Exhibit 10(a) 	General Electric Company Annual Executive Incentive Plan, effective January 1, 2020.
Exhibit 10(b) 	Separation Agreement & Release between General Electric Company and Jamie Miller, dated February 17, 2020 (Incorporated by reference
to Exhibit 1.01 to GE's Current Report on Form 8-K, dated February 20, 2020 (Commission file number 001-00035)).
Exhibit 10(c) 	Memorandum of Understanding between General Electric Company and Carolina Dybeck Happe, effective March 1, 2020.
Exhibit 10(d) 	Three-Year Credit Agreement, dated as of April 17, 2020, among General Electric Company, as the Borrower, JPMorgan Chase, N.A., as
Administrative Agent, and the lenders party thereto (Incorporated by reference to Exhibit 10.1 to GE's Current Report on Form 8-K, dated
April 20, 2020 (Commission file number 001-00035)).
Exhibit 11 	Computation of Per Share Earnings.*
Exhibit 31(a) 	Certification Pursuant to Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Amended.
Exhibit 31(b) 	Certification Pursuant to Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Amended.
Exhibit 32 	Certification Pursuant to 18 U.S.C. Section 1350.
Exhibit 101 	The following materials from General Electric Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, formatted in
XBRL (eXtensible Business Reporting Language); (i) Statement of Earnings (Loss) for the three months ended March 31, 2020 and 2019,
(ii) Statement of Financial Position at March 31, 2020 and December 31, 2019, (iii) Statement of Cash Flows for the three months ended
March 31, 2020 and 2019, (iv) Consolidated Statement of Comprehensive Income (Loss) for the three months ended March 31, 2020 and
2019, (v) Statement of Changes in Shareholders' Equity for the three ended March 31, 2020 and 2019, and (vi) Notes to Consolidated
Financial Statements.
Exhibit 104 	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
* 	Data required by Financial Accounting Standards Board Accounting Standards Codification 260, 	Earnings Per Share, is
provided in Note 16 to the Consolidated Financial Statements in this Report.
FORM 10-Q CROSS REFERENCE INDEX
Item Number 	Page(s)
Part I – FINANCIAL INFORMATION
Item 1. 	Financial Statements 	30-58
Item 2. 	Management’s Discussion and Analysis of Financial Condition and Results of Operations 	3-28
Item 3. 	Quantitative and Qualitative Disclosures About Market Risk 	20-21, 50-52
Item 4. 	Controls and Procedures 	28
Part II – OTHER INFORMATION
Item 1. 	Legal Proceedings 	29
Item 1A. 	Risk Factors 	28
Item 2. 	Unregistered Sales of Equity Securities and Use of Proceeds 	Not applicable(a)
Item 3. 	Defaults Upon Senior Securities 	Not applicable
Item 4. 	Mine Safety Disclosures 	Not applicable
Item 5. 	Other Information 	Not applicable
Item 6. 	Exhibits 	60
Signatures 	61
(a) GE did not repurchase any equity securities during the three months ended March 31, 2020, and no repurchase program has been authorized.
60 	2020 1Q FORM 10-Q

-- 76 of 93 --

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
April 29, 2020 	/s/ Thomas S. Timko
Date 	Thomas S. Timko
Vice President, Chief Accounting Officer and Controller
Principal Accounting Officer
2020 1Q FORM 10-Q 	61

-- 77 of 93 --

Exhibit 10(a)
General Electric Company Annual Executive Incentive Plan
(As amended and restated effective January 1, 2020)
I. Purpose
The General Electric Company Annual Executive Incentive Plan (“the “Plan”) is an annual performance-based bonus
plan that incentivizes and rewards eligible executive leaders of the Company for delivering on financial, operating and
strategic goals of their business during a Plan Year.
II. Eligibility
The Company has the sole discretion to determine who is eligible to participate in the Plan. It is expected, however, that
the following principles shall normally apply.
Eligibility shall generally be limited to employees who (i) are assigned to a job band at the Executive Band level or above
in a participating country, (ii) are compensated through the Company’s payroll and (iii) receive written notification of their
eligibility from the Company. To remain eligible, employees must remain so employed for the entire Plan Year and
through the date in the following year that awards are paid under the Plan (the “Active Employment Requirement”).
In its sole discretion, the Company may waive the Active Employment Requirement in any case it deems appropriate, so
long as the eligible employee remained so employed (as an eligible employee) for a minimum of three consecutive
months during the Plan Year. For example, the Active Employment Requirement could be waived for otherwise eligible
employees who:
(1) are on an approved leave of absence during the Plan Year;
(2) are newly hired or newly promoted into the Executive Band or higher positions before October 1st 	of the Plan
Year;
(3) terminate employment during the Plan Year due to death, Disability, Retirement or involuntary termination
without Cause; or
(4) become ineligible to participate in the Plan during the Plan Year as the result of a transfer to a nonparticipating
affiliate or to an ineligible position.
Any awards made in connection with a waiver of the Active Employment Requirement shall be prorated as determined
by the Company in its sole discretion. No proration shall apply for the period of any approved leave of absence.
An otherwise eligible employee who gives notice of his or her intention to resign or who participates in another
Company-sponsored bonus or incentive plan (for the entire Plan Year) is ineligible to receive an award under this Plan.
Receipt of an award (including an award that is deferred) for one Plan Year does not create a right to an award for any
other Plan Year. All awards (including the amounts thereof) are made at the sole discretion of the Company, regardless
of the individual’s, business’s or Company’s performance.
1

-- 78 of 93 --

Exhibit 10(a)
III. Awards
The Company shall determine each eligible employee’s award under the Plan as follows:
Individual Target
Prior to or at the beginning of each Plan Year, each eligible employee’s target award amount (the “Individual Target”) is
determined by the Company in its sole discretion. The Individual Target is based on the eligible employee’s job band
and is equal to a percentage of the eligible employee’s base salary as of December 31st 	of the Plan Year. For example,
the Individual Targets for the 2020 Plan Year are generally as follows:
Executive Band 	Senior Executive Band 	Officer
35% 	70% 	100%
For eligible employees who experience a change in band (among the three bands listed above), the Individual Target
will be adjusted to reflect the number of days during the Plan Year in each band. Any Individual Target may be changed
by the Company from time to time in its sole discretion. Being assigned an Individual Target does not guarantee that a
bonus of any amount will be awarded.
Business Performance Target
At the beginning of each Plan Year, the financial, operating and strategic goals for each business (and Corporate as a
business) are determined by the Management Development and Compensation Committee of the General Electric
Company Board of Directors (the “MDCC”). Based on these performance goals, a threshold, target and maximum level
of performance for each business is established by the MDCC, along with a related payout percentage. The MDCC then
determines the weighting of these goals and payout percentages to set the “Business Performance Target” for each
business.
Business Performance Factor
After the end of the Plan Year, the MDCC will assess each business’s quantitative performance against its Business
Performance Target and qualitative performance in risk management, compliance and other areas. In assessing overall
business performance, the MDCC may (in its discretion) take into account the impact of external market conditions,
corporate transaction activity and other considerations. This assessment is used by the MDCC to determine an overall
percentage by which the Individual Target of each eligible employee within that business shall be adjusted (the
“Business Performance Factor”).
If an eligible employee has transferred employment from one Company business to another during a Plan Year (while
remaining an eligible employee), his or her Business Performance Factor will be adjusted based on when such transfer
occurs. If the transfer of employment occurs during the first quarter of a Plan Year, only the Business Performance
Factor of the eligible employee’s second business shall be used.
2

-- 79 of 93 --

Exhibit 10(a)
Conversely, if the transfer of employment occurs during the last quarter of a Plan Year, only the Business Performance
Factor of the first business shall be used. If the transfer of employment occurs during the second or third quarter of a
Plan Year, the average Business Performance Factor of both businesses shall be used.
Individual Performance Factor
Finally, each eligible employee’s people leader will determine (subject to approval by the MDCC) a further factor by
which to adjust his or her Individual Target based on his or her individual and/or team performance, leadership, risk
management, compliance, integrity and other factors (the “Individual Performance Factor”). These determinations may
not permit the size of the business’s bonus pool (the sum of Individual Targets for its eligible employees, as adjusted for
the Business Performance Factor) to increase.
Other Adjustments
The Company retains complete discretion to further adjust the award amount for any individual for any reason (except
that, for the avoidance of doubt, the MDCC shall retain any discretion that is not delegated as described in Section V).
For example, the Company may modify award levels to address internal and external factors related to individual,
business unit and Company performance and current and future projected business conditions, including factors such as
internal parity, industry trends and market competitiveness, retention, dispute resolution and discipline.
Consistent with the purposes of the Plan, and due to the factors that will be taken into consideration, while the Company
may determine a minimum aggregate payout amount during the Plan Year, individual awards amounts, if any, will vary
from year to year and will not be determined before or during the Plan Year.
IV. Payment of Awards
Awards under the Plan will be reviewed and approved by the Company following the end of the Plan Year. All individual
awards are subject to review by successively higher levels of senior management, and review and approval by the
MDCC.
If not deferred, all approved awards will be paid as soon as practicable after such review, but in any event not later than
March 15 of the year following the Plan Year (or such other date for participating countries outside of the United States
as the Company may determine). Subject to Sections VIII and X, under no circumstances will an individual’s award
under the Plan be considered final unless and until after it is calculated, determined, and paid to the individual, and all
other conditions are satisfied, including any terms and conditions applicable to deferred awards. Awards, net of any
deferred amounts, will be issued via Company payroll (in the employee’s local currency) and are subject to all applicable
payroll deductions and tax withholdings.
V. Administration and Interpretation
The Plan shall be administered by the MDCC, who shall have the full power to construe and interpret the Plan in its sole
discretion, including exercising any and all authority and responsibility given to the Company in this document (including
the Appendix).
3

-- 80 of 93 --

Exhibit 10(a)
Without limiting the foregoing, the MDCC shall have the power to:
(1) 	determine who is eligible to participate in the Plan;
(2) 	determine whether to waive the Active Employment Requirement for any individual;
(3) determine Individual Targets;
(4) establish the performance goals for each business (including Corporate) and its Business Performance
Target;
(5) determine the Business Performance Factor for each business;
(6) adjust each business’s Business Performance Target and/or Business Performance Factor to reflect
extraordinary or unusual events;
(7) otherwise determine the amount of awards consistent with the terms of the Plan; and
(8) establish or amend any rules or administrative procedures necessary or appropriate for Plan administration.
The MDCC may delegate its authority and responsibility under the Plan, except with respect to the determination of (i)
awards for individuals at the level of Senior Vice President and above and/or (ii) the Business Performance Factor.
Accordingly, the Chief Executive Officer (“CEO”) or the Chief Human Resources Officer (“CHRO”), or the delegatee of
either, may exercise the MDCC’s authority and responsibility under the Plan with respect to the determination of awards
for individuals at the level of Vice President and below (excluding the determination of the Business Performance
Factor).
Nothing contained in the Plan shall be interpreted or construed as a promise of employment by the Company for the
Plan Year, or any other time period, or a guarantee of payment of an award.
VI. Severability
The Plan (including any rules or administrative procedures established hereunder) represents the full and complete
understanding between the Company and eligible employees with regard to terms of the Plan and any awards
hereunder. The terms of the Plan (including any rules or administrative procedures) shall control in the event of
inconsistencies with any other Company documents or any statements made by Company employees concerning the
Plan.
If a final determination is made by a court of competent jurisdiction (or duly assigned arbitrator) that any provision
contained in the Plan is unlawful, the Plan shall be considered amended in that instance to apply to such extent as the
court/arbitrator may determine to be enforceable, but only to the extent consistent with the original intent of the drafter.
Alternatively, if such a court/arbitrator finds that any provision contained in this Plan is unlawful -- and that provision
cannot be amended, consistent with the original intent of the drafter, so as to make it lawful -- such finding shall not
affect the effectiveness of any other provision of this Plan.
4

-- 81 of 93 --

Exhibit 10(a)
VII. Non-Assignability and Accounting
The right to any awards (including any deferred awards) or any other rights under the Plan, are not assignable in any
manner whatsoever (except to the extent of beneficiary designations made pursuant to established administrative
procedures). Any account created with respect to a deferred award shall be unfunded, unsecured and shall not
constitute a trust for the benefit of any employee. No employee may create a lien or any other encumbrance on any
present or future interest he or she may have under the Plan.
VIII. Additional Limitations (Clawbacks)
The Plan will be administered in compliance with Section 10D of the Securities Exchange Act of 1934, as amended, any
applicable rules or regulations promulgated by the Securities and Exchange Commission or any national securities
exchange or national securities association on which shares of the Company may be traded, and any Company policy
adopted with respect to compensation recoupment, to the extent the application of such rules, regulations and/or
policies is permissible under applicable local law. This Section VIII will not be the Company’s exclusive remedy with
respect to such matters.
IX. Deferrals
Eligible employees who are employed within the United States may elect to defer awards that may be granted under the
Plan. All deferred awards shall be administered in accordance with established administrative procedures, including
procedures relating to election requirements, the manner in which deferred awards may be invested and the time and
form in which they are distributed. Such procedures are described in the Appendix.
X. Amendment & Termination
The Plan is offered at the sole discretion of the Company, which reserves the right to modify, adjust, change, or
terminate the Plan at any time and for any reason. Any amounts that have been paid under the Plan are subject to
modification, adjustment, change or termination only as described in Section VIII. Any amounts that have been deferred
under the Plan are subject to modification, adjustment, change or termination only as described in Section VIII or as
agreed upon by the employee (or beneficiary), and in each case only as permitted by the Appendix.
XI. Dispute Resolution
Questions or concerns related to the Plan or any Plan awards should be addressed to the employee’s Human
Resources Manager or business Compensation Manager. Any formal employee-initiated dispute relative to the Plan or
awards will be addressed pursuant to the Company’s then current applicable internal grievance or alternative dispute
resolution program, including any final and binding arbitration procedure, consistent with applicable laws and
regulations.
5

-- 82 of 93 --

Exhibit 10(a)
XII. Additional Terms
Plan Effective Date and Plan Year:
The Plan is effective as of January 1, 2018, and will run January 1st through December 31st of 2018 and each year
thereafter (the “Plan Year”) until such time that the Plan is modified, superseded or terminated.
Company:
“Company” shall mean the General Electric Company and any affiliates (companies or business entities in which
General Electric Company has a 50% or more interest) that participate in the Plan, except as provided in the Appendix
or otherwise noted.
Applicable Law:
The place of administration of the Plan shall be deemed within the State of New York. The Plan shall be governed by
and construed in accordance with the laws of the State of New York, without regard to conflicts of law provisions therein,
to the extent permissible under 	applicable local law.
Awards that are not deferred are intended to be exempt from Section 409A of the Internal Revenue Code, and awards
that are deferred are intended to be fully compliant with Section 409A. In each case, the Plan shall be administered and
interpreted in a manner consistent with such intent, including in a manner that avoids the imposition of penalties under
Section 409A.
Cause:
“Cause” means, as determined in the sole discretion of the Company, an eligible employee’s:
(1) breach of the Employee Innovation and Proprietary Information Agreement or any other confidentiality, non-
solicitation, or non-competition agreement with the Company or breach of a material term of any other agreement
between the eligible employee and the Company;
(2) engagement in conduct that results in, or has the potential to cause, material harm financially, reputationally,
or otherwise to the Company;
(3) commission of an act of dishonesty, fraud, embezzlement or theft;
(4) conviction of, or plea of guilty or no contest to a felony or crime involving moral turpitude;
(5) failure to perform satisfactorily the assigned duties of the eligible employee’s position after receiving written
notification of the failure from the eligible employee’s manager; or
6

-- 83 of 93 --

Exhibit 10(a)
(6) failure to comply with the Company’s policies and procedures, including, but not limited to, The Spirit and
Letter or the Fair Employment Practices Policy.
Disability:
For eligible employees employed in the United States, “Disability” shall mean separating from service with the Company
after becoming eligible for disability benefits under the GE Long-Term Disability Plan. For eligible employees employed
outside of the United States, “Disability” shall have the definition provided in such employing country’s disability plan.
Retirement:
For eligible employees employed in the United States, “Retirement” shall mean separating from service with the
Company on or after age 60. For eligible employees employed outside of the United States, “Retirement” shall have the
definition provided in such employing country’s retirement plan.
Overpayment:
To the extent permitted under applicable law, in the event that a Plan participant receives an overpayment or otherwise
owes the Company money which has not been repaid during the course of or at the conclusion of employment with the
Company, the Company reserves the right to adjust any award under the Plan by the amount of the overpayment or to
otherwise recover the overpayment by any lawful means. If such deductions are insufficient, the employee will be
required to reimburse the Company for the balance, unless expressly waived by the Company.
7

-- 84 of 93 --

Exhibit 10(a)
APPENDIX
ADMINISTRATIVE PROCEDURES FOR THE GENERAL ELECTRIC COMPANY ANNUAL EXECUTIVE INCENTIVE
PLAN
(Effective commencing with the 2018 Plan Year)
Section 1. 	HISTORY AND APPLICABILITY OF PRIOR RULES
Prior to 2011, incentive compensation was payable under the GE Incentive Compensation Plan. For 2011 through 2017,
incentive compensation was payable pursuant to independent Company action, which included a prior iteration of the
GE Annual Executive Incentive Plan for 2015 through 2017.
The rules associated with deferrals of allotments payable under the GE Incentive Compensation Plan (including
participant election requirements, the manner in which deferred incentive compensation allotments may be invested and
the time and form in which they are distributed) are reflected in the GE Incentive Compensation Plan document and
various administrative procedures (collectively, the “Prior Rules”). The Prior Rules include, but are not limited to, the
Special Administrative Procedures for the GE Incentive Compensation Plan to Ensure Compliance with Code Section
409A (the “Special Procedures”).
When the Company ceased awarding incentive compensation under the GE Incentive Compensation Plan and began
awarding it pursuant to independent Company action, the Company, through the action of the Senior Vice President,
Human Resources, specifically made the Prior Rules applicable to deferrals of allotments pursuant to independent
Company action.
These procedures are effective with respect to all awards made under the Annual Executive Incentive Plan for the 2018
plan year and later. The Special Procedures (which are partially repeated below in Section 2) are also effective for all
such awards. The Prior Rules continue to be effective for awards made for earlier years.
Section 2. 	DEFERRAL OF AWARDS
2.1. In General
A participant may elect to defer any award for which he or she is eligible. For this purpose, awards under the Plan shall
be considered “New Allotments” under the Special Procedures. For convenience, certain rules in the Special Procedures
applicable to “New Allotments” are repeated in the remainder of this Section 2.
2.2. Elections
Elections to defer awards (including elections under Subsection 2.3 as to the form in which such deferred awards will be
paid) shall be made no later than the end of the year preceding the year for which the award is made, in accordance
with established administrative procedures. All such elections shall be irrevocable.
8

-- 85 of 93 --

Exhibit 10(a)
2.3. Available Forms
A participant may choose to receive a deferred award in a lump sum or in installments of either 10, 15 or 20 years. If no
election as to the form of payment is made in accordance with established administrative procedures, payments shall be
made in 10-year installments.
2.4. Commencement
Payment of deferred awards (including any interest or dividend equivalents allocable thereto) shall commence on April 1
of the year following Separation from Service, or as soon thereafter as is practicable; provided, however, that in the case
of a Specified Employee, no payments shall be made during the first six months following Separation from Service.
2.5. Re-employment
Any re-employment after Separation from Service shall be disregarded in determining whether deferred awards
commence to be paid (or continue to be paid).
2.6. Death
If a participant dies before all payments of a deferred award have been made, payments shall continue to the beneficiary
or beneficiaries at the same time and in the same form as if the participant had lived.
2.7. Compliance with Code Section 409A
The rules in this Section 2 are intended to ensure that the Plan complies with Internal Revenue Code Section 409A and
applicable guidance thereunder, and the Plan shall be administered and interpreted in a manner consistent with such
intent.
Without limiting the foregoing:
(a) The rules in this Section 2 override anything to the contrary either in the Plan, any other administrative
procedures or the communications and election materials provided to participants in the course of administering
the Plan.
(b) Under no circumstances shall a scheduled payment of a deferred award be accelerated, nor shall a
subsequent deferral be permitted with respect to such amounts.
2.8. Definitions
For purposes of this Section 2, the following terms have the designated meanings:
“Company” means General Electric Company.
"Separation from Service" means a participant's termination of employment with the Company and all Affiliates (defined
for this purpose as any company or business entity
9

-- 86 of 93 --

Exhibit 10(a)
in which the Company has a 50% or more interest whether or not a participating employer in the Plan); provided that
Separation from Service for purposes of the Plan shall be interpreted consistent with the requirements of Code Section
409A and regulations and other guidance issued thereunder.
"Specified Employee" means a specified employee as described in the Company’s Procedures for Determining
Specified Employees under Code Section 409A, as amended from time to time.
Section 3. 	ACCOUNTING FOR DEFERRED AWARDS
3.1. In General
At the participant’s election, deferred awards will be accounted for in one or more of the following three media: cash,
Standard and Poor’s 500 Index (“S&P 500”) Units or GE common stock (“Stock”) Units.
3.2. Cash
The portion of any award accounted for in cash shall be credited with interest daily based upon the prior calendar
month’s average yield for U. S. Treasury notes and bonds with maturities of from ten to twenty years.
3.3. S&P 500 Units
The number of S&P 500 Units credited to a participant’s account with respect to any deferral will be determined by
dividing (1) the average closing value of the S&P 500 Index as reported by Standard and Poor’s during the
measurement period by (2) the dollar amount of the deferral to be accounted for in S&P 500 Units. The measurement
period will be the 20 trading days ending on the date the Company approves awards under the Plan for the year (and
including that date if it is a trading date).
Each portion of an account hypothetically invested in S&P 500 Units will be credited quarterly, on GE’s dividend record
date for the quarter, with dividend equivalents (in the form of additional S&P 500 Units) based upon the consecutive
prior calendar quarter's quarterly dividend as reported by Standard and Poor's.
3.4. Stock Units
The number of Stock Units credited to a participant’s account with respect to any deferral will be determined by dividing
(1) the average New York Stock Exchange closing price of GE common stock during the measurement period by (2) the
dollar amount of the deferral to be accounted for in Stock Units. The measurement period will be the 20 trading days
ending on the date the Company approves awards under the Plan for the year (and including that date if it is a trading
date).
Each portion of an account hypothetically invested in Stock Units will be credited quarterly, on GE’s dividend record date
for the quarter, with dividend equivalents (in the form of additional Stock Units) based on the dividend declared on GE
common stock for such quarter.
10

-- 87 of 93 --

Exhibit 10(a)
If there is any change in the GE common stock represented by any deferred award or associated dividend equivalents
previously credited, whether through merger, consolidation, reorganization, recapitalization, share distribution in the
nature of a stock dividend, or other change in corporate structure, appropriate adjustments shall be made, as
determined by the Company in its sole discretion, in the number of shares of GE common stock represented by such
deferred allotments or dividend equivalents.
3.5. Switching
Participants (and beneficiaries) may elect four times each calendar year to switch the media in which their accounts are
hypothetically invested. Switches will be valued based on (1) the date they are properly effectuated in accordance with
administrative procedures, and (2) the applicable New York Stock Exchange closing price of GE common stock and/or
the closing value of the S&P 500 Index as reported by Standard and Poor’s.
A switch must involve at least 25% of a participant’s account balance.
3.6. Payments
All payments of deferred awards (including any interest or dividend equivalents allocable thereto) will be made in cash.
For purposes of making payments, the portion of a participant’s account hypothetically invested in S&P 500 Units will be
valued based on the average closing value of the S&P 500 Index as reported by Standard and Poor’s during the 20
trading days immediately preceding March 15 of the year the payment is to be made (and including that March 15 if it is
a trading date).
Similarly, the portion of a participant’s account hypothetically invested in Stock Units will be valued based on the
average New York Stock Exchange closing price of GE common stock during the 20 trading days immediately preceding
March 15 of the year a payment is to be made (and including that March 15 if it is a trading date).
Section 4. 	GENERAL CONDITIONS
4.1. Creditable Compensation
Awards under the Plan shall be taken into account as creditable pay under the Company benefit plans to the same
extent and in the same manner that they would have been had they been paid under the GE Incentive Compensation
Plan, or pursuant to independent Company action.
4.2. Additional Rules
The Company has the sole discretion to interpret and apply these procedures and may apply other rules and procedures
as it deems necessary or appropriate, including, but not limited to, rules for making deferral elections, valuing and
crediting deferrals, valuing and crediting dividend equivalents, valuing and making switches, defining applicable
measuring periods, determining closing prices and closing index values and determining
11

-- 88 of 93 --

Exhibit 10(a)
what days constitute trading days. Such rules may or may not be communicated to participants, may or may not be
reflected in formal administrative procedures, and may change from year to year. However, no rules or procedures may
be applied that would cause a failure to comply with Code Section 409A.
12

-- 89 of 93 --

Exhibit 10(c)
MEMORANDUM OF UNDERSTANDING
Reference is made to the Employment Agreement (the “Employment Agreement”), dated November 24, 2019, between General Electric
Company (the “Company”) and Carolina Dybeck Happe (“you”). This Memorandum of Understanding is effective as of March 1, 2020, the
date of commencement of your employment with the Company.
Pursuant to this Memorandum of Understanding, you and the Company hereby agree that in applying Section 2(e)(iv) of your Employment
Agreement, for each calendar year of your employment through December 31, 2026, you shall be entitled to receive annual tax equalization
payments on any increase of up to 10 percent per annum in the value of the non-U.S. pension from your previous employer(s) that you held
as of the date of the Employment Agreement, to the extent subject to taxation in the United States in the applicable year. You shall not be
eligible for tax assistance on pension increases in excess of that amount. Any such payments shall be in addition to any tax equalization
payments unrelated to your pension that you may be entitled to receive pursuant to Section 2(e)(iv) of the Employment Agreement.
This Memorandum of Understanding shall be governed by, and constitute a part of, the Employment Agreement in all respects. For the
avoidance of doubt, payments arising under this Memorandum of Understanding shall be paid in a manner consistent with Section 10 of the
Employment Agreement.
GENERAL ELECTRIC COMPANY
/s/ Kevin Cox________________
Kevin Cox
Senior Vice President,
Chief Human Resources Officer
Acknowledged and agreed:
/s/ Carolina Dybeck Happe____
Carolina Dybeck Happe

-- 90 of 93 --

Exhibit 31(a)
Certification Pursuant to
Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Amended
I, H. Lawrence Culp, Jr., certify that:
1. 	I have reviewed this quarterly report on Form 10-Q of General Electric Company;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for the registrant and have:
a) 	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;
b) 	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles;
c) 	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) 	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant’s internal control over financial reporting; and
5. 	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) 	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) 	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control
over financial reporting.
Date: 	April 29, 2020
/s/ H. Lawrence Culp, Jr.
H. Lawrence Culp, Jr.
Chairman and Chief Executive Officer

-- 91 of 93 --

Exhibit 31(b)
Certification Pursuant to
Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Amended
I, Carolina Dybeck Happe, certify that:
1. 	I have reviewed this quarterly report on Form 10-Q of General Electric Company;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for the registrant and have:
a) 	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;
b) 	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles;
c) 	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) 	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant’s internal control over financial reporting; and
5. 	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) 	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) 	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control
over financial reporting.
Date: 	April 29, 2020
/s/ Carolina Dybeck Happe
Carolina Dybeck Happe
Chief Financial Officer

-- 92 of 93 --

Exhibit 32
Certification Pursuant to
18 U.S.C. Section 1350
In connection with the Quarterly Report of General Electric Company (the “registrant”) on Form 10-Q for the period ended 	March 31, 2020, as filed with the
Securities and Exchange Commission on the date hereof (the “report”), we, H. Lawrence Culp, Jr. and Carolina Dybeck Happe, Chief Executive Officer and
Chief Financial Officer, respectively, of the registrant, certify, pursuant to 18 U.S.C. § 1350, that to our knowledge:
(1) 	The report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) 	The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the registrant.
April 29, 2020
/s/ H. Lawrence Culp, Jr.
H. Lawrence Culp, Jr.
Chairman and Chief Executive Officer
/s/ Carolina Dybeck Happe
Carolina Dybeck Happe
Chief Financial Officer

-- 93 of 93 --